-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
MJjtj9MWm4CB3ofFomN+gB5ejmUek9mBJdu4FShLTm5K06MqcQRW6p9Rq+BkOSLw
CdDgkCskyh+PY7h3jaBhpg==
0000912057-02-021634.txt : 20020522
0000912057-02-021634.hdr.sgml : 20020522
20020522172456
ACCESSION NUMBER: 0000912057-02-021634
CONFORMED SUBMISSION TYPE: S-3/A
PUBLIC DOCUMENT COUNT: 5
FILED AS OF DATE: 20020522
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMERICAN MEDICAL SECURITY GROUP INC
CENTRAL INDEX KEY: 0000878897
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 391431799
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: S-3/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-86660
FILM NUMBER: 02660246
BUSINESS ADDRESS:
STREET 1: 3100 AMS BLVD
CITY: GREEN BAY
STATE: WI
ZIP: 54313
BUSINESS PHONE: 9206611111
MAIL ADDRESS:
STREET 1: 3100 AMS BLVD
CITY: GREEN BAY
STATE: WI
ZIP: 54313
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED WISCONSIN SERVICES INC /WI
DATE OF NAME CHANGE: 19930328
S-3/A
1
a2079009zs-3a.htm
S-3/A
QuickLinks
-- Click here to rapidly navigate through this document
As filed with the Securities and Exchange Commission on May 22, 2002
Registration No. 333-86660
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Amendment No. 2
to
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMERICAN MEDICAL SECURITY GROUP, INC.
(Exact name of registrant as specified in its charter)
Wisconsin
(State or other jurisdiction of
incorporation or organization) |
39-1431799
(IRS Employer
Identification No.) |
3100 AMS Boulevard
Green Bay, Wisconsin 54313
(920) 661-1111
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
Timothy J. Moore
Senior Vice President of Corporate Affairs,
General Counsel and Secretary
American Medical Security Group, Inc.
3100 AMS Boulevard
Green Bay, Wisconsin 54313
(920) 661-1111
(Name, address, including zip code, and telephone
number, including area code, of agent for service)
Copies
to:
Jeffrey B. Bartell
Bruce C. Davidson
Quarles & Brady LLP
411 East Wisconsin Avenue
Milwaukee, Wisconsin 53202
(414) 277-5000 |
|
John M. Olson
Foley & Lardner
777 East Wisconsin Avenue
Milwaukee, Wisconsin 53202
(414) 271-2400 |
|
Cynthia A. Rotell
Latham & Watkins
633 West Fifth Street, Suite 4000
Los Angeles, California 90071
(213) 485-1234 |
Approximate date of commencement of proposed sale to the public:
As soon as practicable after this registration statement becomes effective.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following
box. o
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered
only in connection with dividend or interest reinvestment plans, check the following box. o
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering. o
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. o
If
delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. o
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further
amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration
statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
Subject to Completion, Dated May 22, 2002
The information contained in this prospectus is not complete and may be changed. These securities may not be
sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy
these securities in any state where the offer or sale is not permitted.
3,500,000 Shares
Common Stock
$ . per share
Our largest shareholder, Blue Cross & Blue Shield United of Wisconsin, is the sole selling shareholder in this offering and is offering
3,500,000 shares of our common stock. Our common stock is listed on the New York Stock Exchange under the symbol "AMZ." On May 21, 2002, the last reported sale price of our common stock on the
New York Stock Exchange was $18.98 per share.
Investing in our common stock involves risks. See "Risk Factors" beginning on page 9.
|
|
Per Share
|
|
Total
|
Price to the public |
|
$ |
|
|
$ |
|
Underwriting discount |
|
|
|
|
|
|
Proceeds to the selling shareholder |
|
|
|
|
|
|
The
selling shareholder has granted an over-allotment option to the underwriters. Under this option, the underwriters may elect to purchase a maximum of 525,000 additional shares from the
selling shareholder within 30 days following the date of this prospectus to cover over-allotments.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if
this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
CIBC World Markets
Robert W. Baird & Co.
Stifel, Nicolaus & Company
Incorporated
The date of this prospectus is , 2002.
Table of Contents
|
|
Page
|
Prospectus Summary |
|
3 |
Risk Factors |
|
9 |
Forward-Looking Statements |
|
16 |
Common Stock Market Data |
|
17 |
Use of Proceeds |
|
18 |
Dividend Policy |
|
18 |
Capitalization |
|
18 |
Selected Consolidated Financial Data |
|
19 |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
21 |
Business |
|
31 |
Management |
|
43 |
Principal and Selling Shareholders |
|
46 |
Certain Transactions |
|
49 |
Description of Capital Stock |
|
52 |
Shares Eligible for Future Sale |
|
58 |
Underwriting |
|
59 |
Legal Matters |
|
61 |
Experts |
|
61 |
Where You Can Find More Information |
|
61 |
Index to Financial Statements |
|
F-1 |
Prospectus Summary
This summary highlights information contained in other parts of this prospectus. Because it is a summary, it does not contain all of the
information that you should consider before investing in the shares. You should read the entire prospectus carefully.
American Medical Security Group, Inc.
We
develop and offer health and related insurance products designed to provide individuals and small employer groups with maximum choice at a reasonable cost. In order to increase choice for our
insureds, we utilize a preferred provider organization, or PPO model. PPOs provide a wider choice of health professionals and more access to specialists than health maintenance organizations, or HMOs.
To reduce the cost of insurance to our customers, we offer multiple health plan configurations incorporating various co-payment agreements and deductible rates, allowing customers to
choose the benefit plan that fits their individual needs. We also employ a variety of medical cost management programs designed to help manage and control the overall cost of our products including
care management, utilization review and subrogation review. Our proactive care management model is designed to improve the overall quality of care, while also managing the cost of certain complex
chronic and acute medical conditions.
We
believe that increased choice and affordability, through our product design and our cost management programs, make our products attractive to individuals and small group employers willing to accept
increased financial and decision making responsibility for their health care. In addition to our health benefit plans, we also offer dental, life, prescription drug, disability and accidental death
insurance, and provide self-funded benefit administration. We sell our products through a network of licensed independent agents in 32 states and the District of Columbia. We are a
Wisconsin corporation organized in 1983.
Industry
In
recent years a number of factors have caused significant changes within the health insurance industry. These factors have included dramatically increasing medical costs and insurance premiums,
significant efforts by providers to shift the cost of health care to patients, increased regulation and growing demand for consumer choice. As a result it has become increasingly difficult for
insurance companies to operate, resulting in significant industry consolidation and an overall decline in the number of companies in the U.S. marketing health insurance. This impact has been
especially true in the small employer group and individual markets where many small group carriers became unprofitable and were forced out of the market. Many carriers, including ourselves,
implemented successive years of significant rate increases to account for the higher costs associated with health insurance. We believe we have been successful in doing this and as a result our small
employer group business has returned to profitability and we believe it will contribute to future earnings growth.
While
the number of insurers serving the small employer group and individual markets has declined, these markets have been experiencing significant growth. This growing marketplace is seeking health
insurance products that provide flexible plan designs and various price options allowing insureds to choose a benefit package that fits their budget.
Our Approach
As
the individual and small employer group health insurance markets evolve, we believe that we are positioned to grow our business and profitability by focusing on the following competitive strengths:
Focus on PPO products. As consumers demand more choice in health care, PPOs are becoming
3
more popular. PPOs typically provide a wider choice of health professionals and more access to specialty health care than HMOs.
Balanced business model focused on customer choice. We offer a variety of products with a broad range of risk-sharing options
to a geographically diverse market. For example, our small group products allow an employer with four employees to offer four different and distinct health plans.
Excellent customer service. We provide a number of value-added features to our customers including Nurse Healthline, Inc., our
toll-free 24-hour health information line, case management services and toll-free, personal customer service 24 hours-a-day, seven
days a week. In addition, over 95% of our customers' claims are processed within 30 days, and we maintain an approximate 99% financial claim accuracy record.
Outstanding agent relationships. We currently market products through approximately 25,000 independent agents, a 25% increase in the number
of agents from the prior year. We have focused our marketing efforts on agents with whom we have strong existing relationships. As a result, we are continuing to build long-term, mutually
beneficial agent relationships that enhance our overall distribution network.
Process orientation and underwriting discipline. We have developed proprietary and tested medical cost management practices and
underwriting capabilities. Our custom-built, fully integrated management information system provides efficiency and service advantages while maintaining relatively low administrative expenses.
Infrastructure. Our existing information technology infrastructure, geographic location and economies of scale provide us with an
administrative cost advantage. We have developed a custom-built, integrated management information system that includes underwriting, billing, enrollment, claims processing, utilization management,
sales reporting, network analysis and service and status reporting. We believe our existing infrastructure has enough capacity to double our current volume of business.
Centralized, Midwestern location. Our operations are centralized at our Green Bay, Wisconsin corporate campus. We benefit from a stable,
educated workforce and good labor relations.
Our Business Strategy
Our
objective is to become the leading provider of health insurance products to individuals and small employer groups. The key elements of our strategy to achieve our objective are as follows:
-
- Increase
penetration in existing markets
-
- Focus
on products designed for consumer choice
-
- Diversify
our revenue mix
-
- Leverage
our existing operating efficiencies and flexible infrastructure
Products
We
provide tailored products to meet the varied health insurance needs of individuals and small employer groups. Common features of our products include:
-
- Choice
of co-pay, deductible and coinsurance levels
-
- Choice
of PPO networks
-
- Availability
of comprehensive prescription drug coverage
-
- Wellness
and routine care coverage
-
- Nurse
Healthline, Inc., our health information line
Small Employer Group. Small employer group medical insurance products are targeted to employer groups with 2-50 employees. Our
average group size is approximately six employees. Distributed through a network of 20,000 independent agents, small employer group products are customized to allow employers to offer their employees
multiple health plan options in a single package.
4
MedOneSM. We market our MedOneSM medical insurance products to individuals and their families. These products
are designed to meet the various health insurance needs and budgets of consumers. Sold through independent agents, MedOneSM insurance products are designed for cost-conscious
consumers and feature attractive premium rates, protection from catastrophic medical costs and increased patient responsibility for routine health expenses.
Dental. GroupDentalChoiceSM offers our members a choice in benefit plans, with access to any dental provider, and coverage
for a complete range of dental services, from preventative maintenance to major dental expenses. Our dental coverage product, can be purchased through employer sponsored plans or on a voluntary basis
with no employer contribution requirements.
Other. We also offer self-funded benefit administration services for employers that want to assume a portion of the financial
risk for their own health plans. In conjunction with our benefit administration services, we offer excess of loss reinsurance to cover catastrophic losses of the self-funded plan.
Additionally, we offer COBRA administration services to groups subject to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.
We
augment our core business with a select line of products and services. Ancillary benefits available with our plans include term-life, short-term medical, short-term disability, accidental death and
dependent life insurance.
We
provide our members and plan participants with toll-free, personal customer service 24 hours-a-day, seven days a week. In addition, through our wholly
owned subsidiary, Nurse Healthline, Inc., our members and plan participants have access to a toll-free 24-hour health information line staffed by registered nurses.
Spin-off and Other Recent Transactions
In
September 1998, when our name was United Wisconsin Services, Inc., we spun off our managed care companies and specialty products business to our shareholders. We did this by
transferring all of our subsidiaries comprising the managed care and specialty products business to a newly created subsidiary named Newco/UWS, Inc., a Wisconsin corporation, and distributing
100% of the issued and outstanding shares of common stock of Newco/UWS to our shareholders. In connection with the spin-off, we adopted our current name of American Medical Security
Group, Inc., and Newco/UWS changed its name to United Wisconsin Services, Inc., which has since changed its name to Cobalt Corporation.
As
of December 31, 2001, Blue Cross & Blue Shield United of Wisconsin, the selling shareholder in this offering, which is a wholly owned subsidiary of Cobalt, owned approximately 45% of
our outstanding common stock. In early 2002, Cobalt and the selling shareholder amended their Schedule 13D filed with the Securities and Exchange Commission indicating, among other things, a
desire to reduce the selling shareholder's investment in our stock and to nominate four persons for election to our Board of Directors at the 2002 annual meeting of shareholders.
On
March 19, 2002, we entered into a stock purchase agreement with Cobalt and the selling shareholder in which we agreed to repurchase 1,400,000 shares of our common stock from the selling
shareholder at a price of $13.00 per share in cash, or an aggregate of $18,200,000. We completed the share repurchase on March 22, 2002, reducing the selling shareholder's ownership to 39% of
our outstanding common stock, and the selling shareholder withdrew its previously delivered notice of its intention to nominate a slate of directors for election at our 2002 annual meeting of
shareholders.
On
March 19, 2002, in accordance with the terms of the stock purchase agreement, our Board of Directors increased the size of the Board to 14 directors and appointed two new directors nominated
by Cobalt, Thomas R. Hefty and Kenneth L. Evason, effective upon the closing of the share repurchase on March 22, 2002. Pursuant to the stock purchase agreement, Cobalt is entitled to
designate two director nominees to our Board for so long as the selling shareholder holds at least 20% of the issued and
5
outstanding shares of our common stock and will be entitled to designate only one nominee to the Board for so long as the selling shareholder holds at least 10% but less than 20% of the issued and
outstanding shares of our common stock. Mr. Hefty, or his successor on our Board, will resign effective immediately upon the date that the selling shareholder owns less than 20% of the then
issued and outstanding shares of common stock and Mr. Evason, or his successor on our Board, will resign effective immediately upon the date that the selling shareholder owns less than 10% of
the then issued and outstanding shares of our common stock. For so long as Cobalt has any nominees on our Board, the selling shareholder has agreed to vote its shares for the slate of directors
nominated by our Board of Directors. Pursuant to the stock purchase agreement, Cobalt and the selling shareholder have also
agreed to certain "standstill" provisions. For a more complete description of the stock purchase agreement and related matters, see "Certain TransactionsStock Purchase Agreement"
elsewhere in this prospectus.
Because
the record date for our 2002 annual meeting of shareholders is April 15, 2002, purchasers of our common stock in this offering will not be entitled to vote shares purchased in this
offering at this year's annual meeting.
Corporate Information
Our
principal executive offices are located at 3100 AMS Boulevard, Green Bay, Wisconsin 54313. Our telephone number is (920) 661-1111.
6
The Selling Shareholder
Blue Cross & Blue Shield United of Wisconsin, an insurance company and a Wisconsin corporation, is selling all of the shares offered by this prospectus. We agreed to register the shares of the
selling shareholder to be sold in this offering pursuant to a registration rights agreement dated September 1, 1998 and as part of a transaction effected on March 22, 2002 in which we
repurchased 1,400,000 shares of our common stock from the selling shareholder. See "Certain Transactions" included elsewhere in this prospectus. The selling shareholder beneficially owned 4,909,525
shares, or 39%, of our common stock outstanding as of March 31 and April 30, 2002. Following this offering, the selling shareholder will beneficially own 1,409,525 shares, or
approximately 11%, of our common stock, assuming no exercise of the over-allotment option.
The Offering
Common stock offered by the selling shareholder |
|
3,500,000 shares |
Common stock to be outstanding after the
offering |
|
12,590,166 shares |
Use of proceeds |
|
We will not receive any of the proceeds from this offering. |
New York Stock Exchange symbol |
|
AMZ |
Risk factors |
|
See the section entitled "Risk Factors" beginning on page 9 for a discussion of factors you should consider carefully before deciding to buy our common stock. |
-
- Unless
otherwise stated, all information contained in this prospectus assumes no exercise of the over-allotment option granted to the
underwriters.
-
- The
number of shares of common stock outstanding after this offering is based on the number of shares outstanding as of April 30, 2002 and excludes:
-
- 3,454,040
shares of common stock issuable upon exercise of options outstanding as of April 30, 2002 at a weighted average exercise price of $9.38 per
share; and
-
- 241,297
shares of common stock available for future grant under our stock option plans.
7
Summary Consolidated Financial Data
(In thousands, except share data)
|
|
Three Months
Ended March 31,
|
|
Year Ended December 31,
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
1998(1)
|
|
1997(1)
|
Statement of Operations Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium revenue |
|
$ |
194,401 |
|
$ |
222,470 |
|
$ |
838,672 |
|
$ |
951,071 |
|
$ |
1,056,107 |
|
$ |
914,017 |
|
$ |
957,204 |
|
Net investment income |
|
|
3,924 |
|
|
4,514 |
|
|
17,443 |
|
|
19,007 |
|
|
19,766 |
|
|
20,550 |
|
|
22,217 |
|
Net realized investment gains (losses) |
|
|
14 |
|
|
(27 |
) |
|
(779 |
) |
|
(325 |
) |
|
(854 |
) |
|
3,670 |
|
|
1,854 |
|
Other revenue |
|
|
5,405 |
|
|
5,301 |
|
|
21,285 |
|
|
20,112 |
|
|
22,361 |
|
|
22,632 |
|
|
24,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
203,744 |
|
|
232,258 |
|
|
876,621 |
|
|
989,865 |
|
|
1,097,380 |
|
|
960,869 |
|
|
1,005,524 |
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
131,800 |
|
|
166,580 |
|
|
601,942 |
|
|
724,613 |
|
|
860,473 |
|
|
691,767 |
|
|
733,491 |
|
Selling, general and administrative |
|
|
62,024 |
|
|
71,411 |
|
|
257,742 |
|
|
251,767 |
|
|
268,059 |
|
|
242,073 |
|
|
252,160 |
|
Interest |
|
|
494 |
|
|
876 |
|
|
2,877 |
|
|
3,584 |
|
|
3,564 |
|
|
7,691 |
|
|
9,311 |
|
Amortization of goodwill and other intangibles(2) |
|
|
183 |
|
|
907 |
|
|
3,628 |
|
|
3,785 |
|
|
4,273 |
|
|
8,781 |
|
|
7,975 |
|
Write-off of intangible assets and related charges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
194,501 |
|
|
239,774 |
|
|
866,189 |
|
|
983,749 |
|
|
1,136,369 |
|
|
965,765 |
|
|
1,002,937 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, before income taxes |
|
|
9,243 |
|
|
(7,516 |
) |
|
10,432 |
|
|
6,116 |
|
|
(38,989 |
) |
|
(4,896 |
) |
|
2,587 |
Income tax expense (benefit) |
|
|
3,813 |
|
|
(2,376 |
) |
|
6,257 |
|
|
3,447 |
|
|
(13,043 |
) |
|
(1,868 |
) |
|
1,032 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
5,430 |
|
|
(5,140 |
) |
|
4,175 |
|
|
2,669 |
|
|
(25,946 |
) |
|
(3,028 |
) |
|
1,555 |
Income from discontinued operations, less applicable income
taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,003 |
|
|
16,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
$ |
6,975 |
|
$ |
18,150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common sharebasic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
(0.18 |
) |
$ |
0.10 |
|
Discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.60 |
|
|
1.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common sharebasic |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
0.42 |
|
$ |
1.11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common sharediluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
(0.18 |
) |
$ |
0.10 |
|
Discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.60 |
|
|
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common sharediluted |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
0.42 |
|
$ |
1.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
13,803 |
|
|
14,211 |
|
|
14,049 |
|
|
14,899 |
|
|
16,470 |
|
|
16,559 |
|
|
16,423 |
Cash dividends per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
0.36 |
|
$ |
0.48 |
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
|
|
|
|
|
|
|
|
|
|
2002
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and investments |
|
$ |
272,790 |
Total assets |
|
|
448,346 |
Notes payable |
|
|
34,758 |
Total shareholders' equity |
|
|
213,575 |
- (1)
- Our
discontinued operations include the operations of Newco/UWS., Inc., which is now known as Cobalt Corporation, through September 25, 1998, the date on which we spun
off Newco/UWS to our shareholders. Our continuing operations prior to September 11, 1998 include interest on debt assumed by Newco/UWS on September 11, 1998, the spin-off
effective date.
- (2)
- Beginning
January 1, 2002 we adopted Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, which changed
the way we account for goodwill. See Note 2 to the Consolidated Financial Statements for details regarding the impact of this change in accounting.
8
Risk Factors
You should carefully consider the following risk factors and other information in this prospectus before deciding to invest in the
shares.
Risks Relating to Our Business
If we are unable to accurately estimate medical claims and control health care costs, our results of operations may be materially adversely affected.
We
estimate the costs of our future medical claims and other expenses using actuarial methods based upon historical data, cost trends, product mix, seasonality, utilization of health care services and
other relevant factors. We establish premiums based on these methods. The premiums we charge our customers generally are fixed for one-year periods, and therefore, costs we incur in excess
of our medical claim projections generally are not recovered in the contract year through higher premiums. Certain factors may and often do cause actual health care costs to vary from what we
estimated and reflected in premiums. These factors may include:
-
- an
increase in the rates charged by providers of health care services and supplies, including pharmaceuticals;
-
- higher
than expected use of health care services by our members;
-
- the
occurrence of bioterrorism, catastrophes or epidemics;
-
- changes
in the demographics of our members and medical trends affecting them; and
-
- new
mandated benefits or other regulatory changes that increase our costs.
The
occurrence of any of these factors, which are beyond our control, could result in a material adverse effect on our business, financial condition and results of operations.
We conduct business in a heavily regulated industry, and changes in government regulation could increase our costs of compliance or cause us to discontinue marketing our
products in certain states.
Our
business is extensively regulated by federal and state authorities. Some of the new federal and state regulations promulgated under the Health Insurance Portability and Accountability Act of 1996,
or HIPAA, relating to health care reform are unsettled. These regulations may require us to implement additional changes in our current programs and systems in order to maintain compliance, which will
increase our expenses.
Federal
and state legislatures are considering health care reform measures including a "Patients' Bill of Rights", which may result in higher medical costs. Additional proposed reform measures could
materially affect our ability to apply medical underwriting standards to our MedOneSM applicants upon issuance or renewal of coverage. In addition, the implementation of "prompt pay"
laws, whereby a claim must be paid in a certain number of days regardless of whether it is a valid claim or not, subject to a right of recovery, may have a negative effect on our results of
operations.
We
are also subject to changes in state laws that may restrict the manner in which we provide telephonic health information through Nurse Healthline, Inc., which may require us to discontinue
the service in a particular state. States periodically review laws and regulations regarding the selection and pricing of risks, and new regulations regarding these issues could increase our costs and
decrease our
premiums. We have in the past, and may in the future, decide to discontinue marketing our products in states which have enacted, or are considering, various health care reform regulations.
9
Our failure to comply with new or existing government regulation could subject us to significant fines and penalties.
Our
efforts to measure, monitor and adjust our business practices to comply with the law are ongoing. Failure to comply with enacted regulations, including prompt pay laws and the other laws mentioned
above, could require us to pay refunds or result in significant fines, penalties, or the loss of one or more of our licenses. We have been subject to regulatory penalties, assessments and restitution
orders in a number of states in which we operate. We are currently subject to a regulatory proceeding in Florida and may from time to time be subject to inquiries in other states related to our rating
activities and other practices. The result of these regulatory actions is unknown and may have a material adverse effect on us. Furthermore, federal and state laws and regulations continue to evolve.
The costs of compliance may cause us to change our operations significantly, or adversely impact the health care provider networks with which we do business, which may adversely affect our business
and results of operations.
Our current rating practice in certain states may be subject to regulatory review and change which could have a material adverse effect on our operating results.
We currently recalculate the premiums charged to MedOneSM insureds at the annual renewal of the plan. We consider factors including age, geographic location, benefit design, provider
network, family status, smoking status and health status. The use of health status to compute renewal premiums is sometimes called tier rating. This rating practice allows us to calculate premium
rates based on the expectation of future health care costs. The Florida Department of Insurance is currently challenging our rating practice in a regulatory proceeding. An administrative law judge
found in our favor in the Florida regulatory proceeding and has recommended to the Florida Department of Insurance that all claims against us be dropped. The administrative law judge's recommended
order has been sent to the Commissioner of the Florida Department of Insurance for entry of a final order. We and the Department have filed arguments with the Commissioner, who must now decide whether
to adopt the recommended order as presented or modify it. In a similar, but procedurally unrelated action, a Florida circuit court judge made substantially opposite rulings on similar facts and
issues. See the immediately succeeding risk factor and "BusinessLegal ProceedingsFlorida Regulatory and Class Action Litigation."
From time to time, other states may review and question this practice as well. The outcome of these regulatory inquiries and proceedings is uncertain. We may change our rating practices in certain of
these states. If we do, this change may have an impact on our ability to competitively price our products and also may require us to increase the rates charged to our healthier members, potentially
causing those members to seek coverage from our competitors. In addition, it is possible that such regulatory inquiries and proceedings could result in substantial fines or penalties, including the
loss or suspension of our license to sell insurance in one or more states.
We are subject to class actions and other forms of litigation in the ordinary course of our business, including litigation based on new or evolving legal theories, which could
result in significant liabilities and costs.
The
nature of our business subjects us to a variety of legal actions and claims relating but not limited to the following:
-
- denial
of health care benefits;
-
- disputes
over rate increases and practices or termination of coverage;
-
- disputes
with agents over compensation or other matters;
-
- disputes
related to claim administration errors and failure to disclose network rate discounts and other fee and rebate arrangements;
-
- disputes
over our co-payment calculations; and
-
- customer
audits of our compliance with our plan obligations.
10
In
addition, we are defendants in a class action lawsuit in Florida alleging, among other things, that we did not follow applicable regulations in connection with the termination of insurance
coverage. Plaintiffs claim we wrongfully terminated coverage, improperly notified insureds of conversion rights and charged improper premiums for new coverage. Plaintiffs also assert our renewal
rating methodology violates Florida law. On April 24, 2002, the circuit court judge in this action found against us on the above issues and has ordered that the question of damages be tried
before a jury. In a similar, but procedurally unrelated action, an administrative law judge made substantially opposite rulings on similar facts and issues. See the immediately preceding risk factor.
For additional information, see "BusinessLegal ProceedingsFlorida Regulatory Action and Class Action Litigation." We cannot predict with certainty the outcome of this or
other lawsuits or the potential costs involved. Regardless of the outcome, these lawsuits can result in negative publicity and force our management to devote significant time and attention to these
matters as well as subjecting us to significant liability exposure and legal expenses.
Competition in our industry may limit our ability to attract new members or to maintain our existing membership in force.
We
operate in a highly competitive environment. We compete primarily on the basis of price, benefit plan design, strength of provider networks, quality of customer service, reputation and quality of
agent relations. We compete for members with other health insurance providers and managed care companies, many of whom have larger membership in regional markets and greater financial resources than
we do. We can not assure you that we will be able to compete effectively in this industry. As a result, we may be unable to attract new members or maintain our existing membership and our revenues may
be adversely affected.
Our future operating performance is largely dependent on our ability to execute our growth strategy.
We
have experienced a decline in membership over the last several years as part of our strategy to improve profitability and exit certain markets. Our challenge will be to increase the number of
individuals and small employer groups purchasing our products and services while encouraging our
current preferred membership to retain their business relationship with us. If we do not successfully implement our growth goals, it will have an adverse effect on our future operating performance.
A failure of our information system could adversely affect our business.
Information
processing is critical to our business. We depend on our information system for timely and accurate information. Our failure to maintain an effective and efficient information system or
disruptions in our information system could cause disruptions in our business operations, including any of the following:
-
- failure
to comply with prompt pay laws;
-
- loss
of existing members;
-
- difficulty
in attracting new members;
-
- disputes
with members, providers and agents;
-
- regulatory
problems;
-
- increases
in administrative expenses; and
-
- other
adverse consequences.
We depend on the services of non-exclusive independent agents and brokers to market our products to potential customers. We cannot assure you that they will
continue to market our products in the future or that they will not refer our members to our competitors.
We
market our products solely through non-exclusive, independent agents and brokers. In addition, they frequently market the health care products of our competitors as well as our products. Most of
the contracts are terminable
11
without cause upon 30-days notice by either party. We face intense competition for the services and allegiance of independent agents and brokers, and we cannot assure you that agents and
brokers will continue to market our products and services.
If our insurers or reinsurers do not perform their obligations or offer affordable coverage with reasonable deductibles or limits, we could experience significant losses.
Our
risk management program includes several insurance policies we have purchased to cover various property, business and other risks of loss. In addition, we carry several policies to cover our
directors and officers and managed care errors and omissions. Many of the carriers marketing these lines of coverage are experiencing unfavorable claims experience and loss of their own reinsurance
coverage. Several carriers have exited markets and no longer offer certain lines of coverage. Accordingly, there is no assurance that we will continue to be able to purchase insurance coverages for
our own risk management at affordable premiums or with reasonable deductibles and policy limits.
We
have entered into and will continue to enter into a variety of reinsurance arrangements under which we cede business to other insurance companies to mitigate large claims risk. Although reinsurance
allows for greater diversification of risk relating to potential losses arising from large claims, we remain liable if these other insurance companies fail to perform their obligations.
As
a result, any failure of an insurance company to perform its obligations under an agreement could expose us to significant losses.
Any loss of key personnel and the inability to attract and retain qualified employees could have a material adverse impact on our operations.
We
are dependent on the continued services of our management team, including our key executives. Any loss of such personnel without adequate replacement could have a material adverse effect on us.
Members of our senior management have developed relationships with some of our independent agents and brokers. If we are unable to retain these employees, the loss of their services could adversely
impact our ability to maintain relations with certain independent agents and brokers who market our products. Additionally, we need qualified managers and skilled employees with insurance industry
experience to operate our businesses successfully. From time to time there may be shortages of skilled labor which may make it more difficult and expensive for us to attract and retain qualified
employees. If we are unable to attract and retain qualified individuals or our costs to do so increase significantly, our operations could be materially adversely affected.
Our inability to enter into or maintain satisfactory relationships with provider networks could harm our profitability.
Our
profitability could be adversely impacted by our inability to contract on favorable terms with hospitals, physicians, dentists, pharmacies and other health care providers. The failure to secure
cost-effective health care provider contracts may result in a loss of membership or higher medical costs. In addition, the inability to contract with providers, the inability to terminate
contracts with existing providers and enter into arrangements with new providers to serve the same market or the inability of providers to provide adequate care, could adversely affect our results of
operations.
If our insurance subsidiaries are not able to maintain their current rating by A.M. Best, our results of operations could be materially adversely affected.
We
are assigned a rating by A.M. Best Company, a nationally recognized rating agency, which reflects its opinions of our insurance subsidiaries' financial strength, operating results and
ability to meet their ongoing obligations. Decreases in our operating performance and other financial measures may result in a downward adjustment in our insurance subsidiaries' rating. In addition,
other factors beyond our control such as general downward economic cycles and changes implemented by
12
the rating agencies, including changes in the criteria for the underwriting or the capital adequacy model, may result in a decrease in our rating. A downward adjustment in our insurance subsidiaries'
rating by A.M. Best could cause our agents or potential customers to look at us with less favor, which could have a material adverse effect on our results of operations.
Regulations governing our insurance subsidiaries could affect our ability to satisfy our obligations to our creditors as they become due, including under our credit facility.
Our
insurance subsidiaries are subject to regulations that limit their ability to transfer funds to us. If we are unable to obtain funds from our insurance subsidiaries, we will experience reduced
cash flow, which could affect our ability to pay our obligations to creditors as they become due. Over the next three years we will be required to make substantial payments to permanently reduce the
principal amount of outstanding balances under our credit facility. If our insurance subsidiaries are unable to provide these funds to us, we could default on the obligations under the credit
facility. In addition, the credit facility restricts our ability to incur additional debt and therefore we may be unable to obtain additional funding to make these payments.
A recently enacted accounting pronouncement could require a write-off of all or part of our goodwill which would adversely affect our earnings and net worth.
In
June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible
Assets. This statement requires that goodwill and intangible assets that have indefinite useful lives be tested at least annually for impairment and not be amortized. The
effective date of the statement is January 1, 2002 and it may require us to write off all or part of our goodwill during 2002. Goodwill obtained in connection with the original acquisition of
certain of our subsidiaries from their founders in 1996 is a substantial portion of our assets. At December 31, 2001, goodwill and other intangible assets represented $103.9 million of
our total assets of $473.0 million.
Also,
at December 31, 2001, our book value per share was $16.30 and was significantly higher than the $12.45 quoted market price per share. If we determine that the quoted market price per
share is the appropriate measure of our fair value, the resulting impairment would be greater than 50% of the amount of goodwill and other intangibles on our December 31, 2001 balance sheet. If
we determine that
an impairment exists as of January 1, 2002, we would report the charge as the cumulative effect of a change in accounting principles in our consolidated financial statements. Although a
write-off of all or a portion of our goodwill would be a non-cash charge, it could materially reduce our earnings and net worth.
If our regulated insurance subsidiaries are not able to comply with state capital standards, state regulators may require us to take certain actions that could have a material
adverse effect on our results of operations and financial condition.
State
regulations govern the amount of capital required to be retained in our regulated insurance subsidiaries and the ability of those regulated subsidiaries to pay dividends. Those state regulations
include the requirement to maintain minimum levels of statutory capital and surplus, including meeting the requirements of the risk-based capital standards promulgated by the National
Association of Insurance Commissioners. State regulators have broad authority to take certain actions in the event those capital requirements are not met. Those actions could significantly impact the
way we conduct our business, reduce our ability to access capital from the operations of our regulated insurance subsidiaries and have a material adverse effect on our results of operations and
financial condition. Any new minimum capital requirements adopted in the future through state regulation may increase our capital requirements.
13
Risks Relating to This Offering
Our stock price and trading volume may be subject to significant fluctuations.
Since January 1, 2002, the average daily trading volume for our common stock as reported by the NYSE has been approximately 44,000 shares. We are uncertain as to whether a more active trading
market in our common stock will develop following this offering.
From
time to time, the price and trading volume of our common stock may experience periods of significant volatility. In the twelve months ended March 31, 2002, our stock price has ranged from
$4.80 to $18.15 per share. Our stock price and trading volume may fluctuate in response to a number of events and factors, including:
-
- quarterly
variations in our operating results;
-
- changes
in the market's expectations about our future operating results;
-
- changes
in financial estimates and recommendations by securities analysts concerning us or the health insurance industry generally;
-
- operating
and stock price performance of other companies that investors may deem comparable;
-
- news
reports relating to our business and trends in our markets;
-
- changes
in the laws and regulations affecting our business;
-
- acquisitions
and financings by us or others in our industry; and
-
- sales
or acquisitions of substantial amounts of our common stock by our directors and executive officers or principal shareholders, or the perception that
such sales could occur.
In
addition, in recent years the stock market has experienced extreme price and volume fluctuations. This volatility has had a significant effect on the market prices of securities issued by many
companies
for reasons unrelated to their operating performance. These broad market fluctuations may materially adversely affect our stock price, regardless of our operating results.
We have implemented and Wisconsin law contains anti-takeover and other provisions that may adversely affect your rights as a holder of our common stock.
Our
articles of incorporation contain provisions that could have the effect of discouraging or making it more difficult for someone to acquire us through a tender offer, a proxy contest or otherwise,
even though such an acquisition might be economically beneficial to some of our shareholders. Our Board of Directors is divided into three classes of directors serving staggered terms of three years
each. Directors may be removed and the resulting vacancies filled by the shareholders only with the affirmative vote of 80% of the outstanding shares entitled to vote in an election of directors.
These provisions may make the removal of management more difficult, even in cases where removal would be favorable to the interests of our shareholders.
We
have adopted a shareholder rights plan that is intended to discourage major accumulations of our stock without approval by our Board of Directors. The rights generally will cause substantial
dilution to a person or group that attempts to acquire control of us without conditioning the offer on either redemption of the rights or amendment of the rights to prevent this dilution. The rights
could have the effect of delaying, deterring or preventing a change of control.
We
are subject to the Wisconsin Business Corporation Law, which contains several provisions that could have the effect of discouraging non-negotiated takeover proposals or impeding a
business combination. These provisions include:
-
- limiting
the voting power of shareholders who own more than 20% of our stock;
-
- requiring
a supermajority vote of shareholders, in addition to any vote otherwise required, to approve business combinations with a 10% shareholder not
meeting adequacy of price standards;
14
-
- limiting
actions that we can take while a takeover offer for us is being made or after a takeover offer has been publicly announced; and
-
- prohibiting
a business combination between us and a 10% shareholder for a period of three years, unless the combination or the acquisition of the 10%
interest was approved by our Board of Directors prior to the time the shareholder became a 10% or greater beneficial owner of our shares.
We
are also regulated as an insurance holding company by Wisconsin and Georgia, the jurisdictions in which our insurance subsidiaries are domiciled. With some exceptions, these laws require prior
approval by state insurance regulators in the event anyone seeks to acquire more than 10% of our outstanding voting securities.
See "Description of Capital Stock" for a more detailed description of these and other provisions.
We do not intend to pay cash dividends.
We
have not paid any cash dividends since the spin-off became effective September 11, 1998, and we do not plan to declare or pay dividends in the foreseeable future. Instead, we
intend to retain cash for working capital needs, possible acquisitions, to reduce outstanding debt or for other corporate purposes. In addition, our credit agreement prohibits us from declaring or
paying any cash dividends without the lenders' consent.
15
Forward-Looking Statements
This prospectus contains forward-looking statements within the meaning of the federal securities laws. These statements relate, among other things, to the
following: earnings, liquidity, business strategy, product expansion and growth and effects of changes in government regulation. These statements may be found under "Prospectus Summary," "Risk
Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Business." Forward-looking statements typically are identified by use of terms such as "may,"
"will," "expect," "believe," "anticipate," "estimate" and similar words, although some forward-looking statements are expressed differently. You should be aware that our actual results could differ
materially from those contained in the forward-looking statements due to a number of factors, including:
-
- Unexpected
increases in health care costs resulting from advances in medical technology, increased utilization of medical services and prescription drugs
resulting from bioterrorism or otherwise, possible epidemics and natural or man-made disasters and other factors affecting the delivery and cost of health care that are beyond our control.
There are also known trends, such as the aging of the population, that can have an uncertain effect on health care costs.
-
- Our
ability to distribute and sell our products profitably, including, changes in our business relationships with independent agents who sell our products,
our ability to retain key producing sales agents, our ability to expand our distribution network, competitive factors such as the entrance of additional competitors into our markets, competitive
pricing practices, our ability to generate new sales, sell new products and retain existing members, our ability to predict future health care cost trends and adequately price our products, and our
ability to control expenses during a time of declining revenue and membership.
-
- Federal
and state laws adopted in recent years, currently proposed, such as the Patients' Bill of Rights, or that may be proposed in the future, which affect
or may affect our operations, products, profitability or business prospects. Reform laws adopted in recent years generally limit our ability to use risk selection as a method of controlling costs for
our small employer group business.
-
- Regulatory
factors, including delays in regulatory approvals of rate increases and policy forms; regulatory action resulting from market conduct activity and
general administrative compliance with state and federal laws; restrictions on the ability of our subsidiaries to transfer funds to us or our other subsidiaries in the form of cash dividends, loans or
advances without prior approval or notification; the granting and revoking of licenses to transact business; the amount and type of investments that we may hold; minimum reserve and surplus
requirements; and risk-based capital requirements.
-
- Factors
related to our efforts to maintain an appropriate medical loss ratio in our small employer group and MedOneSM health business,
including implementing significant rate increases, terminating business in unprofitable markets, introducing redesigned products, and the willingness of employers and individuals to accept rate
increases, premium repricing and redesigned products.
-
- The
development of and changes in claims reserves.
-
- The
effectiveness of our strategy to expand sales of our MedOneSM products for individuals and families, to focus our small employer group
health product sales in core markets and to grow our ancillary products, including our life, dental and self-funded benefit administration business.
-
- The
cost and other effects of legal and administrative proceedings, including the expense of investigating, litigating and settling any claims or paying any
judgments against us, and the general increase in litigation involving managed care and medical insurers.
-
- Adverse
outcomes of the Florida class action or other litigation in excess of provisions made by us.
16
-
- Restrictions
imposed by financing arrangements that limit our ability to incur additional debt, pay future cash dividends and transfer assets.
-
- Changes
in rating agency policies and practices and the ability of our insurance subsidiaries to maintain or exceed their current A- (Excellent)
rating by A.M. Best.
-
- General
economic conditions, including changes in employment, interest rates and inflation that may impact the performance of our investment portfolio or
decisions of individuals and employers to purchase our products.
-
- Our
ability to maintain attractive preferred provider networks for our insureds.
-
- Factors
affecting our ability to hire and retain key executive, managerial, professional and technical employees.
-
- Changes
in accounting principles and the effects related to such changes.
-
- Other
business or investment considerations that we may disclose from time to time in our Securities and Exchange Commission filings or in other publicly
disseminated written documents.
We
undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should also carefully consider the
statements under "Risk Factors" and other sections of this prospectus, which address additional factors that could cause our actual results to differ from those set forth in the forward-looking
statements.
Common Stock Market Data
Our common stock is traded on the New York Stock Exchange, or NYSE, under the symbol "AMZ." The following table sets forth the per share high and low sales
prices for our common stock as reported on the NYSE. We paid no cash dividends during the periods indicated.
|
|
2002
|
|
2001
|
|
2000
|
|
|
Share Price
|
|
Share Price
|
|
Share Price
|
|
|
High
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Low
|
|
Quarter Ended: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31 |
|
$ |
18.15 |
|
$ |
11.00 |
|
$ |
7.00 |
|
$ |
4.75 |
|
$ |
7.75 |
|
$ |
5.38 |
|
|
June 30 (through May 21, 2002) |
|
|
20.60 |
|
|
15.45 |
|
|
6.96 |
|
|
5.00 |
|
|
7.25 |
|
|
5.00 |
|
|
September 30 |
|
|
|
|
|
|
|
|
6.85 |
|
|
4.80 |
|
|
8.50 |
|
|
6.25 |
|
|
December 31 |
|
|
|
|
|
|
|
|
12.45 |
|
|
5.60 |
|
|
6.38 |
|
|
4.25 |
Our
credit agreement contains a covenant that prohibits us from declaring or paying any cash dividends. In addition, state insurance regulations limit dividends paid by our insurance subsidiaries to
us. See "Management's Discussion and Analysis of Financial Condition and Results of OperationsLiquidity and Capital Resources" for a discussion of insurance subsidiary dividend
limitations.
As
of April 15, 2002, there were 239 shareholders of record of our common stock. Based on information obtained from our transfer agent and from participants in security position listings and
otherwise, we have reason to believe there are approximately 2,400 beneficial owners of shares of our common stock.
17
Use of Proceeds
The selling shareholder will receive all of the net proceeds from the sale of shares of common stock in this offering. We will not receive any of the proceeds
from the sale of shares of common stock by the selling shareholder in this offering. See "Underwriting" for a description of our obligation to pay part of the expenses of this offering.
Dividend Policy
We do not currently pay cash dividends and we do not plan to declare or pay dividends in the foreseeable future, but will instead retain cash for working
capital needs, possible acquisitions, to reduce outstanding debt or for other corporate purposes. In addition, our credit agreement prohibits us from declaring or paying any cash dividends without the
lenders' consent.
Capitalization
The following table sets forth our capitalization as of March 31, 2002. We are not selling any shares and will not receive any proceeds from this
offering. The only adjustment to the balance sheet to reflect this offering will be related to our commitment to pay certain expenses of the offering, which will reduce our retained earnings. See
"Underwriting" for a description of our obligation to pay part of the expenses of the offering. You should read this table together with "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and the consolidated financial statements and the related notes thereto appearing elsewhere in this prospectus.
|
|
March 31, 2002
|
|
|
|
(In thousands)
|
|
Debt: |
|
|
|
|
|
Notes payable |
|
$ |
34,758 |
|
Shareholders' equity: |
|
|
|
|
|
Redeemable preferred stockSeries A Adjustable Rate Nonconvertible, $1,000 stated value, 22,879 shares authorized |
|
|
|
|
|
Preferred stockSeries B Junior Cumulative (no par value, 10,000 shares authorized) |
|
|
|
|
|
Preferred stock (no par value, 467,121 shares authorized) |
|
|
|
|
|
Common stock (no par value, $1 stated value, 50,000,000 shares authorized, 16,654,315 issued and 12,590,166 outstanding) |
|
|
16,654 |
|
|
Paid-in capital |
|
|
187,892 |
|
|
Retained earnings |
|
|
45,900 |
|
|
Accumulated other comprehensive loss (net of tax benefit) |
|
|
(74 |
) |
|
Treasury stock (4,064,149 shares at cost) |
|
|
(36,797 |
) |
|
|
|
|
|
|
Total shareholders' equity |
|
|
213,575 |
|
|
|
|
|
Total capitalization |
|
$ |
248,333 |
|
|
|
|
|
18
Selected Consolidated Financial Data
This section presents our selected historical consolidated financial data. You should read carefully the consolidated financial statements included in this
prospectus, including the notes to the consolidated financial statements. The selected data in this section is not intended to replace the consolidated financial statements.
We
derived the statement of operations data for the years ended December 31, 1999, 2000 and 2001 and balance sheet data as of December 31, 2000 and 2001 from the audited consolidated
financial statements included in this prospectus. Those consolidated financial statements were audited by Ernst & Young LLP, independent auditors. We derived the statement of operations data
for the years ended December 31, 1997 and 1998 and balance sheet data as of December 31, 1997 through 1999 from audited consolidated financial statements that are not included in this
prospectus. We derived the statement of operations data for the three months ended March 31, 2002 and 2001, and the balance sheet data as of March 31, 2002, from the unaudited
consolidated financial statements included in this prospectus which, in management's opinion, include all adjustments (consisting of only normal recurring adjustments) necessary for a fair
presentation of the information set forth herein. Results for the three months ended March 31, 2002 are not necessarily indicative of the results to be expected for the full year.
|
|
Three Months
Ended March 31,
|
|
Year Ended December 31,
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
1998(1)
|
|
1997(1)
|
|
|
(In thousands, except share data)
|
Statement of Operations Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium revenue |
|
$ |
194,401 |
|
$ |
222,470 |
|
$ |
838,672 |
|
$ |
951,071 |
|
$ |
1,056,107 |
|
$ |
914,017 |
|
$ |
957,204 |
|
Net investment income |
|
|
3,924 |
|
|
4,514 |
|
|
17,443 |
|
|
19,007 |
|
|
19,766 |
|
|
20,550 |
|
|
22,217 |
|
Net realized investment gains (losses) |
|
|
14 |
|
|
(27 |
) |
|
(779 |
) |
|
(325 |
) |
|
(854 |
) |
|
3,670 |
|
|
1,854 |
|
Other revenue |
|
|
5,405 |
|
|
5,301 |
|
|
21,285 |
|
|
20,112 |
|
|
22,361 |
|
|
22,632 |
|
|
24,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
203,744 |
|
|
232,258 |
|
|
876,621 |
|
|
989,865 |
|
|
1,097,380 |
|
|
960,869 |
|
|
1,005,524 |
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
131,800 |
|
|
166,580 |
|
|
601,942 |
|
|
724,613 |
|
|
860,473 |
|
|
691,767 |
|
|
733,491 |
|
Selling, general and administrative |
|
|
62,024 |
|
|
71,411 |
|
|
257,742 |
|
|
251,767 |
|
|
268,059 |
|
|
242,073 |
|
|
252,160 |
|
Interest |
|
|
494 |
|
|
876 |
|
|
2,877 |
|
|
3,584 |
|
|
3,564 |
|
|
7,691 |
|
|
9,311 |
|
Amortization of goodwill and other intangibles(2) |
|
|
183 |
|
|
907 |
|
|
3,628 |
|
|
3,785 |
|
|
4,273 |
|
|
8,781 |
|
|
7,975 |
|
Write-off of intangible assets and related charges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
194,501 |
|
|
239,774 |
|
|
866,189 |
|
|
983,749 |
|
|
1,136,369 |
|
|
965,765 |
|
|
1,002,937 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before income taxes |
|
|
9,243 |
|
|
(7,516 |
) |
|
10,432 |
|
|
6,116 |
|
|
(38,989 |
) |
|
(4,896 |
) |
|
2,587 |
Income tax expense (benefit) |
|
|
3,813 |
|
|
(2,376 |
) |
|
6,257 |
|
|
3,447 |
|
|
(13,043 |
) |
|
(1,868 |
) |
|
1,032 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
5,430 |
|
|
(5,140 |
) |
|
4,175 |
|
|
2,669 |
|
|
(25,946 |
) |
|
(3,028 |
) |
|
1,555 |
Income from discontinued operations, less applicable income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,003 |
|
|
16,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
$ |
6,975 |
|
$ |
18,150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common sharebasic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
(0.18 |
) |
$ |
0.10 |
|
Discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.60 |
|
|
1.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common sharebasic |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
0.42 |
|
$ |
1.11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common sharediluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
(0.18 |
) |
$ |
0.10 |
|
Discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.60 |
|
|
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common sharediluted |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
$ |
0.42 |
|
$ |
1.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
13,803 |
|
|
14,211 |
|
|
14,049 |
|
|
14,899 |
|
|
16,470 |
|
|
16,559 |
|
|
16,423 |
Cash dividends per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
0.36 |
|
$ |
0.48 |
19
|
|
|
|
|
|
December 31,
|
|
|
March 31,
2002
|
|
|
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
1998
|
|
1997
|
|
|
|
|
(In thousands)
|
|
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and investments |
|
$ |
272,790 |
|
|
|
$ |
300,253 |
|
$ |
284,982 |
|
$ |
293,539 |
|
$ |
309,562 |
|
$ |
316,858 |
Total assets |
|
|
448,346 |
|
|
|
|
473,015 |
|
|
471,923 |
|
|
503,094 |
|
|
498,722 |
|
|
648,136 |
Notes payable |
|
|
34,758 |
|
|
|
|
40,058 |
|
|
41,258 |
|
|
42,523 |
|
|
55,064 |
|
|
124,578 |
Total shareholders' equity |
|
|
213,575 |
|
|
|
|
229,400 |
|
|
221,177 |
|
|
220,280 |
|
|
266,451 |
|
|
326,377 |
- (1)
- Our
discontinued operations include the operations of Newco/UWS, Inc., now known as Cobalt Corporation, through September 25, 1998, the date on which we
spun off Newco/UWS to our shareholders. Our continuing operations prior to September 11, 1998 include interest on debt assumed by Newco/UWS on September 11, 1998, the
spin-off effective date.
- (2)
- Beginning
January 1, 2002, we adopted Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, which changed
the way we account for goodwill. See Note 2 to the Consolidated Financial Statements for details regarding the impact of this change in accounting.
20
Management's Discussion and Analysis of
Financial Condition and Results of Operations
Overview
We
are a provider of individual and small employer group insurance products. Our principal product offerings are health insurance for small employer groups and health insurance for individuals and
families. We refer in this prospectus to health insurance products marketed to individuals and families as MedOneSM. We also offer dental, life, prescription drug, disability and
accidental death insurance, and provide self-funded benefit administration. We market our products in 32 states and the District of Columbia through independent agents. We have
approximately 75 sales managers located in sales offices throughout the United States to support the independent agents. Our products generally provide discounts to insureds that utilize preferred
provider organizations or PPOs. We own a preferred provider network and also contract with other networks to ensure cost-effective health care choices to our members.
Summary of First Quarter 2002 Results
We reported net income of $5.4 million or $0.37 per diluted share for the first quarter of 2002. This compares to a net loss of $5.1 million or $0.36 per share for the first
quarter of 2001. The improvement in profitability from the first quarter of the prior year primarily reflects improvement in the small employer group loss ratio, a charge related to legal matters in
the first quarter of 2001, and a change in accounting for goodwill and other intangible assets.
The
improvement in the small employer group loss ratio is attributed to management's strategic plan including increased premium rates on new and renewal business, focused marketing efforts for small
employer group products in markets with the best prospects for profitability and future growth, and redesigned products to meet the changing needs of today's insurance consumers.
The
results for the first quarter of 2001 reflect an after-tax charge of $5.8 million or $0.41 per share for legal matters related to an adverse ruling in a lawsuit brought against us by
Skilstaf, Inc. Effective January 1, 2002, we adopted new rules on accounting for goodwill and other intangible assets. Goodwill is no longer amortized, but is instead tested
annually for impairment. The first quarter 2001 results include goodwill amortization of $671,000 or $0.05 per share. See our Notes to Consolidated Financial Statements, Note 2, "Recent
Accounting Pronouncements," for further discussion regarding the impact of the accounting change.
Summary of 2001 Results
Our
financial performance improved considerably in 2001. The key factor in the improvement was the health loss ratio, which by year-end had dropped to its lowest point in over three years.
This positive momentum is attributed to strategic decisions we made in late 1999 including (1) raising premiums on our new and renewal business, (2) focusing our marketing efforts for
small employer group products in markets with the best prospects for profitability and growth, (3) redesigning our products to offer price and coverage choices, and (4) expanding the
distribution of our MedOneSM products.
During
the first quarter of 2001, we received an adverse decision by the Eleventh Circuit Federal Court of Appeals affirming a 1999 $6.9 million jury verdict in a lawsuit brought against us by
Skilstaf, Inc., an employee leasing company. As a result, our 2001 reported results reflect an after-tax charge of $5.8 million or $0.41 per share. See our Notes to
Consolidated Financial Statements, Note 8, "Commitments and Contingencies," for more detailed information regarding this case. Management has characterized this charge as a nonrecurring item in
the following discussion of results of operations due to the unusual nature and size of the lawsuit and because it relates to a contract in force between 1992 and 1996.
21
Following
is a discussion of management's strategic decisions made in late 1999 and their effect on our 2001 operations:
Product Pricing
Significant
technological advancements in the health care field have continued in the past few years. As a result of this and other factors, including the inflationary effects of the Health Insurance
Portability and Accountability Act of 1996, or HIPAA, and Medicare cost-shifting, our costs associated with health care have also increased. In the face of escalating claims cost trends
that emerged in late 1998 and 1999, management implemented premium rate increases on our existing block of business. This action contributed greatly to the improvement in the health loss ratio and
resulting earnings performance. After the effect of buydowns in coverage and terminations, average medical premium per member per month increased 14% from 2000 to 2001. In comparison, average medical
claims costs per member per month increased only 7% for the same period. We are committed to a pricing strategy intended to maintain premium rate increases at a level necessary to achieve our target
profit margins.
Focused Small Employer Group Marketing
We
continue to analyze our geographic markets and are focusing our marketing efforts in those areas that offer the greatest potential for appropriate returns. As a consequence of government
regulations and rapidly rising health care inflation resulting from advances in technology and drug treatments, our small employer group business experienced losses in 1998 and 1999. Since that time,
we have taken steps to return our small employer group business to profitability. Those steps included exiting from certain unprofitable markets, shifting sales and marketing energies away from
underperforming markets and realigning our small employer group agent force to producers with a commitment to us.
As
a result of these actions and the premium rate increases previously discussed, our small employer group business has improved significantly over the past two years and is currently contributing to
our improved financial performance. As anticipated, these focused efforts to improve profitability resulted in a decline in membership and revenues throughout 2001. We are currently taking steps to
return our small group business to a growth mode while continuing to protect its margins. We remain committed to this business and believe that this large and growing sector of the economy has
significant revenue and earnings potential.
Product Redesign
A
significant portion of our product portfolio was redesigned during 2001 to keep pace with changes in the marketplace and to maximize our competitiveness. Consumers seem to be willing to accept
higher co-payments and deductibles in exchange for more affordable premiums and protection from major medical bills. Our new products for small employer groups and individuals are designed
to provide more affordable coverage for major medical expenses by shifting the financial responsibility for routine day-to-day health care to the patient. These new products
feature attractive rates, real choice and protection from catastrophic medical costs. We have been introducing these products to our sales force for the past several months, and the agent reaction has
been enthusiastic. In markets where the products have been fully launched, management has seen a positive trend in quote requests and new members.
MedOneSM Expansion
Recognizing
the significant earnings potential of the MedOneSM product line, we are continuing to take steps to expand the distribution of this business. There are a number of key
factors that make MedOneSM a strategic focus and an attractive product line to sell. The current regulatory environment
22
allows us expanded flexibility in pricing, risk selection and plan design. The product line features higher deductibles and co-payments, thereby increasing consumers' involvement in
health care cost decisions. In addition, the MedOneSM business is well positioned in a slowing economy in which employers are faced with reducing their workforce or dropping their group
health coverage. MedOneSM represented 45% of our medical membership at the end of 2001, compared with 34% at the end of 2000. This shift in our product mix contributed to the improvement
in the health loss ratio. While MedOneSM products are more costly to sell and administer than small employer group products, the increased underwriting and risk management flexibility
results in a lower loss ratio. The lower loss ratio was somewhat offset by the increase in the expense ratio during 2001. Management expects this product line to represent about half of our revenues
by 2003.
Outlook for 2002
Increasing
premium rates and realigning marketing efforts caused a drop in our new member enrollment and an increase in existing membership terminations resulting in decreased revenues throughout
2001. While this consequence was anticipated, management believes membership and revenues in 2002 will remain flat with 2001 with some further decline during the first half of 2002 before starting to
improve by mid-year. Premium rate increases should moderate during 2002, which should improve persistency of small employer group membership. In addition, the introduction and roll out of
new products is expected to have a positive impact on new sales. We are currently conducting significant marketing campaigns to recruit new MedOneSM and dental agents. These efforts are
also attracting agents who want to sell our full line of products causing our force of professional, licensed agents selling our small employer group products to grow. We also believe that competitive
pressures should ease somewhat in 2002 as other small employer group insurance carriers either exit the small employer group market or implement significant rate increases. We expect the health loss
ratio to continue to improve, but at a more moderate rate during 2002.
Comparison of Results of Operations
We
experienced unrelated nonrecurring charges during 1999 and 2001. As these nonrecurring items were not reflective of our ongoing operations, management has chosen to exclude their effects from the
"Comparison of Results of Operations" and to describe each item separately. The following table illustrates the effect of nonrecurring items on our results:
|
|
Three Months
ended March 31,
|
|
Year ended December 31,
|
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Income (loss) before nonrecurring item |
|
$ |
5,430 |
|
$ |
710 |
|
$ |
10,025 |
|
$ |
2,669 |
|
$ |
(12,241 |
) |
Nonrecurring item, net of tax |
|
|
|
|
|
(5,850 |
) |
|
(5,850 |
) |
|
|
|
|
(13,705 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
A
summary description of each of the nonrecurring items is as follows:
During
the third quarter of 1999, we ceased marketing and terminated all small employer group business in Florida, all small employer group and individual health insurance business in Maryland and all
remaining business in Minnesota over a period of 18 months. This decision was made after it became clear to management that certain regulatory challenges existed that made it impossible to
return these markets to profitability. We recorded a $13.7 million after-tax charge in 1999 for a premium deficiency reserve to recognize expected losses related to highly regulated
markets.
During
the first quarter of 2001, we received an adverse decision by the Eleventh Circuit Federal Court of Appeals affirming a 1999 $6.9 million jury verdict in a lawsuit brought against the
Company by
23
Skilstaf, Inc., an employee leasing company. We recognized an after-tax charge of $5.8 million or $0.41 per share during the first quarter of 2001 representing the full loss
including punitive damages and other expenses. In July 2001, at the direction of the district court, we paid the full amount of the verdict plus interest. This case is now closed.
Three months ended March 31, 2002 and 2001
Insurance
premiums for the three months ended March 31, 2002 decreased 12.6% to $194.4 million from $222.5 million for the same period in 2001. The decrease primarily resulted from a decline in
membership in select unprofitable small employer group and exited markets and high lapse rates of existing membership in core markets, partially offset by rising premium rates on the continuing block
of business. Average fully insured medical premium per member per month for the first quarter of 2002 increased by 15.0% to $168, compared to the first quarter of 2001, reflecting significant rate
actions taken by us. As a result of our actions to change our product mix, redefine our markets, increase profitability, and reposition ourself for the future, we expect quarterly insurance premiums
to level before improving later in 2002.
Total
medical and dental membership declined from 652,683 members at March 31, 2001 to 539,481 members at March 31, 2002. The membership decrease is primarily the result of our success
in terminating business in several unprofitable markets, including exited markets, and premium rate increases resulting in lower new sales and higher lapses on existing business. Our
MedOneSM product for individuals and families continues to grow as a percentage of our overall business reflecting management's strategy to change our mix of business.
MedOneSM membership now accounts for 46% of our medical membership in force. At the end of 2000 and 2001, MedOneSM membership accounted for 34% and 45%, respectively. We
consider the MedOneSM product to be a key strategic product and continue to take steps to accelerate membership and premium growth in this market.
Net
investment income for the three months ended March 31, 2002 decreased to $3.9 million from $4.5 million for the three months ended March 31, 2001. The decrease in net investment income is
due primarily to a decrease in the average annual investment yield. The average annual investment yield was 6.0% for the first quarter of 2002 compared to 6.6% for the first quarter of 2001. Invested
assets in March 2002 have declined primarily as a result of the repurchase of 1.4 million shares of our common stock for a total cost of $19.5 million, including related transaction costs, from
the selling shareholder.
The
health segment loss ratio for the first quarter of 2002 was 68.5% compared to 75.7% for the first quarter of 2001. The significant improvement was due to management's actions and strategies to
increase premium rates and combat medical inflation. These actions included premium rate increases, claims cost control initiatives and the exit from unprofitable small employer group markets. The
reduction also reflects increased sales of MedOneSM products, which are priced for a lower loss ratio but have higher selling and administrative costs. As anticipated, claim costs per
member per month have increased slightly, but were surpassed by increased premiums per member per month. Average premium per member per month for the first quarter of 2002 increased 15.0% compared
with the first quarter of 2001. Average claims costs increased only 4.1% over the same period.
The
life segment loss ratio for the three months ended March 31, 2002 was 33.1% compared to 40.1% for the three months ended March 31, 2001. The life segment loss ratio tends to
fluctuate from quarter to quarter as actual life claims experience fluctuates. The life segment loss ratio for the three month period ended March 31, 2002 is consistent with historical averages
and anticipated average future results for this segment.
The
selling, general and administrative, or SG&A, expense ratio includes commissions and selling expenses, administrative expenses (less other revenues), and premium taxes and assessments. The SG&A
expense ratio for health segment products for the three months ended March 31, 2002 was 28.2%. This compares to the first quarter of 2001 SG&A expense ratio of 25.2%, excluding the non-
recurring legal charge. The first quarter 2001 reported SG&A expense ratio, including the non-
24
recurring legal charge, was 29.4%. The increase from the prior year, excluding the non-recurring legal charge, largely reflects a product mix change driven by growth in the MedOneSM
business, which has
higher selling and administrative costs but lower claim costs than small employer group products. Lower premium volume also contributed to the increase in the SG&A ratio.
The
health segment combined ratio, which represents the sum of the health loss and expense ratios, was 96.7% for the three months ended March 31, 2002 compared to 100.9% for the same period in
the prior year, excluding the non-recurring legal charge. The first quarter 2001 combined ratio including the non-recurring legal charge was 105.1%.
Years ended December 31, 2001 and 2000
Insurance
premiums decreased 11.8% to $838.7 million in 2001 from $951.1 million in 2000. Premium revenues have decreased as a result of our membership decline. As discussed above,
membership reductions have resulted from product repricing, market exits and focusing marketing efforts in profitable markets. Medical membership declined by 126,000 members during 2001. Our change in
our product mix has also impacted premium revenue. The MedOneSM business, which has become a larger percentage of our total business, has a smaller premium per member compared with the
declining small employer group business. Partially offsetting the membership decline and the change in the product mix is the effect of increasing premium rates.
The
health segment loss ratio improved 460 basis points to 72.6% for 2001 compared to 77.2% for 2000. The 2001 health loss ratio is at its lowest point in over three years. The improvement in the
health loss ratio is due in part to improved performance on our small employer group business resulting from repricing efforts. In 2001, average premiums per member per month increased at a higher
rate than average claims costs per member resulting in a lower loss ratio. The health loss ratio also benefited, to a lesser degree, from the change in product mix to a larger percentage of
MedOneSM business, which has a lower loss ratio. The life segment loss ratio remained relatively stable with the prior year at 36.4% for 2001 compared with 34.5% for 2000.
Net
investment income decreased to $17.4 million in 2001 from $19.0 million in 2000. The decrease resulted mainly from a decrease in the annual investment yield. The annual investment
yield was 6.4% for 2001 compared to 6.7% for the prior year. Investment gains and losses are realized in the normal investment process in response to market opportunities.
Other
revenue, which primarily consists of administrative fee income from claim processing on self-funded business and other administrative services, increased slightly to
$21.3 million in 2001 from $20.1 million in 2000. The increase resulted from a general increase in fees charged during 2001.
The
expense ratio includes commissions, general and administrative expenses (less other revenues), premium taxes and assessments. The health segment expense ratio, excluding the first quarter
litigation charge, increased to 26.6% in 2001 from 24.2% in 2000. The increase largely reflected the change in our product mix. MedOneSM business has higher agent commissions and issue
costs than small employer group products, but lower claim costs. The decrease in premium volume also contributed to the increase in the health expense ratio. For 2002, we expect the health segment
expense ratio to increase slightly primarily as the result of investments in our distribution system and other selling costs and a continued expansion of the MedOneSM business.
The
health segment combined ratio, which represents the sum of the health loss ratio and the expense ratio, improved 220 basis points to 99.2% for 2001 from 101.4% for 2000. The 2.2% improvement in
the combined ratio resulted in an improvement in pre-tax income of $18.1 million in 2001 over 2000.
Interest
expense on outstanding debt decreased to $2.9 million in 2001 from $3.6 million in 2000. The interest rate charged on the line of credit is tied to the short-term
borrowing rate, which declined throughout most of 2001 resulting in decreased interest expense for us. Amortization of goodwill and other intangible assets remained relatively stable at
$3.6 million for 2001 compared to $3.8 million for
25
the prior year. As discussed in detail below under the caption "Recent Accounting Pronouncements," we will apply new accounting rules for goodwill and intangibles effective January 1, 2002.
The
effective tax rate for 2001 was 60.0%. Excluding the effect of the first quarter litigation charge, the effective tax rate was 48.4% for 2001 compared to 56.4% for 2000. The change in the
effective tax rate relates to the amortization of non-deductible goodwill and other permanent items in relation to pre-tax income. We had deferred tax assets recorded, net of
valuation allowances, of $2.9 million related to state net operating loss carryforwards at December 31, 2001. State net operating loss carryforwards begin to expire in 2008. We believe
that the deferred tax assets will be realized primarily through future state taxable income.
Years ended December 31, 2000 and 1999
Insurance
premiums decreased 9.9% to $951.1 million for 2000 from $1,056.1 million reported for 1999. We acquired the majority of the fully insured group health business of Continental
Assurance Company on January 1, 1999. Premiums on the Continental Assurance Company block of business declined approximately $70 million from 1999 to 2000, which accounted for the
majority of the decrease in premium. The remainder of the decline in premiums from the prior year resulted from declining small employer group membership due to the exit from unprofitable markets.
Partially offsetting the impact
of the declining membership was the continued increase in premiums per member per month. Our average fully insured medical premium per member per month increased 7% to $136, compared to $127 for 1999.
The
health segment loss ratio improved 320 basis points to 77.2% in 2000 from 80.4% reported in 1999, excluding the nonrecurring charge. The significant improvement was due to management's actions and
strategies implemented during 2000 to manage medical inflation. These actions included premium increases, claims cost control initiatives and the exit from certain unprofitable small employer group
markets and the related release of premium deficiency reserves. The improvement also reflected increased sales of MedOneSM products, which are priced for a lower loss ratio due to its
increased deductibles and co-payments. The life segment loss ratio improved to 34.5% for 2000 from 39.2% in 1999.
Net
investment income decreased to $19.0 million in 2000 from $19.8 million in 1999. The decrease resulted from a slight decrease in average invested assets from 1999 to 2000. Average
invested assets at cost decreased from $294.7 million at the end of 1999 to $283.8 million at the end of 2000. Investment gains and losses are realized in the normal investment process
in response to market opportunities.
Other
revenue, which primarily consists of administrative fee income from claim processing on self funded business and other administrative services, decreased slightly to $20.1 million in 2000
from $22.4 million in 1999. The decrease resulted from a decline in administrative fee revenue from blocks of business acquired in prior years.
The
expense ratio includes commissions, general and administrative expenses (less other revenues), premium taxes and assessments. As anticipated, the health segment expense ratio increased to 24.2% in
2000 from 23.0% in 1999. The increase largely reflected the change in our product mix. MedOneSM business, which expanded significantly during 2000, has higher agent commissions and issue
costs than our small employer group products, but lower claim costs. In addition, in the third quarter of 2000, we received a one-time assessment from the State of Minnesota related to our
exit from the MedOneSM health insurance market in that state in early 1999. The assessment was $1.2 million in excess of our original provision for the assessment. Management
expects no similar assessments from other exited markets. The decrease in premium volume also contributed to the increase in the health expense ratio.
The
health segment combined ratio, which represents the sum of the health loss and expense ratios, improved 200 basis points to 101.4% for 2000 from 103.4% for 1999. The 2.0% improvement in the
combined ratio resulted in an improvement in pre-tax income of $18.2 million to us in 2000.
26
Interest
expense on outstanding debt remained flat compared to 1999 at $3.6 million. Amortization of goodwill and other intangible assets declined from 1999 to 2000 to $3.8 million from
$4.3 million.
The
effective tax rate for 2000 was 56.4% compared with 33.5% for 1999. The change in the effective tax rate relates to the amortization of non-deductible goodwill and other permanent
items in relation to pre-tax income. We reported pre-tax income of $6.1 million in 2000 compared to a pre-tax loss of $39.0 million in 1999.
Critical Accounting Policies
Liabilities for Unpaid Claims
Our
liabilities for unpaid claims are based on an estimation process that is complex and uses information obtained from both company specific and industry data, as well as general economic
information. These estimates are developed using actuarial methods based upon historical data for payment patterns, cost trends, product mix, seasonality, utilization of health care services and other
relevant factors. The amount recorded for unpaid claims liabilities is sensitive to judgments and assumptions made in the estimation process. The most significant assumptions used in the estimation
process include determining claims cost trends, the expected consistency in the frequency and severity of claims incurred but not yet reported, changes in the timing of claims submission patterns from
providers, changes in our speed of processing claims and expected costs to settle unpaid claims.
Actual
conditions could differ from those assumed in the estimation process given the general economic and regulatory environment of our operations. Due to the uncertainties associated with the
factors used in these assumptions, we could report materially different amounts in our statement of operations for a particular period under different conditions or using different assumptions. As is
common in the health insurance industry, we believe that actual results may vary within a reasonable range of possible outcomes. We believe that the recorded liabilities for unpaid claims are in the
higher end of a reasonable range of outcomes. We closely monitor and evaluate developments and emerging trends in claims costs to determine the reasonableness of judgments made. A retrospective test
is performed on prior period claims liabilities and, as adjustments to the liabilities become necessary, the adjustments are reflected in current operations. We believe that the amount of medical and
other benefits payable is adequate to cover our liabilities for unpaid claims.
In
determining the liability for unpaid claims at December 31, 2001, management considered the potential impact of the September 11, 2001 events. Although the events of
September 11, 2001 did not have a direct material effect on us, we anticipated an indirect impact including, but not limited to, increased utilization by the general population of mental health
services for stress, anxiety, depression and similar conditions in the fourth quarter. Also, subsequent bio-terrorism threats and attacks were anticipated to result in increased
utilization of health care services including office visits, laboratory tests and prescription drugs for flu-like symptoms in the fourth quarter. During the first quarter of 2002, we did
not discern a material adverse effect related to these events and, therefore, no longer hold reserves for those matters as of March 31, 2002.
Litigation
We
are involved in various legal and regulatory actions occurring in the normal course of business. The liabilities recorded for litigation are generally determined on a
case-by-case basis and typically relate to disputes over policy coverage and benefits. In determining the amount to be recorded, judgments are made by management based on the
facts and the merits of the case, advice from outside legal counsel, the general legal and regulatory environment of the originating state, historical results of similar cases and other relevant
factors. The average cost for the settlement of the actions occurring in the normal course of our business approximates $30,000. However, inherent uncertainties surround legal
27
proceedings and actual results could differ from those assumed in determining the liabilities. The possibility exists that a decision could be rendered against us including punitive or other damage
awards, which may have a material impact on the results of our operations. In estimating the liabilities for litigation as of December 31, 2001, we considered the recent unfavorable litigation
environment we have experienced in certain states. Management's evaluation of the likely impact of these actions could change in the future and an unfavorable outcome could have a material effect on
our financial condition, results of operations or cash flow of a future period. See our Notes to Consolidated Financial Statements, Note 8, "Commitments and Contingencies," for a detailed
discussion of our material pending litigation.
Recent Accounting Pronouncements
In
June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible
Assets, or Statement 142, effective for fiscal years beginning after December 15, 2001. We adopted Statement 142 on January 1, 2002.
Statement 142 impacted us in two ways. First, goodwill and intangible assets deemed to have indefinite lives will no
longer be amortized. Other intangible assets will continue to be amortized over their useful lives. Second, goodwill and intangible assets with indefinite lives will be subject to an initial
impairment test in accordance with Statement 142, and any remaining balance of goodwill and intangible assets will be subject to future annual impairment testing.
We
are in the process of performing the first of the required impairment tests of goodwill and intangible assets deemed to have indefinite lives in 2002, effective as of January 1, 2002, by
comparing the fair value of our reporting units to their carrying amounts (book value), including goodwill. In determining the fair value of our reporting units, we will consider valuation techniques
such as the quoted market price of our stock, the present value of future cash flows and market comparison of similar assets and liabilities.
At
December 31, 2001, our book value per share was $16.30 and was significantly higher than the $12.45 quoted market price per share. We have not yet determined what the effect of these tests
will be on our earnings and financial position. If we determine that the quoted market price per share is the appropriate measure of our fair value, the resulting impairment would be greater than 50%
of the amount of goodwill on our December 31, 2001 balance sheet. If it is determined that an impairment exists as of January 1, 2002, the charge would be reported as the cumulative
effect of a change in accounting principle in our consolidated financial statements and would have no impact on cash flows or the statutory-basis capital and surplus of our insurance subsidiaries.
Liquidity and Capital Resources
Our
sources of cash flow consist primarily of insurance premiums, administrative fee revenue and investment income. The primary uses of cash include payment of medical and other benefits, selling,
general and administrative expenses and debt service costs. Positive cash flows are invested pending future payments of medical and other benefits and other operating expenses. Our investment policies
are designed to maximize yield, preserve principal and provide liquidity to meet anticipated payment obligations.
Our
cash provided by operations was $3.1 million for the three months ended March 31, 2002. This compares to cash used in operations of $8.1 million for the three months ended March 31,
2001. The improvement in cash flow primarily reflects our increased profitability. We expect cash flow to remain positive for the year 2002.
Our
cash provided by operations was $17.6 million for 2001 and cash used in operations was $3.2 million for the year ended 2000. Excluding the payment for the Skilstaf litigation, cash
provided by operations was $25.2 million for 2001. The increase in cash flows from operations is primarily the result
28
of improved underwriting margins in 2001 over 2000. Consistent with our earnings, cash flows increased significantly during the last half of 2001.
We
are well capitalized and have a debt to total capital ratio of 14.0% at March 31, 2002, which is low by industry standards.
Our
insurance subsidiaries operate in states that require certain levels of regulatory capital and surplus and may restrict dividends to their parent companies. The insurance regulator in each
insurer's state of domicile may disapprove any dividend which, together with other dividends paid by an insurance company in the prior 12 months, exceeds the regulatory maximum, computed as the
lesser (or in one instance, the greater) of 10% of statutory surplus or total statutory net gain from operations as of the end of the preceding calendar year. Our principal insurance subsidiary is
subject to rules that limit dividends to the lesser of those two measures. In February 2002, we received a $5.0 million dividend from an insurance subsidiary that was used to make the
required principal payment on our credit facility in 2002. In March 2002, we received a $20.0 million dividend from an insurance subsidiary with regulatory approval in conjunction with
the repurchase of 1.4 million shares of our common stock from the selling shareholder. Consequently, any additional dividends of any amount this fiscal year will require regulatory approval.
The
National Association of Insurance Commissioners has adopted risk-based capital standards for life and health insurers designed to evaluate the adequacy of statutory capital and surplus
in relation to various business risks faced by such insurers. The risk-based capital formula is used by state insurance regulators as an early warning tool to identify insurance companies
that potentially are inadequately capitalized. At December 31, 2001, each of our insurance subsidiaries had risk-based capital ratios substantially above the levels that would
require action by us or a regulator.
During
2001, we purchased 367,000 shares of our outstanding common stock at an aggregate purchase price of $2.2 million. In October 2001, we reached our maximum authorized purchase
threshold, bringing the total purchased under the program to 2.7 million shares at an aggregate purchase price of $18.0 million.
We
maintain a revolving bank line of credit agreement with an outstanding balance and maximum commitment of $30.2 million as of March 31, 2002. At December 31, 2001, the
outstanding balance and maximum commitment under the credit agreement was $35.2 million. In February 2002, in accordance with the revolving bank line of credit, we paid $5.0 million of
the outstanding balance. Our obligations under the credit agreement are guaranteed by our subsidiary American Medical Security Holdings, Inc. and secured by pledges of the stock of American
Medical Security Holdings, Inc. and United Wisconsin Life Insurance Company, our primary insurance subsidiary.
The
credit agreement contains customary covenants which, among other matters, require us to achieve certain minimum financial results and restrict our ability to incur additional debt, pay future cash
dividends and dispose of assets outside the ordinary course of business. We were in compliance with all such covenants at March 31, 2002 and anticipate continued compliance in the foreseeable
future. We believe that the implementation of Statement of Financial Accounting Standards No. 142 will not adversely impact our compliance with debt covenants.
Our
credit agreement was amended in January 2001 and April 2001 to revise the minimum financial requirements of certain covenants. The April 2001 amendment also revised our
applicable interest rate on outstanding loans and the schedule of mandatory future commitment reductions including a $4.8 million maximum commitment reduction from $40.0 million to
$35.2 million. The credit agreement was also amended in March 2002 to allow for the repurchase of 1,400,000 shares of our common stock at a total cost of $19.5 million, including
related expenses, from the selling shareholder and further revise the minimum financial requirements under certain covenants and the schedule of mandatory future commitment reductions.
29
Annual
principal amounts that mature related to the credit agreement are $10.0 million in 2003, $10.0 million in 2004 and $10.2 million in 2005. We anticipate using future cash
flows from operations and existing capital and surplus, if necessary, to fund these capital resource needs.
We
do not expect to pay any cash dividends in the foreseeable future and intend to employ our earnings in the continued development of our business. Our future dividend policy will depend on our
earnings, capital requirements, debt covenant restrictions, financial condition and other factors considered relevant by the Board of Directors.
Market Risk Exposure
Our
primary investment objective for our portfolio of investment securities is to maximize investment income while controlling risks and preserving principal. We seek to meet this investment objective
through diversity of coupon rates, liquidity, investment type, industry, issuer, duration and geographic location. Investment grade debt securities made up 97% of our total investment portfolio at
December 31, 2001. The below investment grade debt securities were investment grade when purchased and subsequently downgraded. None of the below investment grade securities were in default at
December 31, 2001. We use outside investment managers who seek to maximize return on the portfolio within our investment guidelines. At March 31, 2002 and December 31, 2001,
greater than 99% of our total investment portfolio was invested in debt securities.
The
bond portfolio had an average quality rating of AA at March 31, 2002 and December 31, 2001 and AA- at December 31, 2000, as measured by Standard & Poor. Almost the
entire portfolio was classified as available for sale. We had no investment mortgage loans, nonpublicly traded securities (except for principal only strips of U.S. government securities), real estate
held for investment or financial derivatives. The market value of the total available for sale investment portfolio exceeded amortized cost by $2.9 million at December 31, 2001 as
compared with March 31, 2002 and December 31, 2000 when the amortized cost of the total investment portfolio exceeded market value by $0.1 million and $6.1 million,
respectively. We believe that cash flow from operations will be sufficient for our cash flow needs and that liquidation of our investment portfolio will not be necessary.
Our
primary market risk is interest rate fluctuation. Assuming an immediate increase of 100 basis points in interest rates, the net hypothetical decline in fair value of shareholders' equity is
estimated to be $5.6 million after-tax at December 31, 2001. This amount represents approximately 2.4% of our shareholders' equity.
At
December 31, 2001, the fair value of our borrowings under the line of credit facility approximated the carrying value. Market risk was estimated as the potential increase in the fair value
resulting from a hypothetical 1% decrease in our weighted average short-term borrowing rate at December 31, 2001, and was not materially different from the year-end
carrying value.
Inflation
Health
care costs have been rising and are expected to continue to rise at a rate that exceeds the consumer price index. Our cost control measures and premium rate increases are designed to reduce the
adverse effect of medical cost inflation on our operations. In addition, we use our underwriting and medical management capabilities to help control inflation in health care costs. However, there can
be no assurance that our efforts will offset fully the impact of inflation or that premium revenue increases will equal or exceed increasing health care costs.
30
Business
General
We
develop and offer health and related insurance products designed to provide individuals and small employer groups with maximum choice at a reasonable cost. In order to increase choice for our
insureds, we utilize a preferred provider organization, or PPO model. PPOs provide a wider choice of health professionals and more access to specialists than health maintenance organizations, or HMOs.
To reduce the cost of insurance to our customers, we offer multiple health plan configurations incorporating various co-payment agreements and deductible rates, allowing customers to
choose the benefit plan that fits their individual needs. We also employ a variety of medical cost management programs designed to help manage and control the overall cost of our products including
care management, utilization review and subrogation review. Our proactive care management model is designed to improve the overall quality of care, while also managing the cost of certain complex
chronic and acute medical conditions.
We
believe that increased choice and affordability, through our product design and our cost management programs, make our products attractive to individuals and small group employers willing to accept
increased financial and decision making responsibility for their health care. In addition to our health benefit plans, we also offer dental, life, prescription drug, disability and accidental death
insurance, and provide self-funded benefit administration. We sell our products through a network of licensed independent agents in 32 states and the District of Columbia. We are a
Wisconsin corporation organized in 1983.
Industry
In
recent years a number of factors have caused significant changes within the health insurance industry. Dramatically increasing medical costs, as a result of continuing advances in heath care
technology as well as higher utilization, have caused significant increases in insurance premiums. According to the National Coalition on Health Care, an average American family spends one out of
every eight dollars on health care, four times greater than they spent in 1980. Additionally, there have been increased efforts by providers to shift the cost of health care to patients with private
health care coverage as a result of the Balanced Budget Act of 1997, which reduced Medicare reimbursements to hospitals by an estimated $100 billion over five years.
There
has also been increasing demand for choice by insureds. Armed with an increasing amount of health care information available through public sources, including the Internet, insureds are acting
like consumers and exercising more control over health care decisions. As a result, we believe the health care delivery system is becoming more patient-directed as opposed to physician-directed.
Furthermore, the industry has evolved away from HMOs and their more restrictive network models toward PPOs. PPOs represent a managed care "middle ground" in which individuals and their employers have
a wider choice of medical providers. According to William H. Mercer, Inc., a healthcare consulting firm, nearly half of all insured U.S. employees are now enrolled in PPO plans.
Finally,
the industry has been subject to an increasing amount of regulation. According to a 1999 Health Insurance Association of America study, the number of state mandates affecting the industry
increased 25-fold in the last two decades. This trend continues with current state regulatory activity underway relating to individual and small employer group reform, prompt payment
issues and mental health parity. At the federal level, legislative actions being considered include the "Patients' Bill of Rights", the Privacy Act, mental health parity and others.
As
a result it has become increasingly difficult for insurance companies to operate, resulting in a significant industry consolidation and an overall decline in the number of companies in the U.S.
marketing health insurance. Many of these companies went out of business or were forced to sell their
31
health insurance lines of business to competitors. According to Irving Levin Associates, a healthcare consulting firm, there have been 275 mergers or acquisitions in the managed care industry since
1994.
Small Employer Group and Individual Markets
The
small employer group and individual markets are rapidly growing segments of the overall health benefits industry. According to the Small Business Administration, the small employer group sector
includes 25 million small businesses, nearly 75% of all U.S. private establishments, and employs over half of the private sector workforce. In 1998, according to a report by the Small Business
Administration, seven of the 10 industries that added the most new jobs were in sectors dominated by small businesses.
The
individual market sector is also demonstrating significant growth potential in an uncertain economic environment. An increasing number of individuals are seeking their own health care coverage by
virtue of losing their employment and benefits. In other cases, individuals are seeking coverage because their employers have stopped sponsoring health insurance.
The
small group sector was specifically impacted by rising claims cost trends resulting from the Health Insurance Portability and Accountability Act of 1996, or HIPAA. Essentially, the legislation
guaranteed coverage for small employers and certain individuals, without traditional underwriting. At the same time, state rating caps limited the ability of insurers to set premium prices based on
actuarial risk. As a result, most small group carriers became unprofitable and were forced to implement successive years of significant rate increases to account for the higher costs associated with
the additional risks.
Rising
medical costs, exacerbated by an economic recession, have changed the dynamics in the small employer group market. Employers are increasingly forced to choose between eliminating employee
health benefits entirely or limiting their contributions and administrative role, thereby increasing the responsibility of employees for their own health care decisions and payments. Small employers
electing to retain employee health care benefits are seeking affordable and flexible plans that provide coverage for significant health care problems, while leaving with the insured responsibility for
routine health care costs.
During
the past several years, in response to dramatic changes in the industry and regulatory environment, we have implemented aggressive rate action necessary to counter significant cost pressure,
particularly in the small employer group sector. We believe those costs issues have now been largely accounted for in our pricing. The small employer group business segment has returned to
profitability, and we believe it will contribute to future earnings growth.
Our Approach
We
offer unique health and other insurance products designed to provide individuals and small employer groups maximum choice at a reasonable cost. Unlike other insurance companies that focus on the
health benefits industry in general, we focus exclusively on the individual and small employer group markets. Our approach to these markets is based on the following key attributes:
Focus on PPO products. As consumers demand more choice in health care, PPOs represent a more attractive delivery model because they
typically provide a wider choice of health professionals and more access to specialty health care than HMOs. We utilize a PPO delivery model and in each geographic market we serve, we offer our
insureds a choice of PPO networks.
Balanced business model focused on customer choice. We offer a variety of health plans with various co-payment and deductible
levels, allowing consumers to choose the best plans to fit their individual needs. For example, our small group products allow an employer with four employees to offer four different and distinct
health plans.
32
Excellent customer service. We provide a number of value-added features to customers, including Nurse Healthline, Inc., our
toll-free 24 hour-a-day health information line, case management services and toll-free, personal customer service 24 hours-a-day, seven days a
week. In addition, over 95% of our customers' claims are processed within 30 days and we maintain an approximate 99% financial claim accuracy record.
Outstanding agent relationships. We currently market products through approximately 25,000 independent agents, a 25% increase in the number
of agents from the prior year. We have focused our marketing efforts on agents with whom we have strong existing relationships. As a result, we are continuing to build long-term, mutually
beneficial agent relationships that enhance our overall distribution network.
Process orientation and underwriting discipline. We have developed proprietary and tested medical cost management practices and
underwriting capabilities. Our custom-built, fully integrated management information system provides efficiency and service advantages while maintaining relatively low administrative expenses.
Infrastructure. Our existing information technology infrastructure, geographic location and economies of scale provide us with an
administrative cost advantage. We have developed a custom-built, integrated management information system that includes underwriting, billing, enrollment, claims processing, utilization management,
sales reporting, network analysis and service and status reporting. We believe our existing infrastructure has enough capacity to allow us to double our current volume of business.
Centralized, Midwestern location. Our operations are centralized at our Green Bay, Wisconsin corporate campus. We benefit from a stable,
educated workforce and good labor relations.
Strategy
Our
objective is to become the leading provider of health insurance products to individuals and small employer groups. The key elements of our strategy to achieve our objective are as follows:
Increase penetration in existing markets. We intend to increase our penetration in our existing markets by continuing to introduce flexible
new products for small employer groups. We intend to roll out new products that feature more attractive rates for employers, as a result of higher deductibles and co-payments for the
insureds, while providing the insured with maximum flexibility through a choice of PPO networks. In the individual insurance market, we have recently introduced, in response to consumer demand for
more affordable health coverage, a lower premium product that has been well received by our members. We intend to aggressively recruit additional agents licensed to sell our individual products in
order to increase our sales of the products in the markets we serve.
Focus on products designed for consumer choice. We will continue to develop and offer benefit plan structures that utilize broad networks
of health care providers as well as deductible and co-payment structures designed to allow our members to take more active decision making and financial responsibility for their routine
health care needs.
Diversify our revenue mix. We seek to diversify our revenue mix by pursuing sales of products and services that enable us to increase our
revenue stream and generate more stable and predictable margins than our small employer group product. As a result, we are more actively marketing our health insurance for individuals and dental
insurance for both individuals and small employer groups. Dental products are sold to members purchasing our health insurance. We also sell dental insurance to groups on a stand-alone basis.
Leverage our existing operating efficiencies and flexible infrastructure. We have developed and maintain a low fixed cost organizational
structure providing us significant capacity to expand our book of business.
33
To take advantage of our low administrative cost structure we intend to aggressively pursue additional sales of our existing products through the introduction of new small employer group products and
the expansion of our sales force for products marketed to individuals. We will continue to invest in our flexible IT system in order to streamline our internal processes and generate additional
efficiencies and to add functionality enabling us to offer additional services to our agents and members. We estimate that our current physical operations and flexible IT system provide us with enough
capacity to quickly and economically double our existing base of insureds.
Products
We
provide tailored products to meet the varied health insurance needs of our primary markets, including individuals and small employer groups. Common features of our products include:
-
- Choice
of co-pay, deductible and coinsurance levels
-
- Choice
of PPO networks
-
- Availability
of comprehensive prescription drug coverage
-
- Wellness
and routine care coverage
-
- Nurse
Healthline, Inc., our 24 hour-a-day health information line
Small Employer Group
Small
employer group medical insurance products are targeted to employer groups with 2-50 employees. Our average group size is approximately six employees. Distributed through a network of
20,000 independent agents, small employer group products are customized for businesses to offer their employees multiple health plan options in a single package. For example, this strategy allows an
employer with four employees to offer four different and distinct health plans, one for each employee. Although the premium cost of the plans may vary, the ability to offer different plans to
individual employees is without any additional cost to the employer.
MedOneSM
MedOneSM
medical insurance products are marketed to individuals and their families. These products are designed to meet the various health insurance needs and budgets of consumers. Sold
through independent agents, MedOneSM insurance products are designed for cost-conscious consumers and feature more attractive premium rates, protection from catastrophic
medical costs and increased patient responsibility for routine health expenses. Premiums may be periodically adjusted upon renewal of plans to reflect underwriting criteria. Insureds may select
deductible and co-pay features to offset premium increases. In addition, we also offer custom, private label products for individuals and families that are sold through arrangements with
select general agents.
Dental
GroupDentalChoiceSM
offers our members a choice in benefit plans, with access to any dental provider, and coverage for a complete range of dental services from preventative maintenance
to major dental expenses. Our dental product can be purchased through employer sponsored plans or on a voluntary basis with no employer contribution requirements. Dental coverage can be purchased with
our group medical insurance or on a stand-alone basis. Approximately 68% of our dental members have stand-alone plans. More than half of the stand-alone members were originally tied to our group
medical products which have since lapsed.
34
Other
We
also offer self-funded benefit administration services for employers that want to assume a portion of the financial risk for their own health plans. In conjunction with our benefit
administration services, we offer excess of loss reinsurance to cover catastrophic losses of the self-funded plan. Additionally, we offer COBRA administration services to groups subject to
regulations under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.
We
augment our core business with a select line of products and services. Ancillary benefits available with our plans include term life, short-term medical, short-term
disability, accidental death and dependent life insurance. Voluntary term life insurance products may be elected by employees with no employer contribution requirements.
We
provide our members and plan participants with toll-free, personal customer service 24 hours-a-day, seven days a week. In addition, through our wholly
owned subsidiary, Nurse Healthline, Inc., our members and plan participants have access to a toll-free 24 hour-a-day health information line staffed by registered nurses.
Providers
Our wholly owned subsidiary, Accountable Health Plans of America, Inc., operates a commercial PPO network that is utilized by approximately 20% of our members and
contracts with providers primarily in Texas, Florida, Iowa, Nebraska, Wisconsin, Arizona, North Dakota and South Dakota. We also lease our PPO network to other insurers, third party administrators and
employers that self insure their benefit plans for a monthly per member fee. Approximately 33% of Accountable Health Plan's membership is derived from us.
We
contract with approximately 60 commercial provider networks for our fully insured and self-funded product offerings. A master payor agreement is in place for each provider network that
allows us to access each network's provider contracts for our PPO and exclusive provider organization products.
We
currently contract with Merck-Medco Managed Care, LLC for management of prescription benefits offered with our products. This arrangement allows members to access their prescription benefits
at thousands of retail outlets nationwide or through a mail-order service. It is designed to provide cost benefits to us and ease of administration. This arrangement expires at the end of
2002, and we are currently evaluating Merck-Medco's offerings against its competitors.
Medical Cost Management and Other Services
Our
new care management model is a single streamlined process merging utilization review, including pre-certification, concurrent review and retrospective review, with discharge planning
and case management. Under this model certain patients are assigned a care manager to assist the insured during the entire episode of care. The integrated model is designed to support
physician-directed treatment plans, improve cost savings, promote quality of care for our members and enhance member and provider satisfaction. We continue to apply the more traditional approach to
reviewing certain select hospital admission and medical services; however, for other complex and costly conditions, we are applying our new, proactive care management approach. Our care management
program provides coordination of care to patients with chronic, complex medical conditions. Designated clinical staff manage transplant-related care situations. Clinical direction is provided by our
Chief Medical Officer, two full-time medical directors and licensed nurse professionals.
Our
utilization review activities are accredited by the American Accreditation HealthCare Commission/URAC and meet national standards.
35
We
also offer a demand management telephone service through our Nurse Healthline, Inc. subsidiary. Members can access Nurse Healthline registered nurses 24 hours-a-day, 365 days a year.
By using a computerized algorithm-based system, Nurse Healthline is able to provide information to members to assist them in gauging the severity of a problem and accessing appropriate health care.
Nurse Healthline also offers a maternal wellness program designed to encourage expectant mothers to receive appropriate prenatal care and to provide them with educational materials. Through the
maternal wellness program, Nurse Healthline is able to identify potential high risk pregnancies and when appropriate, refer members to our care management staff to develop a plan promoting quality,
cost-effective care.
Our
subrogation department is responsible for investigating potential injury claims prior to final claims adjudication to determine if other insurance coverage is available. Claims are identified
primarily through the use of a diagnosis code table built into the adjudication system, and are investigated via the telephone to expedite the process. We also pursue recoveries
post-adjudication when we learn that the insured has other insurance coverage that is considered primary. The majority of savings achieved are due to the identification of motor vehicle
accidents, as well as work-related injuries and illnesses.
Our
special investigation team proactively searches for fraud and abuse on questionable claims submitted by providers and insureds. As a corporate member of the National Healthcare
Anti-Fraud Association, we follow all state regulatory compliance requirements for filing fraud cases. When appropriate, information is shared with the federal and state regulatory and law
enforcement agencies. In addition, we pursue recoveries post-adjudication when fraud or misrepresentation has been established.
Sales and Marketing
We
currently market our products in 32 states and the District of Columbia. The leading states with respect to medical membership during 2001 were Florida, Illinois, Michigan, Texas, Arizona and
Wisconsin, which together accounted for over 50% of our medical membership. Our small employer group products are marketed to employers with 2-50 employees. Our average group size
is approximately six employees.
We
conduct product sales through licensed independent agents. During 2001, we continued to increase the number of agents selling our products to support our initiative to grow MedOneSM
sales. We market products through approximately 25,000 independent agents. Custom private label products for individuals and their families are marketed under arrangements with select general agents.
Distribution of these products is limited to the general agent and their contracted agent force. Agents are paid commissions on premiums generated from new and renewal sales. We offer an attractive
incentive and service package to agents, creating an environment as an agent friendly company.
We
divide our sales territory into two regions, each of which is the responsibility of a Regional Vice President. The Regional Vice Presidents work with approximately 75 sales managers in offices
located throughout the United States in coordinating our sales and marketing efforts. Sales office staff provide product training to agents and support local agent needs. In addition, our Vice
President, Sales and Marketing, Special Markets, oversees proprietary marketers that together accounted for premium production of approximately 7% of total premium revenue in 2001. Proprietary
marketers are independent agents that produce primarily MedOneSM business through lead generation and independent sub-agents located throughout our sales territory.
We
also market, on a limited basis, a MedOneSM medical insurance product for individuals over the Internet through several online insurance agencies. In 2001, we introduced eAMS.com, a
secured website for agents designed to support their sales activities in marketing our products. The website allows agents to track their business, get news from the home and field offices, print
forms and promotional material and track commissions and incentives.
36
Properties
Our headquarters are located in Green Bay, Wisconsin, in a 400,000 square foot office building owned by one of our subsidiaries, U&C Real Estate Partnership. U&C Real Estate
Partnership leases the property to another subsidiary of ours, American Medical Security, Inc. The property is pledged as collateral to the commercial lender pursuant to a mortgage that continues
until January 1, 2004. As further security, the lease and rents are also assigned to the commerical lender. We also lease property at approximately 30 locations throughout the United States
primarily for our field sales and provider network offices.
Operations and Information Technology
Our
core operational and administrative functions are supported by a single, custom-built, fully integrated management information system. The efficiency, cost and service advantages of this
integrated information technology platform differentiate us from many of our competitors. The information system supports all operational functions including: underwriting, billing, enrollment, claims
processing, customer service, agent licensing and compensation, utilization management, network analysis and sales reporting. All of our operational data is contained on a single on-line
database, enabling us to query information and perform data analysis to identify and report trends in utilization, product mix, claims costs and other relevant business factors. This ability assists
us in maintaining our current pricing strategy and in making business decisions based on comprehensive, accurate and timely information. It also gives us the capability to leverage our customer
service reputation while maintaining relatively low administrative expenses. In addition, the cost to support and maintain an integrated system is low, and our system has a high record of
availability.
We
use extensive personal computer-based network and software applications that are integrated with our platform system and we continuously upgrade and enhance our technology and software applications
to meet our current business needs. We have integrated software into our system with specific functionality for case management and for the repricing of claims in accordance with PPO
contracts providing us with further cost savings. Our system is highly scaleable with considerable capacity to expand our business through upgrades with minimal investment required.
We
provide eAMS.com, an Internet portal for our independent sales agents. The website provides agents with account status and activity, compensation information, updated provider network information,
forms access and other general company communications. Through the use of the website, agents are able to provide potential customers with application forms, quotes and current information, which
creates efficiency and cost savings.
Competition
The
market for our health insurance products is highly competitive. The major competition for our products comes from national and regional firms. Many of our competitors have larger membership in
regional markets or greater financial resources. The small employer group business is typically agency-controlled and is highly price sensitive. The small employer group business is put out for bid
more frequently than larger group business. In addition, because most of our products are marketed primarily through independent agencies, most of which represent more than one company, we experience
competition within each agency. We and other insurers in the small employer group health insurance market compete primarily on the basis of price, benefit plan design, strength of provider networks,
quality of customer service, reputation and quality of agent relations.
Reinsurance
We
have entered into a variety of reinsurance arrangements under which we cede business to other insurance companies to mitigate large claim risk and assume risk from other insurance carriers in
37
connection with certain acquisitions and other business. See our Notes to Consolidated Financial Statements, Note 1, "Organization and Significant Accounting PoliciesReinsurance"
for a summary of reinsurance assumed and ceded.
We
transfer, through excess of loss arrangements, certain of our risks on the small employer group health business and life insurance business. This reinsurance allows for greater diversification of
risk to
control exposure to potential losses arising from large claims. In addition, it permits us to enhance our premium and asset growth while maintaining favorable risk-based capital ratios.
All excess of loss reinsurers with which we contract are currently rated A- (Excellent) or better by A.M. Best.
Investments
We
attempt to minimize our business risk through conservative investment policies. Investment guidelines set quality, concentration and return parameters. Individual fixed income issues must carry an
investment grade rating at the time of purchase, with an ongoing average portfolio rating of "A-" or better, based on ratings of Standard & Poor's Corporation or another nationally
recognized securities rating organization. Investment grade debt securities made up 97% of our total investment portfolio at December 31, 2001. Below investment grade debt securities in our
investment portfolio were investment grade when purchased and subsequently downgraded. We invest in securities authorized by applicable state laws and regulations and follow investment policies
designed to maximize yield, preserve principal and provide liquidity. Our portfolio contains no investments in mortgage loans, non-publicly traded securities (except for principal only
strips of U.S. government securities), real estate held for investment or financial derivatives.
With
the exception of short-term investments and securities on deposit with various state regulators, we have delegated investment responsibilities to external investment managers. Such
investment responsibilities, however, must be carried out within the investment parameters established by us, which are amended from time to time. See "Management's Discussion and Analysis of
Financial Condition and Results of OperationsMarket Risk Exposure" and our Notes to Consolidated Financial Statements, Note 4, "Investments," for additional information on our
investments.
Regulation
Government
regulation of employee benefit plans, including health care coverage and health plans, is a changing area of law that varies from jurisdiction to jurisdiction and generally gives
responsible state and federal administrative agencies broad discretion with respect to the regulation of health plans, health insurers and related entities. We strive to maintain compliance in all
material respects with all federal and state regulations applicable to our current operations. To maintain such compliance, it may be necessary for us to make changes from time to time in our
services, products, structure or operations. Additional governmental regulation or future interpretation of existing regulations could increase the cost of our compliance or otherwise affect our
operations, products, profitability or business prospects.
We
are unable to predict what additional government regulations affecting our business may be enacted in the future or how existing or future regulations might be interpreted. Most jurisdictions have
enacted small employer group insurance and rating reforms that generally limit the ability of insurers and health plans to use risk selection as a method of controlling costs for the small employer
group business. These laws sometimes limit or eliminate use of pre-existing condition exclusions, use of health status and rating and use of industry codes and rating, and limit the amount
of rate increases from year to year. Under these laws, cost control through provider contracting and managing care may become more important, and we believe our experience in these areas will allow us
to compete effectively. We regularly monitor state and federal legislative and regulatory activity as it affects our business.
38
Federal Insurance Regulation
In
recent years, federal legislation significantly expanded federal regulation of small group health plans and health care coverage. The Health Insurance Portability and Accountability Act of 1996,
commonly referred to as HIPAA, places restrictions on the use of pre-existing conditions and eligibility restrictions based upon health status, and prohibited cancellation of coverage due
to claims experience or health status. HIPAA also prohibits insurance companies from declining coverage to small employers. Additional federal laws that took effect in 1998 include prohibitions
against separate, lower dollar maximums for mental health benefits and requirements relating to minimum coverage for maternity inpatient hospitalization. Many requirements of the federal legislation
are similar to small group reforms that have been in place for many years.
HIPAA
also established new requirements regarding the confidentiality and security of patient health information and standard formats for the electronic transmission of health care data, including
code sets. Final privacy rules adopted in 2001 will require changes in the way health information is handled. The privacy regulations require most covered entities to be in compliance by
April 2003. Final regulations regarding the standard formats for the transmission of health care information have also been released and require compliance by October 2003. We are taking
action to comply with the privacy and standardization regulations. The regulations will have the effect of increasing our expenses.
During
2001, we implemented procedures to comply with the privacy standards for personal information required by the Gramm-Leach-Bliley Act, or GLBA. GLBA also allows, among other things, bank holding
companies to engage in a substantially broader range of activities, including insurance underwriting, and allows insurers and other financial insurance companies to acquire banks.
The
U. S. Department of Labor has published regulations that revise claims procedures for employee benefit plans governed by ERISA effective for claims filed on or after July 1, 2002. The
regulations govern the time frame for making benefit decisions for claims and appeals, and notification of claimants' rights under the regulations. We are taking action to comply with the claims
procedure regulations.
Congress
has proposed numerous other health care reform measures in recent years. Congress continues to consider legislation referred to as a "Patients' Bill of Rights" which could affect various
aspects of our business. We are unable to predict when or whether such legislation or any additional federal proposals will be enacted. See "Risk Factors" above.
State Insurance Regulation
Our
insurance subsidiaries are subject to extensive regulation by various insurance regulatory bodies in each state in which the respective entities are licensed. This extensive supervisory power over
insurance companies is designed to protect policyholders, rather than investors, and relates to:
-
- the
licensing of insurance companies;
-
- the
approval of forms and insurance policies used, and, in some cases, the rates charged in connection with those forms;
-
- the
nature of, and limitation on, an insurance company's investments;
-
- policy
administration and claim paying procedures;
-
- periodic
examination of the operations of insurance companies;
-
- the
form and content of annual financial statements and other reports required to be filed on the financial condition of insurance companies;
-
- capital
adequacy; and
39
-
- transactions
with affiliates and changes in control.
Our
insurance subsidiaries are required to file periodic statutory financial statements in each jurisdiction in which they are licensed. On an ongoing basis, states consider various health care reform
measures relating to network management, mandated benefits, underwriting, appeals and administrative procedures and other matters.
The
National Association of Insurance Commissioners has adopted risk-based capital requirements for life and health insurers to evaluate the adequacy of statutory capital and surplus in
relation to investment and insurance risks associated with asset quality, mortality and morbidity, asset and liability matching and other business factors. The risk-based capital formula
is used by state insurance regulators as an early warning tool to identify insurance companies that potentially are inadequately capitalized. At December 31, 2001, our insurance subsidiaries
had risk-based capital ratios substantially above the levels that would require action by us or a regulator.
Dividends
paid by our insurance subsidiaries to us are limited by state insurance regulations. For additional information on dividend restrictions, see our Notes to Consolidated Financial Statements,
Note 9, "Shareholders' EquityRestrictions on Dividends From Subsidiaries."
Insurance Holding Company Systems
We
are an insurance holding company system under applicable state laws. As such, we and our insurance subsidiaries are subject to regulation under state insurance holding company laws and regulations
in the states in which the insurance subsidiaries are domiciled. The insurance holding company laws and regulations generally require annual registration with the state departments of insurance and
the filing of reports describing capital structure, ownership, financial condition, certain intercompany transactions and general business operations. Various notice and reporting requirements often
apply to transactions between an insurer and its affiliated companies, depending on the size and nature of the transactions. Certain state insurance holding company laws and regulations also require
prior regulatory approval or notice of certain material intercompany transactions. Direct or indirect acquisition of control of an insurance company requires the prior approval of state regulators in
the insurer's state of domicile and sometimes other jurisdictions as well. Acquisition of a controlling interest of our stock would constitute an acquisition of a controlling interest in each of our
insurance subsidiaries. Under applicable state law, control is generally presumed to exist in any person who beneficially owns or controls greater than 10% of a company's shares.
Other State Regulations
Certain
of our subsidiaries are licensed as third party administrators. Regulations governing third party administrators, although differing greatly from state to state, generally contain requirements
for administrative procedures, periodic reporting obligations and minimum financial requirements. Certain of the operations of our subsidiaries are also subject to laws and/or regulations governing
PPO, managed care and utilization review activities. PPO and managed care regulations generally contain requirements pertaining to grievance procedures, third party review of certain coverage
determinations, provider networks, provider contracting and reporting requirements that vary from state to state. Utilization review regulations generally require compliance with specific standards
for the performance of utilization review services including confidentiality, staffing, appeals and reporting requirements. In some cases, the regulated PPO, managed care and utilization review
activities are delegated by subsidiaries to a third party.
ERISA
The
provision of goods and services to or through certain types of employee health benefit plans is subject to the Employee Retirement Income Security Act of 1974, as amended, which is commonly
40
referred to as ERISA. ERISA is a complex set of laws and regulations that are subject to periodic interpretation by the United States Department of Labor and the Internal Revenue Service. ERISA
governs how our business units may do business with employers whose employee benefit plans are covered by ERISA, particularly employers that self fund benefit plans. There have been legislative
attempts to limit ERISA's preemptive effect on state laws. If such limitations were to be enacted, they might increase our liability exposure under state law-based suits relating to
employee health benefits offered by our health plans and could permit greater state regulation of other aspects of those businesses' operations.
Legal Proceedings
Florida Regulatory Action and Class Action Litigation
In
May 2001, the Florida Department of Insurance issued an administrative complaint against our wholly owned subsidiary, United Wisconsin Life Insurance Company, or UWLIC, challenging UWLIC's rating
and other practices in Florida relating to our MedOneSM products. MedOneSM products sold by us in Florida are written pursuant to a group master policy issued to an
association domiciled in a state other than Florida. Therefore, management believes we are exempt from most of Florida rating requirements and that we have not violated rating or other regulations
applicable to us. The complaint seeks penalties or other administrative actions including possible suspension or revocation of UWLIC's certificate of authority to do business in Florida. The case was
presented to an Administrative Law Judge in a hearing held in January 2002.
In
a separate proceeding, a class action lawsuit was filed against two of our subsidiaries, American Medical Security, Inc. and UWLIC in February 2000 in the Circuit Court for Palm Beach County,
Florida, by Evelyn Addison and others alleging that we failed to follow Florida law in discontinuing writing certain health insurance policies and offering new policies in 1998, and that we wrongfully
terminated coverage, improperly notified insureds of conversion rights and charged improper premiums for new coverage. Plaintiffs also alleged that our renewal rating methodology violates Florida law.
Plaintiffs are seeking unspecified damages. A bench trial on the liability issues of the case was held in Circuit Court in March 2002.
We
believe that the administrative matter and the class action lawsuit, although procedurally unrelated, arise from essentially the same set of facts and involve substantially similar legal issues.
The substantially similar issues in the two cases include: (1) whether group coverage issued by us to individuals from 1993 to the present is exempt from most portions of Chapter 627, Part VII,
of the Florida Insurance Code, which relates to insurance rates and contracts for group health insurance policies; (2) whether we complied with Florida law when we discontinued certain coverage
and replaced
the discontinued coverage with certain other coverage in 1999; (3) whether Florida law prohibits tier rating of out-of-state groups; and (4) whether we properly notified insureds whose
coverage had been discontinued of their rights to purchase conversion coverage.
In a Recommended Order entered April 25, 2002, the Administrative Law Judge in the administrative hearing found in our favor on all of the above issues and held that the evidence presented by
the Florida Department of Insurance did not support a conclusion that we had violated any provisions of the Florida insurance statutes or regulations. The Administrative Law Judge recommended that all
counts of the Department's administrative complaint be dismissed. The Recommended Order has been sent to the Commissioner of the Florida Department of Insurance for entry of a final order. We and the
Department have filed arguments with the Commissioner, who must now decide whether to adopt the Recommended Order as presented or modify it.
In
a Final Judgment entered April 24, 2002, the Circuit Court in the class action lawsuit found against us on all of the above issues and ordered that the question of damages be tried before a
jury at a time
41
to be scheduled by the Court. The damages portion of the lawsuit is expected to be heard before a jury later this year.
In
light of the conflicting findings of the Administrative Law Judge and the Circuit Court Judge, we intend to request that the Court in the class action lawsuit reconsider its ruling. If the ruling
is not reconsidered, we intend to appeal the ruling at the conclusion of the damages phase of the trial.
Skilstaf Litigation
In
August 1999, a $6.9 million verdict was entered against American Medical Security, Inc., our third party administrator subsidiary, in the United States District Court for the
Middle District of Alabama. Following unsuccessful appeals to the Eleventh Circuit Federal Appeals Court and the U.S. Supreme Court, we paid the full amount of the verdict plus interest in
July 2001.
Health Administrators Litigation
In
February 2000, a $5.4 million verdict was entered against American Medical Security, Inc. and United Wisconsin Life Insurance Company, one of our insurance subsidiaries, in the
Common Pleas Court of Delaware County, Ohio, Civil Division, in a lawsuit brought against American Medical Security and United Wisconsin Life Insurance in 1996 by Health Administrators of
America, Inc., an insurance agency owned and operated by a former agent of American Medical Security. The lawsuit alleges breach of written and oral contracts involving commission amounts and
fraud. The case was heard and decided by a magistrate who awarded damages to Health Administrators, based on breach of written commission and agent contracts and ruled in favor of us on breach of oral
contracts and fraud. We filed objections with the Common Pleas Court requesting that the magistrate's decision against us be reversed. The Common Pleas Court approved the magistrate's decision in
April 2000. As a result, we filed a notice of appeal with the Court of Appeals, Delaware County, Ohio, Fifth Appellate District. On March 29, 2001, the Court of Appeals affirmed a
portion of the verdict, with modifications, representing approximately $3.0 million in damages, and reversed and remanded the remaining issues in the case representing approximately
$2.4 million in damages. We appealed the $3.0 million portion of the damages to the Ohio Supreme Court, which, in July 2001, declined to take the appeal. We paid substantially all
of the approximately $3.0 million judgment in December 2001. Briefs have been submitted for the remanded portion of the case, and the parties are awaiting the trial court's decision.
We
are involved in the previouly described and various other legal and regulatory actions occurring in the normal course of business. Based on current information including consultation with outside
counsel, management believes any ultimate liability that may arise from the above-mentioned and all other legal and regulatory actions would not materially affect our consolidated financial position
or results of operations. However, management's evaluation of the likely impact of these actions could change in the future and an unfavorable outcome could have a material adverse effect on our
consolidated financial position, results of operations or cash flow of a future period.
Employees
As
of December 31, 2001, we had 1,702 employees, 1,467 of which are located at our home office facility in Green Bay, Wisconsin. None of our employees are represented by a union.
Trademarks
We
have filed for and maintain various service marks, trademarks and trade names at the federal level and in various states. Although we consider our registered service marks, trademarks and trade
names important in the operation of our business, our business is not dependent on any individual service mark, trademark or trade name.
42
Management
Management and Board of Directors
This
section sets forth information as of March 31, 2002 covering our executive officers and directors. All of our officers serve terms of one year and until their successors are elected and
qualified. Our board of directors is divided into three classes, with directors in each class serving staggered terms of three years each and until their successors are elected and qualified.
Name
|
|
Age
|
|
Title
|
Samuel V. Miller |
|
56 |
|
Chairman of the Board, President, Chief Executive Officer and Director |
Gary D. Guengerich |
|
56 |
|
Executive Vice President, Chief Financial Officer and Treasurer |
James C. Modaff |
|
44 |
|
Executive Vice President and Chief Actuary |
Thomas G. Zielinski |
|
54 |
|
Executive Vice President, Operations |
Timothy J. Moore |
|
50 |
|
Senior Vice President of Corporate Affairs, General Counsel and Secretary |
Timothy F. O'Keefe |
|
47 |
|
Senior Vice President and Chief Marketing Officer |
Clifford A. Bowers |
|
50 |
|
Vice President, Corporate Communications |
John R. Wirch |
|
48 |
|
Vice President, Human Resources |
Roger H. Ballou |
|
50 |
|
Director |
W. Francis Brennan |
|
65 |
|
Director |
Mark A. Brodhagen, DDS |
|
53 |
|
Director |
Kenneth L. Evason |
|
52 |
|
Director |
Thomas R. Hefty |
|
54 |
|
Director |
James C. Hickman |
|
74 |
|
Director |
William R. Johnson |
|
75 |
|
Director |
Eugene A. Menden |
|
71 |
|
Director |
Edward L. Meyer, Jr. |
|
64 |
|
Director |
Michael T. Riordan |
|
51 |
|
Director |
H.T. Richard Schreyer |
|
61 |
|
Director |
Frank L. Skillern |
|
65 |
|
Director |
J. Gus Swoboda |
|
66 |
|
Director |
Samuel V. Miller has been our Chairman of the Board, President and Chief Executive Officer since September 1998.
Prior to that time, he was an Executive Vice President with us since December 1995. Mr. Miller also served as President and Chief Executive Officer of American Medical Security
Holdings, Inc., one of our subsidiaries, since October 1996. During 1994 and 1995, Mr. Miller was a member of the executive staff planning group with the Travelers Group, serving
as Chairman and Group Chief Executive of National Benefit Insurance Company and Primerica Financial Services Ltd. of Canada. Prior to 1994, Mr. Miller spent 10 years as President
and Chief Executive Officer of American Express Life Assurance Company.
Gary D. Guengerich has been our Executive Vice President and Chief Financial Officer since September 1998. He has also served as our
Treasurer since August 2001 and at certain other times during his employment with us. Mr. Guengerich served in the same capacities with American Medical Security Holdings, Inc.
since November 1997. Prior to joining us, Mr. Guengerich was Senior Vice President and Comptroller of First Colony Life Insurance where he was employed since 1981.
James C. Modaff has been our Executive Vice President and Chief Actuary since August 1999. Prior to joining us, he was a principal
of Milliman & Robertson, Inc., a national actuarial and consulting firm, for the majority of his 14-year career with the firm.
43
Thomas G. Zielinski has been our Executive Vice President of Operations since August 1999. Prior to joining us, he was a Vice
President of Humana, Inc., a health services company, where he served as Executive Director of the Wisconsin Service Center of Humana, Inc. and in various other capacities, including
Vice President, with a predecessor company of Humana, Inc. since 1981.
Timothy J. Moore has been our Senior Vice President of Corporate Affairs, General Counsel and Secretary since September 1998. He
also served in that capacity with American Medical Security Holdings, Inc. since March 1997. Prior to that time, Mr. Moore was a partner with the national law firm of Katten
Muchin & Zavis, practicing at the firm from 1987 to 1997.
Timothy F. O'Keefe has been our Senior Vice President and Chief Marketing Officer since January 2002. Prior to joining us, he was
President of the Major Medical Division of Conseco, Inc.'s Insurance Operations, having served in other senior management positions from 1997 until he became President in 1998. From 1991 to
1997 he held various positions, including Chief Marketing Officer, with various subsidiaries of Pioneer Financial Services.
Clifford A. Bowers has been our Vice President of Corporate Communications since September 1998. He also served in that capacity
with American Medical Security Holdings, Inc. since October 1997. From 1988 to 1997, Mr. Bowers was Director of Communications with Fort Howard Corporation, a paper manufacturer. Prior
to that time, Mr. Bowers held management positions with Tenneco, Manville and Brunswick corporations.
John R. Wirch has been our Vice President of Human Resources since September 1998. He also served in that capacity with American
Medical Security Holdings, Inc. since February 1996. Prior to that time, Mr. Wirch was Vice President of Human Resources for Little Rapids Corporation, a manufacturer of specialty
papers, from 1993 to 1996, having served as Director of Human Resources of Little Rapids Corporation from 1980 to 1993.
Roger H. Ballou is President and Chief Executive Officer of CDI Corporation, a staffing and project management company. He is a former
Chairman and Chief Executive Officer of Global Vacation Group where he served from March 1998 to September 2000. Immediately prior to that time, Mr. Ballou served as a senior
advisor to Thayer Capital Partners, a venture capital firm. From 1995 to 1997, Mr. Ballou served as Vice Chairman and Chief Marketing Officer and then as President and Chief Operating Officer
of Alamo Rent-a-Car. From 1989 to 1995, Mr. Ballou was President of the Travel Services Group of American Express Company. Mr. Ballou is a Director of CDI and
Alliance Data Systems Corp., a transaction, credit and database marketing services firm.
W. Francis Brennan is a retired Executive Vice President of UNUM Corporation, a life and health insurance company, where he served on the
boards of UNUM's insurance affiliates in the United States, Canada, the United Kingdom and Japan. He joined UNUM in 1984 and retired in 1995. Prior to joining UNUM, Mr. Brennan was a Vice
President with Connecticut General Life Insurance Company.
Mark A. Brodhagen, DDS, a practicing dentist, is the owner and President of Mark A. Brodhagen DDS, SC, doing business as Brodhagen Dental
Care, in Green Bay, Wisconsin, which he founded in 1974. He is a member of the Wisconsin and American Dental Associations. He has also served as a dental consultant to a number of managed health care
companies.
Kenneth L. Evason has been a Director, President and Chief Executive Officer of Jacobus Wealth Management, Inc., an investment
management company, since June 2001. From 1987 to 2000, he was President and Chief Executive Officer of Clarica U.S. Inc., formerly known as Mutual Group, U.S., a financial services
organization.
Thomas R. Hefty has been Chairman of the Board, President and Chief Executive Officer of Cobalt since 1998, and has been Chairman of the
Board since 1988 and President since 1986 of the selling
44
shareholder. Prior to our spin-off of Cobalt in 1998, Mr. Hefty was President of United Wisconsin Services, Inc. from 1986 through 1998 and Chairman of the Board and Chief
Executive Officer of United Wisconsin Services, Inc. from 1991 through 1998. He was Deputy Insurance Commissioner for the Office of the Commissioner of Insurance for the State of Wisconsin from 1979
to 1982. Mr. Hefty is a Director of the selling shareholder, Cobalt and Artisan Funds, Inc., an investment company.
James C. Hickman has been an Emeritus Professor and Emeritus Dean of the School of Business at the University of Wisconsin-Madison since
July 1993. He was a Professor at the School of Business from 1972 to 1993, serving as Dean from 1985 to 1990.
William R. Johnson has been Chairman of the Board of Johansen Capital Associates, Inc., a financial and investment consulting firm,
since 1986. Before establishing Johansen Capital, he was founder, Chairman, President and Chief Executive Officer of National Investment Services of America, Inc.
Eugene A. Menden is a retired Vice President and director of Marquette Medical Systems, Inc., formerly known as Marquette
Electronics, Inc., a manufacturer of medical electronic products, where he also held various other senior management positions in his over 20-year career with the company. He
retired in 1992.
Edward L. Meyer is Chairman of the Board of Anamax Corporation, a food by-products recycling company, and its affiliated
companies. He was named Chairman of the Board in 1997, after serving as President and Secretary earlier in his 40-year career with Anamax Corporation. Mr. Meyer is a director of
Marshall & Ilsley Corporation, a bank holding company.
Michael T. Riordan was the Chairman, President and Chief Executive Officer of Paragon Trade Brands, Inc., a disposable diaper
manufacturer, from May 2000 to February 2002. He was President and Chief Operating Officer of Fort James Corporation, a consumer products company, from 1997 to 1998 and held various
positions including Chairman, President and Chief Executive Officer with Fort Howard Corporation from 1992 to 1997. He is also a director of The Dial Corporation and Wallace Computer
Services, Inc.
H.T. Richard Schreyer was managing partner and audit partner in Ernst & Young LLP's Milwaukee office from 1985 until his retirement
from the accounting firm in 1998. He served in various other management positions during his 35-year career with Ernst & Young LLP.
Frank L. Skillern was Chief Executive Officer of American Express Centurion Bank, a consumer bank located in Salt Lake City, Utah, from
1996 until his retirement in 1999. He was Chairman of the Board of Directors of American Express Centurion Bank from his retirement to December 2000, having served as a director since 1991.
From 1994 to 1996 he was President, Consumer Card Group, USA, American
Express Travel Related Services Company, having served as an Executive Vice President for the prior two years.
J. Gus Swoboda is a retired Senior Vice President of Wisconsin Public Service Corporation, an electric and gas utility, where he also held
various other senior management positions. He joined Wisconsin Public Service in 1959 and retired in 1997. Mr. Swoboda was the Chairman of the Board of First Northern Capital Corp. from 1995
until its acquisition by Bank Mutual Corporation in November 2000. He is a director of Bank Mutual Corporation, and Chairman of the Board of its subsidiary, First Northern Saving Bank.
Mr. Evason
and Mr. Hefty became directors and serve on the Board pursuant to the terms of our March 19, 2002 stock purchase agreement with Cobalt Corporation and the selling
shareholder. See "Certain TransactionsStock Purchase Agreement."
45
Principal and Selling Shareholders
The following table sets forth information with respect to the beneficial ownership of our common stock as of March 31, 2002, and as adjusted to reflect
the sale of the common stock in this offering, by:
-
- each
person known by us to own beneficially more than 5% of our common stock;
-
- each
of our directors;
-
- each
of our executive officers named in the executive compensation table incorporated by reference in this prospectus;
-
- all
of our directors and executive officers as a group; and
-
- the
selling shareholder.
We
have determined beneficial ownership in accordance with the rules of the Securities and Exchange Commission. Unless otherwise indicated, the persons included in this table have sole voting and
investment power with respect to all the shares of common stock beneficially owned by them, subject to applicable community property laws. The number of shares beneficially owned by a person includes
shares of common stock that are subject to stock options that are either currently exercisable or exercisable within 60 days after March 31, 2002. These shares are also deemed
outstanding for the purpose of computing the percentage of outstanding shares owned by the person. These shares are not deemed outstanding, however, for the purpose of computing the percentage
ownership of any other person. Information is as of March 31, 2002 with respect to Mr. Miller and the selling shareholder and, with respect to other principal shareholders, is as of
their most recently filed report with the Securities and Exchange Commission in accordance with Section 13(d) or 13(g) of the Exchange Act.
This
table does not reflect the exercise of the over-allotment option granted by the selling shareholder to the underwriters nor does the table reflect the possibility that any of our
principal shareholders will purchase shares in this offering.
|
|
Shares of Common Stock
Beneficially Owned Prior
To Offering(1)
|
|
|
|
Shares of Common Stock
Beneficially Owned After
Offering
|
|
|
|
Shares of Common
Stock Offered
|
|
Name of Beneficial Owner
|
|
|
Number
|
|
Percentage
|
|
Number
|
|
Percentage
|
|
Blue Cross & Blue Shield
United of Wisconsin(2)
401 West Michigan Street
Milwaukee, WI 53203 |
|
4,909,525 |
|
39.0 |
% |
3,500,000 |
|
1,409,525 |
|
11.2 |
% |
Dimensional Fund
Advisors Inc.
1299 Ocean Avenue,
11thFloor
Santa Monica, CA 90401 |
|
1,195,900 |
|
9.5 |
|
|
|
1,195,900 |
|
9.5 |
|
Heartland Advisors, Inc.(3)
789 North Water Street
Milwaukee, WI 53202 |
|
1,111,600 |
|
8.8 |
|
|
|
1,111,600 |
|
8.8 |
|
Wellington Management
Company, LLP(4)
75 State Street
Boston, MA 02109 |
|
1,088,400 |
|
8.6 |
|
|
|
1,088,400 |
|
8.6 |
|
46
Samuel V. Miller(5)(6)
3100 AMS Boulevard
Green Bay, WI 54313 |
|
758,818 |
|
5.7 |
|
|
|
758,818 |
|
5.7 |
|
Roger H. Ballou |
|
20,848 |
|
* |
|
|
|
20,848 |
|
* |
|
W. Francis Brennan |
|
29,000 |
|
* |
|
|
|
29,000 |
|
* |
|
Mark A. Brodhagen |
|
1,667 |
|
* |
|
|
|
1,667 |
|
* |
|
Kenneth L. Evason(6) |
|
|
|
* |
|
|
|
|
|
* |
|
Thomas R. Hefty(2)(6) |
|
176,705 |
|
1.4 |
|
|
|
176,705 |
|
1.4 |
|
James C. Hickman(6) |
|
19,200 |
|
* |
|
|
|
19,200 |
|
* |
|
William R. Johnson(6) |
|
38,000 |
|
* |
|
|
|
38,000 |
|
* |
|
Eugene A. Menden(6) |
|
20,500 |
|
* |
|
|
|
20,500 |
|
* |
|
Edward L. Meyer, Jr. |
|
1,667 |
|
* |
|
|
|
1,667 |
|
* |
|
Michael T. Riordan(5) |
|
24,000 |
|
* |
|
|
|
24,000 |
|
* |
|
H.T. Richard Schreyer(5) |
|
6,792 |
|
* |
|
|
|
6,792 |
|
* |
|
Frank L. Skillern |
|
29,000 |
|
* |
|
|
|
29,000 |
|
* |
|
J. Gus Swoboda |
|
20,500 |
|
* |
|
|
|
20,500 |
|
* |
|
Gary D. Guengerich |
|
185,438 |
|
1.5 |
|
|
|
185,438 |
|
1.5 |
|
James C. Modaff |
|
102,750 |
|
* |
|
|
|
102,750 |
|
* |
|
Thomas G. Zielinski |
|
126,893 |
|
1.0 |
|
|
|
126,893 |
|
1.0 |
|
Timothy J. Moore |
|
88,363 |
|
* |
|
|
|
88,363 |
|
* |
|
All directors and executive officers as a group: 21 persons |
|
1,695,768 |
|
12.0 |
|
|
|
1,695,768 |
|
12.0 |
|
- *
- Less than 1%.
- (1)
- Includes
the following number of shares which the individual has the right to acquire within 60 days of March 31, 2002, upon the exercise of stock options:
Mr. Miller, 727,318 shares; Messrs. Ballou, Brennan, Hickman, Johnson, Menden, Riordan, Skillern,
and Swoboda, 19,000 shares each; Messrs. Brodhagen, Meyer and Schreyer, 1,667 shares each; Mr. Hefty, 155,543 shares; Mr. Guengerich, 170,538 shares;
Mr. Modaff, 102,750 shares; Mr. Zielinski, 106,250 shares; Mr. Moore, 79,886 shares; and all directors and executive officers as a group,
1,541,248 shares.
- (2)
- The
4,909,525 shares owned by the selling shareholder after our share repurchase effected on March 22, 2002 are deemed to be beneficially owned by Cobalt Corporation,
401 West Michigan Street, Milwaukee, Wisconsin 53203, and by Wisconsin United for Health Foundation, Inc., 401 East Doty Street, Madison, Wisconsin 53701. Cobalt is the sole owner
of the selling shareholder and the Wisconsin United for Health Foundation beneficially owns approximately 77.5% of the outstanding shares of Cobalt's common stock. As President of the selling
shareholder, Mr. Thomas Hefty, one of our directors, may be deemed an indirect beneficial owner of the 4,909,525 shares owned by the selling shareholder. Mr. Hefty has disclaimed
beneficial ownership of these shares.
- (3)
- The
1,111,600 shares may be deemed beneficially owned by William J. Nasgovitz as a result of his position as President and as a principal shareholder of Heartland
Advisors, Inc. and as an officer and director of Heartland Group, Inc. Mr. Nasgovitz's address is 789 North Water Street, Milwaukee, Wisconsin 53202. Heartland
Advisors, Inc. has sole voting
47
power
with respect to 436,900 shares and sole dispositive power with respect to 1,111,600 shares beneficially owned and does not have shared voting or shared dispositive power with
respect to any shares. Mr. Nasgovitz has sole voting power with respect to 500,000 shares of the 1,111,600 shares beneficially owned.
- (4)
- Wellington
Management Company, LLP has shared voting power with respect to 388,900 shares and shared dispositive power with respect to 1,088,400 shares
beneficially owned and does not have sole voting power or sole dispositive power with respect to any shares.
- (5)
- Includes
the following shares owned jointly with such person's spouse, with respect to which such person shares voting power and dispositive power: Mr. Miller,
6,500 shares; Mr. Riordan, 5,000 shares; and Mr. Schreyer, 2,000 shares.
- (6)
- Messrs. Evason,
Hefty, Hickman, Johnson, Menden and Miller are the beneficial owners of shares of common stock of Cobalt, the parent of the selling shareholder. The individuals
beneficially own the following shares of Cobalt common stock, which includes shares indicated that the individual has the right to acquire within 60 days of March 31, 2002, upon the
exercise of stock options to purchase Cobalt common stock: Mr. Evason, 16,900 shares; Mr. Hefty, 562,163 shares including 528,579 stock options; Mr. Hickman,
6,826 shares including 6,626 stock options; Mr. Johnson, 8,626 shares including 6,626 stock options; Mr. Menden, 8,126 shares including
6,626 stock options; and Mr. Miller, 200,019 shares including 198,019 stock options.
48
Certain Transactions
Spin-off Transaction
On May 27, 1998, when we were known as United Wisconsin Services, Inc., our Board of Directors approved a plan to spin off our managed care companies and
specialty products business to our shareholders. On September 11, 1998, we contributed all of our subsidiaries comprising the managed care and specialty products business to a newly created
subsidiary named Newco/UWS, Inc., a Wisconsin corporation. On September 25, 1998, we spun off the managed care and specialty products business through a distribution of 100% of the
issued and outstanding shares of common stock of Newco/UWS to our shareholders as of September 11, 1998. In connection with the spin-off, we adopted our current name of American
Medical Security Group, Inc. and Newco/UWS changed its name to United Wisconsin Services, Inc., which is now known as Cobalt Corporation. As a result of the transactions entered into in
connection with the spin-off, Cobalt owns the businesses and assets of, and is responsible for the liabilities associated with, the managed care and specialty products business formerly
conducted by us. We continue to own the business and assets of, and are responsible for the liabilities associated with our individual and small employer group business.
As
of December 31, 2001, Blue Cross & Blue Shield United of Wisconsin, the selling shareholder in this offering, which is a wholly owned subsidiary of Cobalt, owned approximately 45% of
our outstanding common stock. In early 2002, Cobalt and the selling shareholder amended their Schedule 13D filed with the Securities and Exchange Commission indicating, among other things, a
desire to reduce the selling shareholder's investment in our stock and to nominate four persons for election to our Board of Directors at the 2002 annual meeting of shareholders.
Stock Purchase Agreement
On
March 19, 2002, we entered into a stock purchase agreement with Cobalt and the selling shareholder whereby we agreed to repurchase 1,400,000 shares of common stock from the selling
shareholder at a price of $13.00 per share in cash, which is equal to the five-day average closing price for the five trading days prior to March 19, 2002, discounted by 6%, or an
aggregate of $18,200,000. We completed the share repurchase on March 22, 2002, which reduced the selling shareholder's ownership to 39% of our outstanding common stock.
In
addition, pursuant to the stock purchase agreement Cobalt and the selling shareholder agreed to an underwritten secondary offering by the selling shareholder of at least 3,000,000 shares of
our common stock, with the exact number of shares to be as many shares as the underwriters advise may be sold therein. We agreed to cooperate in, and pay a portion of the expenses of, the offering.
This offering is being conducted in satisfaction of the obligations contained in the stock purchase agreement and the 1998 registration rights agreement described below under
"Registration Rights Agreement."
Upon
consummation of the share repurchase, the selling shareholder withdrew its previously disclosed notice of intention to nominate four persons for election at our 2002 annual meeting of
shareholders. In accordance with the terms of the stock purchase agreement, on March 19, 2002, our Board of Directors increased the size of our Board to 14 directors and appointed two
new directors nominated by Cobalt, Thomas R. Hefty and Kenneth L. Evason, effective upon the closing of the share repurchase, which occurred on March 22, 2002. Pursuant to the
stock purchase agreement, Cobalt is entitled to designate two director nominees to the Board for so long as the selling shareholder holds at least 20% of the issued and outstanding shares of our
common stock and is entitled to designate only one nominee to our Board for so long as the selling shareholder holds at least 10% but less than 20% of the issued and outstanding shares of our common
stock. Mr. Hefty, or his successor on our Board, will resign effective upon the date that the selling shareholder owns less than 20% of the then issued and outstanding shares of our common
stock and Mr. Evason, or his successor on our Board, will
49
resign effective immediately upon the date that the selling shareholder owns less than 10% of the then issued and outstanding shares of our common stock.
The
stock purchase agreement also contains certain standstill provisions whereby Cobalt agreed that, for so long as Cobalt has any nominee on the Board, Cobalt and the selling shareholder will not,
directly or indirectly,
-
- acquire
any of our voting securities;
-
- make
or in any way participate in any solicitation of proxies or otherwise influence any person on how to vote (or act by written consent with respect to)
any of our voting securities for the election of directors or approval of shareholder proposals;
-
- seek,
propose or make any public statement that is critical of our management or reasonably likely to be publicly disclosed regarding any business
combination, sale or purchase of assets or securities or other extraordinary transaction involving us or our subsidiaries;
-
- deposit
any of our voting securities in any voting trust, arrangement or agreement (other than a trust, arrangement or agreement that is not formed for the
purpose of taking, and does not take, any actions prohibited by the standstill provisions);
-
- call
or seek to have called any meeting of our shareholders;
-
- otherwise
act to control or influence our management, Board, or policies or make any public statement critical of any nominees recommended by our Board of
Directors for election as directors;
-
- seek
representation on, or a change in the composition of, our Board, except in accordance with the stock purchase agreement;
-
- make
any public statement (including a request to waive the standstill provision), or any other statement that would require public disclosure, regarding any
of the foregoing;
-
- have
any discussions or enter into any arrangements with any other person regarding any of the above provisions; or
-
- make
or disclose any written request, or any written or oral request to our Board, to amend, waive or terminate any of the above provisions, other than oral
disclosure to management not requiring public disclosure.
Cobalt
also agreed that, for so long as Cobalt has any nominees on the Board, all shares of our common stock beneficially owned by Cobalt or the selling shareholder will be present and counted for
purposes of a quorum at all of our shareholders' meetings at which directors will be elected and will be voted in favor of any nominees recommended by our Board of Directors for election as directors.
Cobalt and the selling shareholder are free to vote their shares in their sole discretion on any other matters and are free to vote their shares in their sole discretion on the election of directors
in the event that we are in breach of our obligations relating to the designation of the Cobalt nominees to our Board of Directors.
Cobalt
has the right, at any time after December 31, 2002, or earlier in the event that we are in material breach of our obligations pursuant to the stock purchase agreement, upon
30 days' prior written notice, to terminate such voting agreements and the standstill provisions (other than the provisions relating to its agreement not to seek representation on, or change
the composition of the Board of Directors and not make solicitations, which may not be terminated prior to December 31, 2003) contained in the stock purchase agreement, provided that Cobalt's
nominees then serving on our Board must resign from the Board at the time Cobalt gives notice of termination.
50
We
are required by the stock purchase agreement to amend our shareholder rights agreement upon consummation of this offering if the selling shareholder owns more than 12% of the then issued and
outstanding shares of our common stock. Such amendment will provide that an "Acquiring Person" under the shareholder rights agreement means any person beneficially owning the lesser of (1) 20%
of the outstanding shares of our common stock or (2) the percentage, rounded up to the nearest whole number, of issued and outstanding shares of our common stock then held by the selling
shareholder. If, following consummation of this offering, the selling shareholder's percentage ownership of our common stock decreases, we have the right to further amend the shareholder rights
agreement to lower the percentage of issued and outstanding shares of our common stock then held by the selling shareholder.
If
the selling shareholder sells at least 3,500,000 shares in this offering as proposed, it will own less than 12% of our outstanding common stock and, therefore, the amendment requirement
described in the preceding paragraph will not be triggered.
We
filed a copy of the stock purchase agreement with the Securities and Exchange Commission on March 20, 2002 as an exhibit to our Current Report on Form 8-K dated
March 19, 2002.
Reinsurance Agreements and Certain Insurance Policies
During
1998, we and Cobalt, or our respective subsidiaries, entered into various quota share reinsurance agreements or amendments to existing agreements pursuant to which each company cedes to the
other certain risks related to life insurance, health insurance, dental insurance, point-of-service and other insurance plans. Each company acting as the reinsurer also
provides administrative services to the other company acting as the ceding company. As consideration for such reinsurance, the ceding company receives a ceding commission of approximately 0.5% of the
gross premiums reinsured under each applicable agreement. In addition, our workers compensation and employers liability insurance policy, which is purchased through an independent agent, and our
long-term disability and executive medical reimbursement insurance policies are underwritten by a subsidiary of Cobalt. For fiscal 2001, 2000 and 1999, we received $103,221, $107,406 and
$115,449, respectively, from Cobalt or its subsidiaries pursuant to the reinsurance agreements and paid to Cobalt, its subsidiaries or agents, $362, $28,176 and $78,025, respectively, pursuant to the
reinsurance agreements and $411,701, $536,048 and $461,387, respectively, as premiums for the insurance policies. Thomas R. Hefty, one of our directors, is an executive officer of Cobalt and its
subsidiaries.
Registration Rights Agreement
We
and the selling shareholder have entered into a registration rights agreement dated as of September 1, 1998, which contains certain registration rights granted by us with respect to shares
of our common stock owned by the selling shareholder. Pursuant to the terms of the agreement, the selling shareholder is entitled to certain demand registration rights until the earlier of
July 31, 2008, or the date on which the selling shareholder owns in the aggregate less than 3% of our outstanding common stock. If effected, this offering will constitute one of two demand
registration rights granted to the selling shareholder pursuant to the registration rights agreement. In addition, the selling shareholder is entitled, subject to certain limitations, to include its
shares of our common stock in a registration statement prepared by us for another offering. Also, if the selling shareholder proposes to sell its common stock to a third party, the selling shareholder
may request that we register its shares prior to such sale, and we shall use our best efforts to register all of the shares that the selling shareholder proposes to sell. The selling shareholder has
agreed not to acquire any additional shares of our common stock other than as a result of any stock dividend or distribution, without our consent, until July 31, 2008. The registration rights
agreement continues in effect except as modified by the stock purchase agreement.
51
Description of Capital Stock
The following brief description of our capital stock is only a summary. It is subject in all respects to applicable Wisconsin law and to the provisions of our
restated articles of incorporation, our bylaws and our shareholder rights agreement, copies of which have been filed with the Securities and Exchange Commission, to which you should refer for more
complete information.
Our
authorized capital stock consists of 50,000,000 shares of common stock, no par value per share, and 500,000 shares of preferred stock, no par value per share. As of April 30, 2002, there
were 12,590,166 shares of common stock outstanding and 3,454,040 shares of common stock were issuable upon exercise of outstanding options. As of that date, there were no shares of preferred stock
outstanding; two series of preferred stock have been designated as described below.
Common Stock
Voting Rights. Subject to Section 180.1150(2) of the Wisconsin Business Corporation Law (the "WBCL"), described below
under "Certain Statutory Provisions", holders of common stock are entitled to one vote for each share of common stock held by them on all matters to be voted upon by the shareholders,
including the election of directors. Holders of common stock are not entitled to cumulative voting rights in the election of directors. Directors are elected by a plurality of the votes cast.
Generally, unless a greater vote is required by our articles of incorporation, our bylaws or Wisconsin law, all other matters to be voted on by shareholders must be approved by a majority of the votes
cast on the matter at a meeting at which a quorum is present, subject to any voting rights granted to holders of any then-outstanding preferred stock.
Dividends. Subject to the rights of the holders of any series of preferred stock that may be outstanding, and any applicable restrictions
on the payment of dividends, our Board of Directors, may, in its discretion, declare and pay dividends on the common stock out of earnings or assets legally available for the payment of dividends.
Because we are a holding company, our ability to pay dividends depends
primarily upon the ability of our subsidiaries to pay dividends or otherwise transfer funds to us. Various financing arrangements, charter provisions and regulatory requirements may impose
restrictions on the ability of our insurance subsidiaries to transfer funds to us in the form of dividends, loans or advances.
Liquidation and Dissolution. Subject to the rights of the holders of any series of preferred stock that may be outstanding, if we are
liquidated, any amounts remaining after the payment of liabilities will be paid pro rata to the holders of the common stock.
Other Matters. Holders of common stock are not entitled to any preemptive, conversion or redemption rights. The outstanding shares of
common stock are validly issued, fully paid and nonassessable, except for certain statutory liabilities which may be imposed by Section 180.0622 of the WBCL, as judicially interpreted, for
unpaid employee wages. Section 180.0622(2)(b) provides that the shareholders of a Wisconsin corporation are personally liable, to an amount equal to the consideration for which their
shares without par value were issued, for all debts owing to employees of the corporation for services performed for the corporation, but not exceeding six months service in any one case.
The
common stock is listed on the NYSE under the symbol "AMZ."
The
transfer agent and registrar for the common stock is LaSalle Bank National Association.
Preferred Stock
Our
Board of Directors is authorized to issue shares of preferred stock from time to time, without further shareholder action, in one or more designated series, with such voting rights (if any),
dividend
52
rights, redemption rights, liquidation rights, conversion rights, and such other preferences, limitations and relative rights as are set forth in the resolutions providing for the issue of each
series adopted by the Board of Directors. The rights of holders of the common stock are subject to, and may be adversely affected by, the rights, preferences and privileges of any series of preferred
stock which may be issued. In addition, the issuance of preferred stock, although providing flexibility in connection with possible acquisitions and other corporate purposes could, under some
circumstances, make it more difficult for a third party to gain control of us, discourage bids for the common stock at a premium, or otherwise adversely affect the market price of the common stock. As
of the date of this prospectus, there are no shares of preferred stock issued and outstanding; two series of preferred stock have been designated by the Board of Directors.
In
December 1991, the Board of Directors designated 25,000 shares of our authorized but unissued preferred stock as Series A Adjustable Rate Nonconvertible Preferred Stock to be used as
the employers' matching contribution under the 401(k) plan covering salaried and non-union hourly employees of us and the selling shareholder. On January 3, 1995, we redeemed all of
the outstanding shares of Series A preferred stock and discontinued its use as the employer's matching contribution to the 401(k) plan. We have no present intention to issue any more shares of
Series A preferred stock.
As
described below under "Rights Associated with the Common Stock," 10,000 shares of Series B preferred stock have been created in connection with our rights agreement.
Rights Associated with the Common Stock
On
August 9, 2001, our Board of Directors declared a dividend of one preferred share purchase right for each outstanding share of common stock payable on August 20, 2001 to the
shareholders of record on that date. Each right entitles the registered holder to purchase from us one ten-thousandth of one share (a "unit") of Series B Junior Cumulative Preferred
Stock, no par value per share, at a purchase price of $30 per unit, subject to adjustment. The description and terms of the rights are set forth in a rights agreement between us and LaSalle Bank
National Association, as successor rights agent to Firstar Bank, N.A., as amended.
As
with most shareholder rights agreements, the terms of our rights agreement are complex and not easily summarized, particularly as they relate to the acquisition of our common stock and the
exercisability of the rights. This summary may not contain all of the information that is important to you. Accordingly, if you want more complete information, you should read the rights agreement in
its entirety.
The
rights are attached to all common stock certificates representing outstanding shares, and no separate rights certificates have been distributed. Generally, the rights will separate from the common
stock and be represented by separate certificates approximately 10 business days after a person or group (an "Acquiring Person") acquires or commences a tender offer for 12% or more of our outstanding
common stock.
The
selling shareholder and its affiliates and associates will not be deemed to be an "Acquiring Person" as long as, at any time while they hold more than 12% of our outstanding common stock, they do
not acquire beneficial ownership of any additional shares of common stock other than by dividend or grant from us. The rights agreement has also been amended to clarify its intent and confirm that the
rights
agreement would not be automatically triggered solely by a potential purchaser of Cobalt entering into an agreement to acquire the stock of Cobalt or the selling shareholder or the consummation of
such a transaction. However, in either case, the rights agreement would apply in the event a purchaser owns any of our common stock other than that acquired in a transaction with Cobalt, or later
acquired additional shares of our common stock without the permission of our Board of Directors. We are required by the stock purchase agreement to amend our shareholder rights agreement upon
53
consummation of this offering if the selling shareholder owns more than 12% of the then issued and outstanding shares of our common stock, which will not be the case if the selling shareholder sells
at least 3.5 million shares in this offering, as proposed. See "Certain TransactionsStock Purchase Agreement."
After
the rights separate from the common stock, certificates representing the rights will be mailed to record holders of the common stock. Once distributed, the rights certificates alone will
represent the rights.
All
shares of common stock issued prior to the date the rights separate from the common stock will be issued with the rights attached. The rights are not exercisable until the date the rights separate
from the common stock. The rights will expire on August 20, 2011, unless extended or unless earlier redeemed, exchanged or terminated by us.
The Series B Preferred Stock. 10,000 shares of Series B preferred stock have been designated and 5,000 of those shares have
been initially reserved for issuance upon the exercise of rights pursuant to the rights agreement. Because of the nature of the dividend, liquidation and voting rights of the Series B preferred
stock, the value of a one ten-thousandth share interest in a share of Series B preferred stock purchasable upon exercise of each right should approximate the value of one share of
our common stock. Each share of Series B preferred stock will be entitled to a minimum preferential quarterly dividend payment of $1 per share but will be entitled to an aggregate dividend of
10,000 times the dividend declared per common share. If we are liquidated, the holders of the Series B preferred stock will be entitled to a minimum preferential liquidation payment of $100 per
share plus an amount equal to accrued and unpaid dividends but will be entitled to an aggregate payment of 10,000 times the payment made per common share. Each Series B preferred share will
have 10,000 votes and will vote together with the common stock, except as otherwise provided in the rights agreement or by law. If there is any merger, consolidation or other transaction in which
shares of our common stock are exchanged, each share of Series B preferred will be entitled to receive 10,000 times the amount received per common share. These rights are protected by customary
anti-dilution provisions. Shares of Series B preferred stock are not redeemable.
Triggering Events. If an acquiror obtains or has the right to obtain 12% or more of the outstanding shares of our common stock (other than
as a result of our repurchases of stock), then each right will entitle the holder to purchase a number of shares of our common stock with a then current market value of $60 for $30, unless this amount
is adjusted (in other words, having a value equal to two times the exercise price of the right).
Each
right will entitle the holder to purchase a number of shares of common stock of the acquiror having a then current market value of twice the exercise price of the right if the acquiror obtains
12% or more of our outstanding common stock, and any of the following occurs:
-
- we
merge into another entity;
-
- an
acquiring entity merges into us and our common shares are changed or exchanged; or
-
- 50%
or more of our assets, cash flow or earning power is sold or transferred.
Under
our rights agreement, any rights that are or were owned by an acquiror of more than 12% of our outstanding common stock will be void.
After
an acquiror obtains 12% or more, but less than 50%, of our outstanding common stock, our Board of Directors may, at its option, exchange all or part of the then outstanding and exercisable
rights for shares of common stock or Series B preferred stock. If our Board exercises this option, the exchange ratio will be one share of common stock or one ten-thousandth of a
Series B preferred share per right, adjusted to reflect any stock split, stock dividend or similar transaction.
54
Redemption Provisions. Our Board of Directors may, at its option, redeem all of the outstanding rights at any time prior to 10 business
days following the acquisition by any person of 12% or more of the outstanding shares of our common stock, at a redemption price of $0.001 per right (subject to adjustment in some circumstances). The
right to exercise the rights will terminate when our Board of Directors orders the redemption of the rights, and then the only right of the holders of the rights will be to receive the redemption
price.
Other Matters. Holders of rights have no rights as shareholders, including the right to vote or receive dividends, simply by virtue of
holding the rights.
The
rights agreement may be amended by our Board of Directors without the approval of the holders of the rights prior to the date the rights separate from the common stock. However, after that date,
the rights agreement may not be amended in any manner that would adversely affect the interests of the holders of the rights, excluding the interest of any acquiring person. No amendment may be made
at a time when the rights are not redeemable.
Because
the rights may cause substantial dilution to a person or group that attempts to acquire more than 12% of our stock without approval of our Board of Directors and without conditioning the offer
on redemption of the rights or amendment of the rights to prevent this dilution, the rights may discourage unsolicited offers for our stock. The rights should not affect any potential acquiror willing
to make an offer for all of the outstanding common stock at a price that is fair and not inadequate and otherwise in the best interests of us and our shareholders. The rights also should not interfere
with any merger or other business combination approved by our Board of Directors since our Board may, at its option, at any time until 10 business days following the date a shareholder acquires 12% or
more of our common stock, redeem all the rights as described above. In addition, the rights should not interfere with a proxy contest.
For
more information concerning our rights agreement, you should read the more detailed summary contained in our registration statement on Form 8-A dated August 14, 2001, and
our rights agreement, as amended, which have been filed with the Securities and Exchange Commission.
Certain Charter and Bylaw Provisions
Some
provisions of our articles of incorporation and our bylaws could have the effect of discouraging a potential acquiror or making it more difficult to acquire us by means of a tender offer, a proxy
contest or otherwise, even though this type of acquisition might be economically beneficial to our shareholders. In addition, these provisions may make the removal of management more difficult, even
in cases where the removal would be favorable to the interests of our shareholders.
Board of Directors. Our articles of incorporation divide the Board of Directors into three classes of not less than three nor more than
five directors each. Within those limits, our bylaws provide that the number of directors shall be as determined by the Board of Directors from time to time. One class is elected each year for a
three-year term. A director may be removed from office, with or without cause, only by the affirmative vote of at least 80% of the outstanding shares entitled to vote for the election of
that director, and any vacancy so created may be filled by the affirmative vote of at least 80% of such shares. However, whenever the holders of any one or more series of our preferred stock have the
right, voting separately as a class or by series, to elect directors at an annual or special meeting of shareholders, the election, term of office, filling of vacancies and other features of those
directorships will be governed by the applicable terms of the series of preferred stock, and the directors so elected will not be divided into classes unless expressly so provided by the terms of the
series. These provisions
of our articles of incorporation may only be amended by the affirmative vote of shareholders possessing at least 75% of the voting power of the then outstanding shares of all classes of our stock
generally possessing voting rights in elections of directors, considered for this purpose as one class.
55
Under
the bylaws, vacancies in the Board of Directors, including vacancies created by an increase in the number of directors, may be filled by the remaining directors.
Advance Notice Requirements for Shareholder Proposals and Director Nominees. Our bylaws require advance notice with regard to business
proposed to be submitted by a shareholder at any annual or special meeting of our shareholders, including the nomination of candidates for election as directors. Notice of proposed shareholder
business must be timely given in writing to our corporate secretary prior to the meeting. To be timely, notice must be received at our principal executive offices within the time frames specified in
our bylaws. The notice must also contain certain information specified in our bylaws, including, with respect to a director nomination, the written consent of the nominee to serve as a director if
elected.
Certain Statutory Provisions
The
Wisconsin Business Corporation Law or WBCL, under which we are incorporated, contains certain provisions that may be important when considering the rights of holders of our capital stock. The
description set forth below is intended as a summary only. For complete information, you should review the applicable provisions of the WBCL.
Control Share Voting Restrictions. Section 180.1150(2) of the WBCL provides that the voting power of shares of a "resident domestic
corporation," which we are, held by any "person", including shares issuable upon conversion of convertible securities or upon exercise of options or warrants, in excess of 20% of the voting power in
the election of directors shall be limited to 10% of the full voting power of those shares. This statutory voting restriction is not applicable to shares acquired before April 22, 1986, shares
acquired directly from us, shares as to which our shareholders vote to restore the full voting power and under certain other circumstances more fully described in Section 180.1150(3). This
statutory voting restriction is not applicable to the selling shareholder with respect to the shares of our common stock held by the selling shareholder as of the date of this prospectus.
Fair Price Provisions. Sections 180.1130 to 180.1133 of the WBCL provide that certain business combinations not meeting specified
adequacy-of-price standards must be approved by the vote of at least 80% of the votes entitled to be cast by outstanding voting shares of the corporation, voting together as a
single voting group, and by two-thirds of the votes entitled to be cast by shareholders other than a significant shareholder who is a party to the transaction or an affiliate or associate
of the significant shareholder.
-
- The
term "business combination" is defined to include, subject to certain exceptions, a merger or share exchange of a resident domestic corporation or any
subsidiary with, or the sale or other disposition of substantially all assets of the resident domestic corporation to, any significant shareholder or affiliate of the significant shareholder.
-
- "Significant
shareholder" is defined generally to include a person that is the beneficial owner of 10% or more of the voting power of the outstanding voting
shares of the resident domestic corporation or an affiliate of the resident domestic corporation who was a 10% beneficial owner within the preceding two years.
Actions During a Take-over Offer. Section 180.1134 of the WBCL provides that, in addition to any vote otherwise required
by law or the articles of incorporation, a resident domestic corporation must receive approval at a shareholders' meeting of the holders of a majority of the shares entitled to vote before the
corporation can take the actions listed below while a "take-over offer" is being made for the
56
corporation's voting shares or after a take-over offer has been publicly announced and before it is concluded:
-
- Shareholder
approval is required for the corporation to acquire more than 5% of the corporation's outstanding voting shares at a price above the market value
from any individual who or organization which owns more than 3% of the outstanding voting shares and has held those shares for less than two years, unless an equal or better offer is made to acquire
all voting shares.
-
- Shareholder
approval is also required for the corporation to sell or option assets of the corporation which amount to at least 10% of the market value of the
corporation, unless the corporation has at least three directors who are not officers or employees and a majority of those directors vote not to be governed by this restriction.
Business Combination Provisions. Sections 180.1140 to 180.1144 of the WBCL provide that a "resident domestic corporation," such as
us, may not engage in a "business combination" with an "interested stockholder" for three years after the date (the "stock acquisition date") the interested stockholder acquired his or her 10% or
greater interest, unless the business combination or the acquisition of the 10% or greater interest was approved before the stock acquisition date by the corporation's board of directors. After the
three-year period, a business combination that was not so approved may be consummated only if it is approved by a majority of the outstanding voting shares not held by the interested
stockholder or is made at a specified formula price intended to provide a fair price for the shares held by noninterested stockholders.
-
- A
"business combination" includes a merger or share exchange, or a sale, lease, exchange, mortgage, pledge, transfer or other disposition of assets equal to
at least 5% of the aggregate market value of the stock or assets of the corporation or 10% of its earning power, or the issuance of stock or rights to purchase stock having a market value equal to at
least 5% of the outstanding stock, the adoption of a plan of liquidation or dissolution, and other enumerated transactions involving an interested stockholder or an affiliate or associate of an
interested stockholder.
-
- An
"interested stockholder" is a person who beneficially owns at least 10% of the voting power of the outstanding voting stock of the corporation or who is
an affiliate or associate of the corporation and beneficially owned 10% of the voting power of the then outstanding voting stock at any time within three years prior to the date in question.
Insurance Holding Company Provisions. Because we are an insurance holding company and various of our subsidiaries are insurance companies,
state statutes and administrative rules regulate, among other things, certain transactions in our common stock. These statutes generally provide that the acquisition of 10% or more of our voting
securities creates a rebuttable presumption that "control" of our insurance company subsidiaries is being acquired in the transaction, unless the applicable state regulator, upon application,
determines otherwise. Thus, subject to certain exceptions, any person attempting to acquire 10% or more of our stock must, prior to such acquisition, file certain documents with the appropriate state
insurance regulators and obtain the regulators' prior approval of the acquisition.
These
statutory and administrative restrictions may have the effect of discouraging or making it more difficult for a person to acquire a substantial equity interest in us and may otherwise restrict
the market for the purchase or sale of a significant number of shares of our common stock.
57
Shares Eligible For Future Sale
Upon completion of this offering, we will have 12,590,166 shares of common stock outstanding based upon shares outstanding as of April 30, 2002. All
shares of our common stock outstanding after this offering will be freely tradeable without restriction or further registration under the Securities Act unless held by an "affiliate" of our company,
as that term is defined in Rule 144 under the Securities Act. Sales of shares of our common stock by affiliates will be subject to the volume limitations and other restrictions set forth in Rule 144.
Lock-Up Agreements
We, our directors and the selling shareholder have agreed that, subject to certain exceptions, for a period of 90 days following the date of this prospectus, we and such
persons may not offer, sell, pledge or otherwise dispose of shares of our common stock without the prior written consent of CIBC World Markets Corp.
Stock Options
An additional 3,454,040 shares of our common stock may be issued in the future upon the exercise of options granted under our stock option plans and 241,297 shares of our
common stock are available for grant under our stock option plans. We have registered or will register the issuance of these shares under the Securities Act and, therefore, these shares will be freely
tradeable when issued, subject to the volume limitations and other conditions of Rule 144 in the case of shares held by our affiliates.
Registration Rights
The selling shareholder has rights to cause us to register under the Securities Act the sale of all or part of its remaining shares of our common stock following this offering.
See "Certain TransactionsRegistration Rights Agreement" included elsewhere in this prospectus.
58
Underwriting
We and the selling shareholder have entered into an underwriting agreement with the underwriters named below. CIBC World Markets Corp., Robert W.
Baird & Co. Incorporated and Stifel, Nicolaus & Company, Incorporated are acting as representatives of the underwriters.
The
underwriting agreement provides for the purchase of a specific number of shares of common stock by each of the underwriters. The underwriters' obligations are several, which means that each
underwriter is required to purchase a specified number of shares, but is not responsible for the commitment of any other underwriter to purchase shares. Subject to the terms and conditions of the
underwriting agreement, each underwriter has severally agreed to purchase the number of shares of common stock set forth opposite its name below:
Underwriter
|
|
Number of Shares
|
CIBC World Markets Corp. |
|
|
Robert W. Baird & Co. Incorporated |
|
|
Stifel, Nicolaus & Company, Incorporated |
|
|
|
|
|
|
Total |
|
3,500,000 |
|
|
|
The
underwriters have agreed to purchase all of the shares offered by this prospectus, other than those covered by the over-allotment option described below, if any are purchased. Under
the underwriting agreement, if an underwriter defaults in its commitment to purchase shares, the commitments of non-defaulting underwriters may be increased or the underwriting agreement
may be terminated, depending on the circumstances.
The
shares should be ready for delivery on or about , 2002 against payment in immediately available funds. The underwriters are offering the shares subject to
various conditions and may
reject all or part of any order. The representatives have advised us and the selling shareholder that the underwriters propose to offer the shares directly to the public at the public offering price
that appears on the cover page of this prospectus. In addition, the representatives may offer some of the shares to other securities dealers at such price less a concession of
$ per
share. The underwriters may also allow, and such dealers may reallow, a concession not in excess of $ per share to other dealers. After the shares are released for sale to the
public,
the representatives may change the offering price and other selling terms at various times.
The
selling shareholder has granted the underwriters an over-allotment option. This option, which is exercisable for up to 30 days after the date of this prospectus, permits the
underwriters to purchase a maximum of 525,000 additional shares from the selling shareholder to cover over-allotments. If the underwriters exercise all or part of this option, they will
purchase shares covered by the option at the initial public offering price that appears on the cover page of this prospectus, less the underwriting discount. If this option is exercised in full, the
total price to public will be $ and the total proceeds to the selling shareholder will be $ . We are
receiving no proceeds in this offering. The underwriters have
severally agreed that, to the extent the over-allotment option is exercised, they will each purchase a number of additional shares proportionate to the underwriter's initial amount
reflected in the foregoing table.
59
The
following table provides information regarding the amount of the discount to be paid to the underwriters by the selling shareholder:
|
|
Per Share
|
|
Total Without Exercise of
Over-Allotment Option
|
|
Total With Full Exercise of
Over-Allotment Option
|
Blue Cross & Blue Shield United of Wisconsin |
|
$ |
|
|
$ |
|
$ |
We and the selling shareholder estimate that the total expenses of the offering, excluding the underwriting discount, will be approximately $715,000. We have entered into an arrangement with the
selling shareholder regarding payment of the offering expenses. The principal components of the expenses of the offering, excluding the underwriting discount, will include the fees and expenses of our
accountants and attorneys, the fees of our registrar and transfer agent, the cost of printing this prospectus, and the filing fees paid to the Securities and Exchange Commission and the National
Association of Securities Dealers, Inc. Under our arrangement with the selling shareholder, it is solely responsible for the underwriting discount. With respect to the other offering expenses,
we are responsible for the first $650,000 and we and the selling shareholder will share equally any amount in excess of $650,000. Under this arrangement, we and the selling shareholder estimate that
our portions of the total expenses of the offering, excluding the underwriting discount, will be approximately $682,500 and $32,500, respectively.
We
and the selling shareholder have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933.
Our
directors and the selling shareholder have agreed to a 90-day "lock up" with respect to shares of common stock that they beneficially own, including securities that are
convertible into shares of common stock and securities that are exchangeable or exercisable for shares of common stock. We have entered into a similar lock-up agreement with respect to the issuance
and sale of our equity securities. This means that, subject to certain exceptions, for a period of 90 days following the date of this prospectus, we and such persons may not offer, sell, pledge
or otherwise dispose of these securities without the prior written consent of CIBC World Markets Corp.
The
representatives have informed us that they do not expect discretionary sales by the underwriters to exceed five percent of the shares offered by this prospectus.
Rules
of the Securities and Exchange Commission may limit the ability of the underwriters to bid for or purchase shares before the distribution of the shares is completed. However, the underwriters
may engage in the following activities in accordance with the rules:
-
- Stabilizing transactionsThe representatives may make bids or purchases for the purpose of
pegging, fixing or maintaining the price of the shares, so long as stabilizing bids do not exceed a specified maximum.
-
- Over-allotments and syndicate covering transactionsThe underwriters may sell more
shares of our common stock in connection with this offering than the number of shares that they have committed to purchase. This over-allotment creates a short position for the
underwriters. This short sales position may involve either "covered" short sales or "naked" short sales. Covered short sales are short sales made in an
amount not greater than the underwriters' over-allotment option to purchase additional shares in this offering described above. The underwriters may close out any covered short position
either by exercising their over-allotment option or by purchasing shares in the open market. To determine how they will close the covered short position, the underwriters will consider,
among other things, the price of shares available for purchase in the open market, as compared to the price at which they may purchase shares through the over-allotment option. Naked short
sales are short sales in excess of the over-allotment option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short
60
position
is more likely to be created if the underwriters are concerned that, in the open market after pricing, there may be downward pressure on the price of the shares that could adversely affect
investors who purchase shares in this offering.
-
- Penalty bidsIf the representatives purchase shares in the open market in a stabilizing
transaction or syndicate covering transaction, they may reclaim a selling concession from the underwriters and selling group members who sold those shares as part of this offering.
-
- Passive market makingMarket makers in the shares who are underwriters or prospective
underwriters may make bids for or purchases of shares, subject to limitations, until the time, if ever, at which a stabilizing bid is made.
Similar
to other purchase transactions, the underwriters' purchases to cover the syndicate short sales or to stabilize the market price of our common stock may have the effect of raising or
maintaining the market price of our common stock or preventing or mitigating a decline in the market price of our common stock. As a result, the price of the shares of our common stock may be higher
than the price that might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of the shares if it discourages resales of the shares.
Neither
we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of the shares. These transactions may occur on the
New York Stock Exchange or otherwise. If such transactions are commenced, they may be discontinued without notice at any time.
Legal Matters
The validity of the shares of our common stock offered by this prospectus will be passed upon for us by Quarles & Brady LLP, Milwaukee, Wisconsin.
Latham & Watkins, Los Angeles, California, has acted as
counsel for the underwriters with respect to certain legal matters in connection with the offering. Foley & Lardner, Milwaukee, Wisconsin, has acted as counsel for the selling shareholder with
respect to certain legal matters in connection with the offering.
Experts
Our consolidated financial statements at December 31, 2001 and 2000, and for each of the three years in the period ended December 31, 2001, and
schedules appearing in and incorporated by reference in this prospectus have been audited by Ernst & Young LLP, independent auditors, as set forth in their report appearing elsewhere in
this prospectus, and are included in reliance upon that report given on the authority of the firm as experts in accounting and auditing.
Where You Can Find More Information
We have filed a registration statement on Form S-3 with the Securities and Exchange Commission in connection with this offering. We file
annual quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission. You may read and copy the registration statement and any other documents we
have filed at the Securities and Exchange Commission's Public Reference Room at 450 Fifth Street, N.W., Washington, D.C. 20549. Please call the Securities and Exchange Commission at
1-800-SEC-0330 for further information on the Public Reference Room. Our Securities and Exchange Commission filings are also available to the public at the
Securities and Exchange Commission's Internet site at "http://www.sec.gov".
This
prospectus is part of a registration statement and does not contain all of the information included in the registration statement. Whenever a reference is made in this prospectus to any of our
contracts
61
or other documents, the reference may not be complete and, for a copy of the contract or document, you should refer to the exhibits that are part of the registration statement.
The
Securities and Exchange Commission allows us to "incorporate by reference" into this prospectus the information we file with it, which means that we can disclose important information to you by
referring you to those documents. Information incorporated by reference is part of this prospectus. Later information filed with the Securities and Exchange Commission will update and supersede this
information.
We
incorporate by reference the documents listed below and any future filings made with the Securities and Exchange Commission under Sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of
1934 (including documents filed after the date of the amendment to the registration statement of which this preliminary prospectus is a part and prior to the effectiveness of the registration
statement) until this offering is completed:
-
- Annual
Report on Form 10-K for the year ended December 31, 2001 (including the information incorporated by reference in the
Form 10-K from the proxy statement for our 2002 annual meeting of shareholders filed on April 22, 2002).
-
- Quarterly
Report on Form 10-Q for the quarter ended March 31, 2002.
-
- Current
Reports on Form 8-K filed February 5, March 20, March 26 and April 26, 2002.
-
- The
description of our common stock incorporated by reference in our Registration Statement on Form 8-A dated June 13, 1994, and
any amendment or report filed for the purpose of updating that description.
-
- The
description of the preferred share purchase rights issued pursuant to our shareholder rights agreement contained in our Registration Statement on
Form 8-A dated August 14, 2001, and any amendment or report filed for the purpose of updating that description.
An
updated description of our capital stock is included in this prospectus under "Description of Capital Stock."
You
may request a copy of any of these filings, at no cost, by contacting us by telephone or in writing at:
American
Medical Security Group, Inc.
Attn: Corporate Secretary
3100 AMS Boulevard
Green Bay, WI 54307-9032
Phone: (920) 661-1111
62
Index to Financial Statements
|
|
Page
|
Consolidated Financial Statements |
|
|
Report of Independent Auditors |
|
F-2 |
Consolidated Balance Sheets at March 31, 2002 (unaudited) and December 31, 2001 and 2000 |
|
F-3 |
Consolidated Statements of Operations for the three months ended March 31, 2002 and 2001 (unaudited) and the years ended December 31, 2001, 2000 and 1999 |
|
F-4 |
Consolidated Statements of Cash Flows for the three months ended March 31, 2002 and 2001 (unaudited) and the years ended December 31, 2001, 2000 and 1999 |
|
F-5 |
Consolidated Statements of Changes in Shareholders' Equity and Comprehensive Income (Loss) for the three months ended March 31, 2002 (unaudited) and the years ended December 31, 2001, 2000 and 1999 |
|
F-6 |
Notes to Consolidated Financial Statements |
|
F-7 |
The following financial statement schedules are also included: |
|
|
|
Schedule IICondensed Financial Information of Registrant |
|
F-32 |
|
Schedule IIISupplementary Insurance Information |
|
F-35 |
|
Schedule IVReinsurance |
|
F-36 |
|
Schedule VValuation and Qualifying Accounts |
|
F-37 |
All
other schedules for which provision is made in applicable accounting regulations of the Securities and Exchange Commission are not required under the related instructions or are inapplicable, and
therefore have been omitted.
F-1
Report of Ernst & Young LLP, Independent Auditors
Board of Directors and Shareholders
American Medical Security Group, Inc.
We
have audited the accompanying consolidated balance sheets of American Medical Security Group, Inc. and its subsidiaries, (the "Company") as of December 31, 2001 and 2000, and the
related consolidated statements of operations, changes in shareholders' equity and comprehensive income (loss) and cash flows for each of the three years in the period ended December 31, 2001.
Our audits also included the financial statement schedules listed in the Index on Page F-1. These financial statements and schedules are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits.
We
conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In
our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2001 and
2000, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2001, in conformity with accounting principles generally
accepted in the United States. Also, in our opinion, the related financial statement schedules, when considered in relation to the basic financial statements taken as a whole, present fairly in all
material respects the information set forth therein.
Milwaukee, Wisconsin
January 31, 2002
F-2
American Medical Security Group, Inc.
Consolidated Balance Sheets
(in thousands, except share data)
|
|
|
|
December 31,
|
|
|
|
March 31,
2002
|
|
|
|
2001
|
|
2000
|
|
|
|
(unaudited)
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
Securities available for sale, at fair value: |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
$ |
250,217 |
|
$ |
269,753 |
|
$ |
262,428 |
|
|
|
Equity securitiespreferred |
|
|
|
|
|
722 |
|
|
2,368 |
|
|
Fixed maturity securities held to maturity, at amortized cost |
|
|
4,303 |
|
|
4,286 |
|
|
4,320 |
|
|
Trading securities, at fair value |
|
|
666 |
|
|
517 |
|
|
260 |
|
|
|
|
|
|
|
|
|
|
|
|
Total investments |
|
|
255,186 |
|
|
275,278 |
|
|
269,376 |
|
Cash and cash equivalents |
|
|
17,604 |
|
|
24,975 |
|
|
15,606 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
34,460 |
|
|
33,381 |
|
|
32,451 |
|
|
Goodwill, net |
|
|
92,944 |
|
|
100,343 |
|
|
103,241 |
|
|
Other intangibles, net |
|
|
3,408 |
|
|
3,591 |
|
|
4,321 |
|
|
Other assets |
|
|
44,744 |
|
|
35,447 |
|
|
46,928 |
|
|
|
|
|
|
|
|
|
|
|
Total other assets |
|
|
175,556 |
|
|
172,762 |
|
|
186,941 |
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
448,346 |
|
$ |
473,015 |
|
$ |
471,923 |
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders' Equity: |
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits payable |
|
$ |
132,569 |
|
$ |
135,504 |
|
$ |
145,310 |
|
|
Advance premiums |
|
|
16,634 |
|
|
16,737 |
|
|
17,568 |
|
|
Payables and accrued expenses |
|
|
26,656 |
|
|
28,032 |
|
|
25,902 |
|
|
Notes payable |
|
|
34,758 |
|
|
40,058 |
|
|
41,258 |
|
|
Other liabilities |
|
|
24,154 |
|
|
23,284 |
|
|
20,708 |
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
234,771 |
|
|
243,615 |
|
|
250,746 |
|
Redeemable preferred stockSeries A adjustable rate |
|
|
|
|
|
|
|
|
|
|
|
Nonconvertible, $1,000 stated value, 22,879 shares authorized |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
|
|
|
Preferred stock (no par value, 477,121 shares authorized) |
|
|
|
|
|
|
|
|
|
|
|
Common stock (no par value, $1 stated value, 50,000,000 shares authorized, 16,654,315 issued and 12,590,166 outstanding for 2002, 16,654,315 issued and 13,955,439 outstanding for 2001, 16,654,315 issued and 14,270,945
outstanding for 2000) |
|
|
16,654 |
|
|
16,654 |
|
|
16,654 |
|
|
Paid-in capital |
|
|
187,892 |
|
|
187,927 |
|
|
187,956 |
|
|
Retained earnings |
|
|
45,900 |
|
|
40,470 |
|
|
36,295 |
|
|
Accumulated other comprehensive income (loss) (net of tax benefit of $40 for 2002, expense of $1,024 for 2001 and benefit of $2,126 for 2000) |
|
|
(74 |
) |
|
1,903 |
|
|
(3,948 |
) |
|
Treasury stock (4,064,149 shares for 2002, 2,698,876 for 2001 and 2,383,370 for 2000, at cost) |
|
|
(36,797 |
) |
|
(17,554 |
) |
|
(15,780 |
) |
|
|
|
|
|
|
|
|
|
|
Total shareholders' equity |
|
|
213,575 |
|
|
229,400 |
|
|
221,177 |
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity |
|
$ |
448,346 |
|
$ |
473,015 |
|
$ |
471,923 |
|
|
|
|
|
|
|
|
|
See accompanying Notes to Consolidated Financial Statements
F-3
American Medical Security Group, Inc.
Consolidated Statements of Operations
(In thousands, except share data)
|
|
Three months ended March 31,
|
|
Year ended December 31,
|
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
194,401 |
|
$ |
222,470 |
|
$ |
838,672 |
|
$ |
951,071 |
|
$ |
1,056,107 |
|
|
Net investment income |
|
|
3,924 |
|
|
4,514 |
|
|
17,443 |
|
|
19,007 |
|
|
19,766 |
|
|
Net realized investment gains (losses) |
|
|
14 |
|
|
(27 |
) |
|
(779 |
) |
|
(325 |
) |
|
(854 |
) |
|
Other revenue |
|
|
5,405 |
|
|
5,301 |
|
|
21,285 |
|
|
20,112 |
|
|
22,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
203,744 |
|
|
232,258 |
|
|
876,621 |
|
|
989,865 |
|
|
1,097,380 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
131,800 |
|
|
166,580 |
|
|
601,942 |
|
|
724,613 |
|
|
860,473 |
|
|
Selling, general and administrative |
|
|
62,024 |
|
|
71,411 |
|
|
257,742 |
|
|
251,767 |
|
|
268,059 |
|
|
Interest |
|
|
494 |
|
|
876 |
|
|
2,877 |
|
|
3,584 |
|
|
3,564 |
|
|
Amortization of goodwill and other intangibles |
|
|
183 |
|
|
907 |
|
|
3,628 |
|
|
3,785 |
|
|
4,273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
194,501 |
|
|
239,774 |
|
|
866,189 |
|
|
983,749 |
|
|
1,136,369 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
9,243 |
|
|
(7,516 |
) |
|
10,432 |
|
|
6,116 |
|
|
(38,989 |
) |
Income tax expense (benefit) |
|
|
3,813 |
|
|
(2,376 |
) |
|
6,257 |
|
|
3,447 |
|
|
(13,043 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common sharebasic |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common sharediluted |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying Notes to Consolidated Financial Statements
F-4
American Medical Security Group, Inc.
Consolidated Statements of Cash Flows
(In thousands)
|
|
Three Months Ended
March 31,
|
|
Year ended December 31,
|
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
Operating Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
2,226 |
|
|
2,427 |
|
|
10,493 |
|
|
9,762 |
|
|
11,038 |
|
|
|
Net realized investment losses (gains) |
|
|
(14 |
) |
|
27 |
|
|
779 |
|
|
325 |
|
|
854 |
|
|
|
Net change in trading securities |
|
|
(149 |
) |
|
16 |
|
|
(257 |
) |
|
(260 |
) |
|
|
|
|
|
Deferred income tax expense (benefit) |
|
|
(2,694 |
) |
|
(2,571 |
) |
|
609 |
|
|
6,029 |
|
|
(7,112 |
) |
|
|
Changes in operating accounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets |
|
|
1,870 |
|
|
1,408 |
|
|
7,722 |
|
|
9,119 |
|
|
(12,945 |
) |
|
|
|
Medical and other benefits payable |
|
|
(2,935 |
) |
|
(12,025 |
) |
|
(9,806 |
) |
|
(23,807 |
) |
|
55,984 |
|
|
|
|
Advance premiums |
|
|
(103 |
) |
|
445 |
|
|
(831 |
) |
|
291 |
|
|
(880 |
) |
|
|
|
Payables and accrued expenses |
|
|
(1,376 |
) |
|
8,237 |
|
|
2,130 |
|
|
858 |
|
|
1,605 |
|
|
|
|
Other liabilities |
|
|
860 |
|
|
(880 |
) |
|
2,576 |
|
|
(8,145 |
) |
|
3,830 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities |
|
|
3,115 |
|
|
(8,056 |
) |
|
17,590 |
|
|
(3,159 |
) |
|
26,428 |
|
Investing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of available for sale securities |
|
|
(32,283 |
) |
|
(40,470 |
) |
|
(143,148 |
) |
|
(14,512 |
) |
|
(190,834 |
) |
|
Proceeds from sale of available for sale securities |
|
|
49,214 |
|
|
43,679 |
|
|
129,038 |
|
|
25,460 |
|
|
172,086 |
|
|
Proceeds from maturity of available for sale securities |
|
|
|
|
|
3,050 |
|
|
15,417 |
|
|
4,045 |
|
|
20,805 |
|
|
Purchases of held to maturity securities |
|
|
(1,335 |
) |
|
|
|
|
|
|
|
|
|
|
(686 |
) |
|
Proceeds from maturity of held to maturity securities |
|
|
1,295 |
|
|
|
|
|
|
|
|
630 |
|
|
770 |
|
|
Purchases of property and equipment |
|
|
(2,799 |
) |
|
(1,891 |
) |
|
(6,546 |
) |
|
(4,584 |
) |
|
(2,976 |
) |
|
Proceeds from sale of property and equipment |
|
|
|
|
|
|
|
|
21 |
|
|
13 |
|
|
1,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
14,092 |
|
|
4,368 |
|
|
(5,218 |
) |
|
11,052 |
|
|
214 |
|
Financing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
262 |
|
|
|
|
|
413 |
|
|
4 |
|
|
5 |
|
|
Purchase of treasury stock |
|
|
(19,540 |
) |
|
(1,134 |
) |
|
(2,216 |
) |
|
(8,292 |
) |
|
(7,488 |
) |
|
Proceeds from notes payable borrowings |
|
|
|
|
|
|
|
|
|
|
|
39,158 |
|
|
5,000 |
|
|
Repayment of notes payable |
|
|
(5,300 |
) |
|
(300 |
) |
|
(1,200 |
) |
|
(40,423 |
) |
|
(17,541 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(24,578 |
) |
|
(1,434 |
) |
|
(3,003 |
) |
|
(9,553 |
) |
|
(20,024 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) during year |
|
|
(7,371 |
) |
|
(5,122 |
) |
|
9,369 |
|
|
(1,660 |
) |
|
6,618 |
|
|
Balance at beginning of year |
|
|
24,975 |
|
|
15,606 |
|
|
15,606 |
|
|
17,266 |
|
|
10,648 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of year |
|
$ |
17,604 |
|
$ |
10,484 |
|
$ |
24,975 |
|
$ |
15,606 |
|
$ |
17,266 |
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying Notes to Consolidated Financial Statements
F-5
American Medical Security Group, Inc.
Consolidated Statements of Changes in Shareholders' Equity and Comprehensive Income (Loss)
(In thousands, except share data)
|
|
Common Stock
|
|
|
|
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
|
|
|
|
|
|
Paid-In
Capital
|
|
Retained
Earnings
|
|
Treasury
Stock
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Total
|
|
Balance at January 1, 1999 |
|
16,653,179 |
|
$ |
16,653 |
|
$ |
188,981 |
|
$ |
59,572 |
|
$ |
1,245 |
|
$ |
|
|
$ |
266,451 |
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
|
|
|
|
|
|
|
|
(25,946 |
) |
|
|
|
|
|
|
|
(25,946 |
) |
|
Change in net unrealized gain (loss) on securities, net of taxes of $6,304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,709 |
) |
|
|
|
|
(11,709 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(37,655 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
467 |
|
|
1 |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
5 |
|
Stock option forfeiture |
|
|
|
|
|
|
|
(1,033 |
) |
|
|
|
|
|
|
|
|
|
|
(1,033 |
) |
Purchase of treasury stock (1,121,500 shares, at cost) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,488 |
) |
|
(7,488 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 1999 |
|
16,653,646 |
|
|
16,654 |
|
|
187,952 |
|
|
33,626 |
|
|
(10,464 |
) |
|
(7,488 |
) |
|
220,280 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
2,669 |
|
|
|
|
|
|
|
|
2,669 |
|
|
Change in net unrealized gain (loss) on securities, net of taxes of $3,508 |
|
|
|
|
|
|
|
|
|
|
|
|
|
6,516 |
|
|
|
|
|
6,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
669 |
|
|
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
Purchase of treasury stock (1,261,870 shares, at cost) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,292 |
) |
|
(8,292 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2000 |
|
16,654,315 |
|
|
16,654 |
|
|
187,956 |
|
|
36,295 |
|
|
(3,948 |
) |
|
(15,780 |
) |
|
221,177 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
4,175 |
|
|
|
|
|
|
|
|
4,175 |
|
|
Change in net unrealized gain (loss) on securities, net of taxes of $3,150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
5,851 |
|
|
|
|
|
5,851 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
|
|
|
|
|
(29 |
) |
|
|
|
|
|
|
|
442 |
|
|
413 |
|
Purchase of treasury stock (367,262 shares, at cost) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,216 |
) |
|
(2,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2001 |
|
16,654,315 |
|
|
16,654 |
|
|
187,927 |
|
|
40,470 |
|
|
1,903 |
|
|
(17,554 |
) |
|
229,400 |
|
(Unaudited): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
5,430 |
|
|
|
|
|
|
|
|
5,430 |
|
|
Change in net unrealized gain (loss) on securities, net of taxes of $1,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,977 |
) |
|
|
|
|
(1,977 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,453 |
|
Issuance of common stock |
|
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
|
297 |
|
|
262 |
|
Purchase of treasury stock (1,400,000 shares, at cost) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(19,540 |
) |
|
(19,540 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2002 (unaudited) |
|
16,654,315 |
|
$ |
16,654 |
|
$ |
187,892 |
|
$ |
45,900 |
|
$ |
(74 |
) |
$ |
(36,797 |
) |
$ |
213,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying Notes to Consolidated Financial Statements
F-6
American Medical Security Group, Inc.
Notes to Consolidated Financial Statements
1. Organization and Significant Accounting Policies
American
Medical Security Group, Inc., together with its subsidiary companies (the "Company"), is a provider of individual and small employer group insurance products. The Company's principal
product offering is health insurance for small employer groups and health insurance for individuals and families ("MedOneSM"). The Company also offers life, dental, prescription drug,
disability and accidental death insurance, and provides self-funded benefit administration. The Company's products are marketed in 32 states and the District of Columbia through
independent agents. Approximately 75 Company sales managers located in sales offices throughout the United States support the independent agents. The Company's products generally provide discounts to
insureds that utilize preferred provider organizations ("PPOs"). The Company owns a preferred provider network and also contracts with other networks to ensure cost-effective health care
choices to its members.
The
consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. Significant intercompany accounts and transactions have been eliminated. The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). The preparation of financial statements in
conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates are based
on knowledge of current events and anticipated future events, and accordingly, actual results may differ from those estimates.
The
accompanying unaudited interim consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair
presentation. Operating results for the three months ended March 31, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002.
Cash
and cash equivalents include operating cash and short-term investments with original maturities of three months or less. These amounts are recorded at cost, which approximates market
value.
The
Company's investments are classified in three categories. Investments that the Company has the positive intent and ability to hold to maturity are classified as
held-to-maturity securities and are reported at amortized cost. Assets which are invested for the purpose of supporting the Company's nonqualified executive retirement plan are
classified as trading securities and reported at fair value, with unrealized gains and losses included in earnings as net investment income. All other investments are classified as
available-for-sale securities and are reported at fair value based on quoted market prices. Unrealized gains and losses on available-for-sale securities
are excluded from earnings and reported as a separate component of shareholders' equity as accumulated other comprehensive income or loss, net of income tax effects. Realized gains and losses from the
sale or write-down for
F-7
other-than-temporary impairments of available-for-sale debt and equity securities are calculated using the specific identification method.
The
fair values of investments are reported in Note 4. The fair values of all other financial instruments approximate their December 31, 2001 and 2000 carrying values.
Property
and equipment are recorded at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful lives, which are 20 to 30 years for
land improvements, 10 to 40 years for buildings and building improvements, three to five years for computer equipment and software and three to 10 years for furniture and other
equipment.
Goodwill
represents the excess of cost over the fair market value of net assets acquired. Goodwill and other intangible assets are currently being amortized on a straight-line basis over a
period of 40 years or less. Accumulated amortization was $20,089,000 and $16,461,000 at December 31, 2001 and 2000, respectively. The Company periodically evaluates whether events and
circumstances have occurred that may affect the estimated useful life or the recoverability of the remaining balance of its intangibles. Based on accounting standards in effect at December 31,
2001, the Company measures impairment of goodwill and other intangibles using undiscounted cash flows, and on that basis, believes that no impairment of goodwill or other intangible assets exists at
December 31, 2001. As discussed in more detail in Note 2, "Recent Accounting Pronouncements," the Financial Accounting Standards Board issued new statements during 2001, which will
impact the Company's accounting for goodwill and other intangibles in future periods.
Policy
acquisition costs consist of commissions and other administrative costs that the Company incurs to acquire new business. The Company currently does not defer policy acquisition costs. Premium
is collected and billed and commissions and other administrative costs are incurred on a month-to-month basis. Policy acquisition costs are expensed in the period incurred.
Reinsurance
premiums, commissions and expense reimbursements on reinsured business are accounted for on a basis consistent with those used in accounting for the original policies issued and the terms
of the reinsurance contracts. Premiums and benefits ceded to other companies have been reported as a reduction of premium revenue and benefits. Reinsurance receivables and prepaid reinsurance premium
amounts are reported as assets.
The
Company limits the maximum net loss that can arise from certain lines of business by reinsuring (ceding) a portion of these risks with other insurance organizations (reinsurers) on an excess of
loss or
F-8
quota share basis. The Company's retention limit per covered life is $500,000 per policy year for medical claims and $50,000 for life claims. The Company is liable on reinsurance ceded in the event
that the reinsurers do not meet their contractual obligations.
A
summary of reinsurance assumed and ceded is as follows:
|
|
Year ended December 31,
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
(In thousands)
|
Reinsurance assumed: |
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
1,515 |
|
$ |
8,725 |
|
$ |
58,924 |
|
Medical and other benefits |
|
|
1,395 |
|
|
9,921 |
|
|
52,137 |
Reinsurance ceded: |
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
2,532 |
|
$ |
2,523 |
|
$ |
4,916 |
|
Medical and other benefits |
|
|
1,910 |
|
|
3,250 |
|
|
7,897 |
The
liabilities for medical and other benefits represent estimates of the ultimate net cost of all reported and unreported claims that are unpaid at year end. These estimates are developed using
actuarial methods based upon historical data for payment patterns, cost trends, product mix, seasonality, utilization of health care services and other relevant factors. The estimates are reviewed
periodically and, as adjustments to the liabilities become necessary, the adjustments are reflected in current operations. Management believes that the amount of medical and other benefits payable is
adequate to cover the Company's liability for unpaid claims as of December 31, 2001.
The
Company recognizes premium deficiency reserves on an existing group of insurance contracts when the sum of expected future claim costs, claim adjustment expenses and related maintenance expenses
exceeds the expected future premium revenue and investment income. Insurance contracts are grouped as relating to highly regulated markets or all other markets consistent with the Company's manner of
acquiring, servicing and measuring the profitability of its business. Highly regulated markets are identified based on significant rating restrictions, states' general legislative and regulatory
environments, and the Company's ability to effectively underwrite risk. The Company continues to evaluate assumptions used in the premium deficiency reserve analysis and records or adjusts premium
deficiency reserves as necessary.
During
1999, the Company established a premium deficiency reserve of $19,200,000 for its highly regulated markets. Premium deficiency reserves are included in medical and other benefits payable in the
Company's consolidated balance sheets. At December 31, 2000, the Company had a remaining recorded premium deficiency reserve of $1,142,000, which was fully amortized during 2001 leaving no
remaining recorded premium deficiency reserve at December 31, 2001.
F-9
Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax
purposes. A valuation allowance is recognized when, based on available evidence, it is more likely than not that the deferred tax asset may not be realized.
Premiums
for health and life policies are recognized ratably over the period that insurance coverage is provided. Other revenue, including administrative fee income from claim processing and other
administrative services, is recognized in the period the service is provided.
The
Company has deferred compensation payable to employees of $3,167,000 and $3,388,000 at December 31, 2001 and 2000, respectively.
Comprehensive
income (loss) is defined as net income (loss) plus or minus other comprehensive income (loss). For the Company, under existing accounting standards, other comprehensive income (loss)
includes unrealized gains and losses, net of income tax effects, on certain investments in debt and equity securities. Comprehensive income (loss) is reported by the Company in the consolidated
statements of changes in shareholders' equity and comprehensive income (loss). For the three months ended March 31, 2001 (not separately presented in the Statements of Changes in Shareholders'
Equity), unaudited comprehensive loss was $1,748,000, comprised of net loss of $5,140,000 and unrealized gain on available for sale securities of $3,392,000.
F-10
A
reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per common share ("EPS") is as follows:
|
|
Three Months Ended
March 31,
|
|
Year ended December 31,
|
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
Numerator (in thousands): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic EPSweighted average shares |
|
|
13,802,666 |
|
|
14,210,643 |
|
|
14,048,545 |
|
|
14,898,652 |
|
|
16,470,096 |
|
|
Effect of dilutive securitiesemployee stock options |
|
|
688,875 |
|
|
|
|
|
179,143 |
|
|
150,651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted EPS |
|
|
14,491,541 |
|
|
14,210,643 |
|
|
14,227,688 |
|
|
15,049,303 |
|
|
16,470,096 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
|
Diluted |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
Options
to purchase 3,243,767 and 3,460,130 shares of common stock were outstanding at December 31, 2001 and 2000, respectively. Of those shares, 1,914,313 and 2,030,170 were excluded from the
computation of diluted earnings (loss) per common share for the respective years because the option's exercise price was greater than the average market price of common shares and, therefore, the
effect would be antidilutive. There was no effect of dilutive securities for 1999 and the three months ended March 31, 2001 because employee stock options were antidilutive during those
periods.
2. Recent Accounting Pronouncements
In June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 142, Goodwill and Other
Intangible Assets ("Statement 142"), effective for fiscal years beginning after December 15, 2001. The new rules
will impact the Company in two ways. First, goodwill and intangible assets deemed to have indefinite lives will no longer be amortized. Other intangible assets will continue to be amortized over their
useful lives. Second, goodwill and intangible assets with indefinite lives will be subject to an initial impairment test in accordance with Statement 142, and any remaining balance of goodwill
and intangible assets will be subject to future annual impairment testing.
The
Company will apply the new rules on accounting for goodwill and other intangible assets beginning in the first quarter of 2002. Application of the nonamortization provisions of
Statement 142 is expected to result in an increase in net income of approximately $2,700,000 per year. The Company will perform the first of the required impairment tests of goodwill and
intangible assets deemed to have indefinite lives in 2002, effective as of January 1, 2002, by comparing the fair value of the Company's reporting units to their carrying amounts (book value),
including goodwill. In determining the fair value of the
F-11
Company's reporting units, management will consider valuation techniques such as the quoted market price of the Company's stock, the present value of future cash flows and market comparison of
similar assets and liabilities.
At
December 31, 2001, the Company's book value per share was $16.30 and was significantly higher than the $12.45 quoted market price per share. As of December 31, 2001 and
March 31, 2002, the Company has not yet determined what the effect of these tests will be on the earnings and financial position of the Company. If management determines that the quoted market
price per share is the appropriate measure of the Company's fair value, the resulting impairment would be greater than 50% of the amount of goodwill on the Company's December 31, 2001 balance
sheet. If it is determined that an impairment exists as of January 1, 2002, the charge would be reported as the cumulative effect of a change in accounting principle in the Company's
consolidated financial statements and would have no impact on cash flows or the statutory-basis capital and surplus of the Company's insurance subsidiaries.
March 31, 2002 Update (unaudited)
On January 1, 2002, the Company adopted Statement 142. Effective January 1, 2002, in accordance with Statement 142, the Company reclassified an intangible
asset, net of related deferred taxes, into goodwill because it did not meet the new recognition criteria for an intangible asset to be recognized apart from goodwill. The amortization period used
prior to 2002 for this intangible asset was the same as the amortization period for goodwill.
The
Company's other intangible asset will continue to be amortized on a straight-line basis over its remaining useful life of five years. This intangible asset had a gross carrying amount of
$7.3 million and accumulated amortization of $3.7 million at December 31, 2001. Future amortization expense for this intangible asset is expected to be approximately
$0.7 million for each of the next five years.
F-12
The
following unaudited table illustrates net income (loss) and net income (loss) per share adjusted to exclude the effects of adopting Statement 142:
|
|
Three months ended
March 31,
|
|
Year ended December 31,
|
|
|
|
2002
|
|
2001
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands, except share and per share data)
|
|
Reported net income (loss) |
|
$ |
5,430 |
|
$ |
(5,140 |
) |
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
Add back: Goodwill amortization |
|
|
|
|
|
671 |
|
|
2,685 |
|
|
2,685 |
|
|
2,827 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income (loss) |
|
$ |
5,430 |
|
$ |
(4,469 |
) |
$ |
6,860 |
|
$ |
5,354 |
|
$ |
(23,119 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income (loss) |
|
$ |
0.39 |
|
$ |
(0.36 |
) |
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
|
Goodwill amortization |
|
|
|
|
|
0.05 |
|
|
0.19 |
|
|
0.18 |
|
|
0.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income (loss) |
|
$ |
0.39 |
|
$ |
(0.31 |
) |
$ |
0.49 |
|
$ |
0.36 |
|
$ |
(1.40 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income (loss) |
|
$ |
0.37 |
|
$ |
(0.36 |
) |
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
|
Goodwill amortization |
|
|
|
|
|
0.05 |
|
|
0.19 |
|
|
0.18 |
|
|
0.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income (loss) |
|
$ |
0.37 |
|
$ |
(0.31 |
) |
$ |
0.48 |
|
$ |
0.36 |
|
$ |
(1.40 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
amortization for 1998 and 1997 was $2,827,000 or $0.17 per share and $2,618,000 or $0.16 per share, respectively.
F-13
3. Medical and Other Benefits Payable
Activity related to liabilities for unpaid claims included in medical and other benefits payable is summarized as follows:
|
|
December 31,
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
(In thousands)
|
Balance at January 1 |
|
$ |
134,690 |
|
$ |
141,177 |
|
$ |
101,700 |
|
Less reinsurance recoverables |
|
|
476 |
|
|
992 |
|
|
1,058 |
|
|
|
|
|
|
|
Net balance at January 1 |
|
|
134,214 |
|
|
140,185 |
|
|
100,642 |
Incurred related to: |
|
|
|
|
|
|
|
|
|
|
Current year |
|
|
612,491 |
|
|
720,897 |
|
|
792,105 |
|
Prior years |
|
|
(12,026 |
) |
|
(3,397 |
) |
|
10,398 |
|
|
|
|
|
|
|
Total incurred |
|
|
600,465 |
|
|
717,500 |
|
|
802,503 |
Paid related to: |
|
|
|
|
|
|
|
|
|
|
Current year |
|
|
487,400 |
|
|
587,828 |
|
|
651,941 |
|
Prior years |
|
|
120,300 |
|
|
135,643 |
|
|
111,019 |
|
|
|
|
|
|
|
Total paid |
|
|
607,700 |
|
|
723,471 |
|
|
762,960 |
|
|
|
|
|
|
|
Net balance at December 31 |
|
|
126,979 |
|
|
134,214 |
|
|
140,185 |
|
Plus reinsurance recoverables |
|
|
1,351 |
|
|
476 |
|
|
992 |
|
|
|
|
|
|
|
Balance at December 31 |
|
$ |
128,330 |
|
$ |
134,690 |
|
$ |
141,177 |
|
|
|
|
|
|
|
The
incurred amounts related to prior years represent the differences between the Company's estimated medical and other benefits payable for prior years' claims and the actual amounts required to
satisfy such claims. Actual amounts differ from previously recorded liabilities due to inherent variabilities associated with estimating health insurance benefits payable. The liabilities for unpaid
claims at December 31, 2000 and 1999 developed redundant in subsequent years by $12,026,000 and $3,397,000, respectively. The developed redundancy on the liability as of December 31,
2000 was due to an improvement in the Company's average medical claims cost per member in late 2000. The liability for unpaid claims at December 31, 1998, developed deficient by $10,398,000 in
the subsequent year as a result of an increase in medical claims trends that was higher than anticipated in late 1998. No additional premiums are collected or returned as a result of incurred claims
from prior years.
In
determining the liability for unpaid claims at December 31, 2001, management considered the potential impact of the September 11, 2001 events. Although the events of
September 11, 2001 did not have a direct material effect on the Company, management anticipated an indirect impact including, but not limited to, increased utilization by the general population
of mental health services for stress, anxiety, depression and similar conditions in the fourth quarter. Also, subsequent bio-terrorism threats and attacks were anticipated to result in
increased utilization of health care services including office visits, laboratory tests and prescription drugs for flu-like symptoms in the fourth quarter. While the impact of these claims
cannot be predicted with certainty, management believes adequate provision has been made for such claims as of December 31, 2001. Accordingly, the outcome of these matters is not expected to
have a material adverse effect on the financial position of the Company.
F-14
4. Investments
Net investment income and net realized investment losses include the following:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Net investment income: |
|
|
|
|
|
|
|
|
|
|
|
Interest on fixed maturities |
|
$ |
15,728 |
|
$ |
17,867 |
|
$ |
18,731 |
|
|
Dividends on equity securities |
|
|
148 |
|
|
148 |
|
|
134 |
|
|
Unrealized loss on trading securities |
|
|
(34 |
) |
|
(21 |
) |
|
|
|
|
Interest on cash equivalents and other investment income |
|
|
2,223 |
|
|
1,629 |
|
|
1,581 |
|
|
Investment expenses |
|
|
(622 |
) |
|
(616 |
) |
|
(680 |
) |
|
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ |
17,443 |
|
$ |
19,007 |
|
$ |
19,766 |
|
|
|
|
|
|
|
|
|
Net realized investment losses: |
|
|
|
|
|
|
|
|
|
|
|
Realized investment losses |
|
$ |
(2,323 |
) |
$ |
(436 |
) |
$ |
(2,205 |
) |
|
Realized investment gains |
|
|
1,544 |
|
|
111 |
|
|
1,351 |
|
|
|
|
|
|
|
|
|
|
|
Net realized investment losses |
|
$ |
(779 |
) |
$ |
(325 |
) |
$ |
(854 |
) |
|
|
|
|
|
|
|
|
Unrealized gains (losses) are computed as the difference between estimated fair value and amortized cost for fixed maturities and equity securities classified
as available for sale. A summary of the net change in unrealized gains (losses), which is included in accumulated other comprehensive income (loss), is as follows:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Fixed maturities |
|
$ |
8,847 |
|
$ |
9,854 |
|
$ |
(17,753 |
) |
Equity securities |
|
|
154 |
|
|
170 |
|
|
(260 |
) |
|
|
|
|
|
|
|
|
|
Net change in unrealized gains (losses) |
|
$ |
9,001 |
|
$ |
10,024 |
|
$ |
(18,013 |
) |
|
|
|
|
|
|
|
|
Changes in accumulated other comprehensive income (loss) related to changes in unrealized gains and losses on securities are as follows:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Change in net unrealized gain (loss) on securities, net of taxes |
|
$ |
6,357 |
|
$ |
6,727 |
|
$ |
(12,264 |
) |
Less: reclassification adjustment for losses included in net income (loss), net of tax benefit of $273,000, $114,000 and $299,000 in 2001, 2000 and 1999 respectively |
|
|
(506 |
) |
|
(211 |
) |
|
(555 |
) |
|
|
|
|
|
|
|
|
|
Change in net unrealized gain (loss) on securities, net of taxes |
|
$ |
5,851 |
|
$ |
6,516 |
|
$ |
(11,709 |
) |
|
|
|
|
|
|
|
|
F-15
The amortized cost and estimated fair values of investments are as follows:
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
|
|
(In thousands)
|
At December 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
Available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
$ |
47,869 |
|
$ |
283 |
|
$ |
(1 |
) |
$ |
48,151 |
|
|
Corporate debt securities |
|
|
115,263 |
|
|
2,447 |
|
|
(1,068 |
) |
|
116,642 |
|
|
Foreign government securities |
|
|
12,391 |
|
|
442 |
|
|
(2 |
) |
|
12,831 |
|
|
Government agency mortgage-backed securities |
|
|
77,966 |
|
|
691 |
|
|
(101 |
) |
|
78,556 |
|
|
Municipal securities |
|
|
13,351 |
|
|
223 |
|
|
(1 |
) |
|
13,573 |
|
|
|
|
|
|
|
|
|
|
|
|
266,840 |
|
|
4,086 |
|
|
(1,173 |
) |
|
269,753 |
|
Equity securitiespreferred |
|
|
708 |
|
|
14 |
|
|
|
|
|
722 |
Held to maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
4,286 |
|
|
73 |
|
|
|
|
|
4,359 |
|
|
|
|
|
|
|
|
|
|
|
$ |
271,834 |
|
$ |
4,173 |
|
$ |
(1,173 |
) |
$ |
274,834 |
|
|
|
|
|
|
|
|
|
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
|
|
(In thousands)
|
At December 31, 2000: |
|
|
|
|
|
|
|
|
|
|
|
|
Available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
$ |
51,657 |
|
$ |
160 |
|
$ |
(340 |
) |
$ |
51,477 |
|
|
Corporate debt securities |
|
|
145,817 |
|
|
213 |
|
|
(5,142 |
) |
|
140,888 |
|
|
Foreign government securities |
|
|
15,614 |
|
|
82 |
|
|
(356 |
) |
|
15,340 |
|
|
Government agency mortgage-backed securities |
|
|
37,718 |
|
|
45 |
|
|
(513 |
) |
|
37,250 |
|
|
Municipal securities |
|
|
17,556 |
|
|
6 |
|
|
(89 |
) |
|
17,473 |
|
|
|
|
|
|
|
|
|
|
|
|
268,362 |
|
|
506 |
|
|
(6,440 |
) |
|
262,428 |
|
Equity securitiespreferred |
|
|
2,508 |
|
|
|
|
|
(140 |
) |
|
2,368 |
Held to maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
4,320 |
|
|
10 |
|
|
(16 |
) |
|
4,314 |
|
|
|
|
|
|
|
|
|
|
|
$ |
275,190 |
|
$ |
516 |
|
$ |
(6,596 |
) |
$ |
269,110 |
|
|
|
|
|
|
|
|
|
F-16
The amortized cost and estimated fair values of debt securities at December 31, 2001 by contractual maturity are shown below. Expected maturities will
differ from contractual maturities because borrowers may have the right to call or prepay obligations.
|
|
Available-for-Sale
|
|
Held-to-Maturity
|
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
|
(In thousands)
|
Due in one year or less |
|
$ |
9,370 |
|
$ |
9,515 |
|
$ |
2,228 |
|
$ |
2,244 |
Due after one through five years |
|
|
99,796 |
|
|
101,646 |
|
|
755 |
|
|
775 |
Due after five through ten years |
|
|
56,392 |
|
|
56,559 |
|
|
1,303 |
|
|
1,340 |
Due after ten years |
|
|
23,316 |
|
|
23,477 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
188,874 |
|
|
191,197 |
|
|
4,286 |
|
|
4,359 |
Government agency mortgage-backed securities |
|
|
77,966 |
|
|
78,556 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
266,840 |
|
$ |
269,753 |
|
$ |
4,286 |
|
$ |
4,359 |
|
|
|
|
|
|
|
|
|
At December 31, 2001, the insurance subsidiaries had fixed securities and cash equivalents on deposit with various state insurance departments with
carrying values of approximately $4,500,000.
5. Property and Equipment
Property and equipment are stated at cost and are summarized as follows:
|
|
December 31,
|
|
|
|
2001
|
|
2000
|
|
|
|
(In thousands)
|
|
Land and land improvements |
|
$ |
3,893 |
|
$ |
3,890 |
|
Building and building improvements |
|
|
24,315 |
|
|
24,301 |
|
Computer equipment and software |
|
|
18,121 |
|
|
13,024 |
|
Furniture and other equipment |
|
|
13,559 |
|
|
13,495 |
|
|
|
|
|
|
|
|
|
|
59,888 |
|
|
54,710 |
|
Less accumulated depreciation |
|
|
(26,507 |
) |
|
(22,259 |
) |
|
|
|
|
|
|
|
|
$ |
33,381 |
|
$ |
32,451 |
|
|
|
|
|
|
|
The Company recognized depreciation expense on property and equipment of $5,555,000, $4,656,000 and $4,544,000 in 2001, 2000 and 1999, respectively.
F-17
6. Debt
Notes payable consists of the following:
|
|
December 31,
|
|
|
2001
|
|
2000
|
|
|
(In thousands)
|
Line of credit, commercial banks, adjusted periodically, interest payments due quarterly through February 2005 |
|
$ |
35,158 |
|
$ |
35,158 |
Mortgage payable, commercial bank, 9.05% interest, monthly principal payments of $100,000 plus interest through January 1, 2004 |
|
|
4,900 |
|
|
6,100 |
|
|
|
|
|
|
|
$ |
40,058 |
|
$ |
41,258 |
|
|
|
|
|
At December 31, 2001, the Company maintained a revolving bank line of credit agreement with a maximum commitment and outstanding balance of advances under the
credit agreement of $35,158,000. Interest is charged on the outstanding balance based upon an indexed floating rate of interest. As
collateral for the outstanding balance, the Company is required to maintain a minimum cash deposit of $2,500,000 in an account at the lender's institution. The credit agreement contains customary
covenants which, among other matters, require the Company to achieve certain minimum financial results and restrict the Company's ability to incur additional debt, pay future cash dividends and
dispose of assets outside the ordinary course of business. The Company was in compliance with all such covenants at December 31, 2001. Obligations under the credit agreement are secured by the
stock of the Company's principal subsidiaries.
The
credit agreement was amended in January 2001 and April 2001 to revise the minimum financial requirements of certain covenants. The April 2001 amendment also revised the
Company's applicable interest rate on outstanding loans and the schedule of mandatory future commitment reductions including a $4,842,000 maximum commitment reduction from $40,000,000 to $35,158,000.
Future
annual principal amounts due for all of the Company's debt, including the credit agreement, as of December 31, 2001 are $6,200,000 for 2002, $11,200,000 for 2003, $12,500,000 for 2004,
and $10,158,000 for 2005. During 2001, 2000 and 1999, interest paid totaled $2,931,000, $4,005,000 and $3,547,000, respectively.
The
mortgage payable is collateralized by the Company's home office property located in Green Bay, Wisconsin. The Company believes the carrying value of all notes payable approximates fair value.
March 31, 2002 Update (Unaudited)
At March 31, 2002, the outstanding balance and maximum commitment related to the credit agreement was $30.2 million.
7. Income Taxes
The Company and most of its subsidiaries file a consolidated federal income tax return. The Company and its subsidiaries file separate state franchise, income and
premium tax returns as applicable.
The
Company had a net current federal income tax payable of $4,012,000 and a net current federal income tax receivable of $2,094,000 at December 31, 2001 and 2000, respectively. The Company and
its subsidiaries had state net business loss carryforwards totaling $92,327,000 at December 31, 2001, which
F-18
will begin to expire in the year 2008. The Company received net federal and state income tax refunds of $466,000 and $6,910,000 in 2001 and 2000, respectively and paid net federal and state income
taxes of $1,496,000 in 1999.
The
components of income tax expense (benefit) are as follows:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Current: |
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
5,410 |
|
$ |
(3,077 |
) |
$ |
(5,965 |
) |
|
State |
|
|
238 |
|
|
495 |
|
|
34 |
|
|
|
|
|
|
|
|
|
|
|
|
5,648 |
|
|
(2,582 |
) |
|
(5,931 |
) |
Deferred: |
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
|
313 |
|
|
5,673 |
|
|
(6,244 |
) |
|
State |
|
|
296 |
|
|
356 |
|
|
(868 |
) |
|
|
|
|
|
|
|
|
|
|
|
609 |
|
|
6,029 |
|
|
(7,112 |
) |
|
|
|
|
|
|
|
|
|
Income tax expense (benefit) |
|
$ |
6,257 |
|
$ |
3,447 |
|
$ |
(13,043 |
) |
|
|
|
|
|
|
|
|
The differences between taxes computed at the federal statutory rate and recorded income taxes are as follows:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Income tax expense (benefit) at federal statutory rate |
|
$ |
3,651 |
|
$ |
2,141 |
|
$ |
(13,658 |
) |
Goodwill amortization |
|
|
829 |
|
|
829 |
|
|
879 |
|
State income and franchise taxes, net of federal benefit |
|
|
571 |
|
|
415 |
|
|
(565 |
) |
Other, net |
|
|
1,206 |
|
|
62 |
|
|
301 |
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit) |
|
$ |
6,257 |
|
$ |
3,447 |
|
$ |
(13,043 |
) |
|
|
|
|
|
|
|
|
F-19
Significant components of the Company's federal and state deferred tax liabilities and assets are as follows:
|
|
December 31, 2001
|
|
December 31, 2000
|
|
|
|
Federal
|
|
State
|
|
Federal
|
|
State
|
|
|
|
(In thousands)
|
|
Deferred tax assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liabilities |
|
$ |
1,231 |
|
$ |
63 |
|
$ |
2,031 |
|
$ |
137 |
|
|
Unearned income |
|
|
782 |
|
|
56 |
|
|
1,348 |
|
|
82 |
|
|
Unrealized losses on investments |
|
|
|
|
|
|
|
|
2,126 |
|
|
|
|
|
Employee compensation and benefits |
|
|
2,561 |
|
|
440 |
|
|
2,977 |
|
|
538 |
|
|
Accrued expenses |
|
|
4,289 |
|
|
611 |
|
|
2,087 |
|
|
371 |
|
|
Specified policy acquisition costs |
|
|
765 |
|
|
39 |
|
|
874 |
|
|
45 |
|
|
Net business loss carryforwards |
|
|
1,082 |
|
|
6,384 |
|
|
1,082 |
|
|
6,176 |
|
|
Other deductible temporary differences |
|
|
2,428 |
|
|
586 |
|
|
2,584 |
|
|
492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,138 |
|
|
8,179 |
|
|
15,109 |
|
|
7,841 |
|
|
Valuation allowances |
|
|
(1,963 |
) |
|
(3,431 |
) |
|
(1,082 |
) |
|
(2,779 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
11,175 |
|
|
4,748 |
|
|
14,027 |
|
|
5,062 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangibles |
|
|
6,457 |
|
|
1,459 |
|
|
6,790 |
|
|
1,533 |
|
|
Prepaid assets |
|
|
1,145 |
|
|
115 |
|
|
1,346 |
|
|
151 |
|
|
Depreciation and amortization |
|
|
1,889 |
|
|
361 |
|
|
1,462 |
|
|
278 |
|
|
Unrealized gain on investments |
|
|
1,024 |
|
|
|
|
|
|
|
|
|
|
|
Other taxable temporary differences |
|
|
1,815 |
|
|
11 |
|
|
2,112 |
|
|
26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,330 |
|
|
1,946 |
|
|
11,710 |
|
|
1,988 |
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax assets (liabilities) |
|
$ |
(1,155 |
) |
$ |
2,802 |
|
$ |
2,317 |
|
$ |
3,074 |
|
|
|
|
|
|
|
|
|
|
|
The federal deferred benefit arising from the deductibility of state deferred tax is included as a component of other federal deferred taxes. The net deferred
taxes are included in other assets in the accompanying consolidated balance sheets.
8. Commitments and Contingencies
On August 26, 1999, a $6,900,000 verdict was entered against the Company in a lawsuit involving allegations regarding the Company's administration of a
self-funded benefit plan for Skilstaf, Inc., an employee leasing company. The Company appealed the verdict and expected the verdict to be reversed or substantially reduced following
appeal. Based upon management's evaluation of the merits of the appeal, the facts of the case and consultation with outside legal counsel, management concluded that the likelihood of the appellate
court affirming the verdict was not probable. As a result, the Company's accrual related to this case at the end of 1999 and 2000 was not material. Following an adverse decision from the Court of
Appeals on March 12, 2001, the Company recognized an additional accrual during the first quarter of 2001 representing the full potential loss including punitive damages and other
F-20
expenses. In July 2001, at the direction of the district court, the Company paid the full amount of the verdict plus interest and the case is closed.
On February 7, 2000, a $5,400,000 verdict was entered against the Company in a lawsuit filed by Health Administrators, Inc., an insurance agency owned and
operated by a former agent of the Company, which alleged breach of contract involving commission amounts due to such agent. The Company appealed the verdict and on March 29, 2001, the Ohio
Court of Appeals affirmed a portion of the verdict, with modifications, representing approximately $3,000,000 in damages. The affirmed portion of the verdict was paid by the Company during 2001 and is
considered closed. The appeals court reversed and
remanded the remaining issue in the case representing approximately $2,400,000 in damages. Briefs have been submitted for the remanded portion of the case and the parties are awaiting the trial
court's decision.
Class Action LitigationStatus at December 31, 2001
In February 2000, a complaint was filed against the Company in the Circuit Court for Palm Beach County, Florida, seeking certification of a statewide class action on
behalf of certain individuals insured by or formerly insured by the Company. Plaintiffs allege the Company did not follow Florida law when it discontinued writing certain health insurance policies and
offered new policies in 1998. Plaintiffs claim the Company wrongfully terminated policies, improperly notified insureds of conversion rights and charged improper premium for the new policies.
Plaintiffs also assert that the Company's renewal rating methodology violates Florida law. Plaintiffs are seeking unspecified damages. A motion for class certification was granted by the Circuit Court
and appealed to the Fourth District Court of Appeals of the State of Florida, which upheld the class certification in October 2001. The Company has an appeal pending with the Florida Supreme
Court with the ultimate objective of seeking to vacate the finding of a certifiable class. The Company and plaintiffs filed cross motions for summary judgment in Circuit Court that were heard and
denied in February 2002. A memorandum filed by plaintiffs in January 2002 in support of their motion for summary judgment raised new arguments that expanded the legal theory, scope and
potential damages of the case. The trial is tentatively scheduled to commence as a bench trial in March 2002. Management believes the Company acted in compliance with applicable Florida law
with regard to the discontinuance and replacement of and conversion of insurance policies and with regard to its renewal rating practices. Although the outcome of the case cannot be predicted with
certainty, management believes this suit is without merit and is defending its position vigorously.
Class Action LitigationMarch 31, 2002 (Unaudited)
In March 2002, a bench trial on the liability issues of the case was held. On April 24, 2002, a judgment was rendered against the Company and the damages portion of the
lawsuit is expected to be heard before a jury later this year. In a separate administrative proceeding based on similar facts with similar issues, the Florida Department of Insurance issued a
complaint against the Company in May 2001, challenging the Company's rating and other practices in Florida. On April 25, 2002, the Administrative Law Judge found in favor of the Company and
held that the evidence presented by the Florida Department of Insurance did not support a conclusion that the Company had violated any provisions of the Florida insurance statutes or regulations. The
Administrative Law Judge recommended that the
F-21
administrative complaint be dismissed. The Administrative Law Judge's Recommended Order has been sent to the Commissioner of the Florida Department of Insurance for entry of a final order. The
Company and the Department have filed arguments with the Commissioner, who must now decide whether to adopt the Recommended Order as presented or modify it. In light of the conflicting findings in
these cases, the Company intends to request that the court in the class action lawsuit reconsider its ruling. If the ruling is not reconsidered, the Company intends to appeal the ruling.
The
Company is involved in various legal and regulatory actions occurring in the normal course of business. Based on current information including consultation with outside counsel, management
believes any ultimate liability that may arise from the above-mentioned and all other legal and regulatory actions would not materially affect the Company's consolidated financial position or results
of operations. However, management's evaluation of the likely impact of these actions could change in the future and an unfavorable outcome could have a material adverse effect on the Company's
consolidated financial position, results of operations or cash flow of a future period.
9. Shareholders' Equity
State
insurance laws and regulations prescribe accounting practices for determining statutory net income and equity for insurance companies. These regulations require, among other matters, the filing
of financial statements prepared in accordance with statutory accounting practices prescribed or permitted for insurance companies. The combined statutory capital and surplus of the Company's
insurance subsidiaries, United Wisconsin Life Insurance Company and American Medical Security Insurance Company of Georgia, at December 31, 2001 and 2000, was $161,789,000 and $153,912,000,
respectively. The combined statutory net income of the Company's insurance subsidiaries was $18,052,000 and $7,808,000 for the years ended December 31, 2001 and 2000, respectively, and the
combined statutory net loss was $20,782,000 for the year ended December 31, 1999.
State
insurance regulations also require the maintenance of a minimum compulsory surplus based on a percentage of premiums written. At December 31, 2001, the Company's insurance subsidiaries
were in compliance with these compulsory regulatory requirements.
Effective
January 1, 2001, the National Association of Insurance Commissioners revised the Accounting Practices and Procedures Manual in a process referred to as Codification. Codification has
changed certain prescribed statutory accounting practices resulting in changes to the accounting practices that the insurance subsidiaries of the Company use to prepare their statutory-basis financial
statements. The impact of Codification to the Company's insurance subsidiaries' statutory-basis capital and surplus was not material.
Dividends
paid by the insurance subsidiaries to the parent Company are limited by state insurance regulations. The insurance regulator in the insurer's state of domicile may disapprove any dividend
which, together with other dividends paid by an insurance company in the prior 12 months, exceeds the regulatory maximum, computed as the lesser of 10% of statutory surplus or total statutory
net gain from operations as of the end of the preceding calendar year. Based upon the financial statements of
F-22
the Company's insurance subsidiaries as of December 31, 2001, as filed with the insurance regulators, dividends are limited to $6,963,000 without prior regulatory approval until
September 2002, at which time the aggregate amount available without regulatory approval is $14,963,000. In February 2002, a $5,000,000 dividend was paid to the parent Company by an
insurance subsidiary.
In
August 2001, the Board of Directors of the Company adopted a shareholders' rights agreement (the "rights agreement") and declared a dividend of one preferred share purchase right for each
outstanding share of common stock of the Company. When exercisable, each right entitles the registered holder to purchase from the Company a unit consisting of one ten-thousandth of a
share of Series B Junior Cumulative Preferred Stock of the Company at a price of $30.00. The rights agreement, as amended, is designed to deter takeover initiatives not considered to be in the
best interests of the Company's shareholders. In the event that a person or a group has become the beneficial owner of 12% or more of the common shares then outstanding, in certain circumstances the
rights become exercisable, and each holder of a right will have the right to receive, upon exercise, common shares having a value equal to two times the exercise price of the right. The rights are
redeemable by action of the Company's Board of Directors at any time prior to their becoming exercisable. The rights expire on August 20, 2011.
10. Employee Benefit Plans
The
Company's employees are included in a qualified defined contribution plan (the "Retirement Savings Plan") with profit sharing and discretionary savings provisions covering all eligible salaried
and hourly employees. Participant contributions up to 6% of the participant's compensation are matched 60% by the Company. Effective January 1, 2002, participant contributions up to 6% of the
participant's compensation are matched 70% by the Company. Profit sharing contributions to the Retirement Savings Plan are determined annually by the Company. Participants vest in Company
contributions in three years. The Company recognized expense associated with the Retirement Savings Plan of $1,881,000, $1,944,000 and $1,610,000 in 2001, 2000 and 1999, respectively.
During
2000, the Company adopted a nonqualified executive retirement plan (the "Nonqualified Plan") to provide key management with the opportunity to accumulate deferred compensation which cannot be
accumulated under the Retirement Savings Plan due to compensation limitations imposed by the Internal Revenue Service. The Nonqualified Plan is funded through a rabbi trust and has contribution and
investment options similar to those of the Retirement Savings Plan. The Company recognized expense associated with the Nonqualified Plan of $53,000 and $77,000 during 2001 and 2000, respectively.
F-23
The
Company has a stock-based compensation plan, the Equity Incentive Plan (the "Plan"), for the benefit of eligible employees and directors of the Company. The Plan permits the grant of nonqualified
stock options ("NQSO"), incentive stock options, stock appreciation rights, restricted stock awards and performance awards. Persons eligible to participate in the Plan include all
full-time active employees and outside directors of the board of directors. The Plan allows for the granting of up to 4,000,000 shares of which 472,297 shares are available for grant as of
December 31, 2001. The Company's 1995 Director Stock Option Plan also permits the grant of NQSOs. The plan allows for the granting of up to 75,000 shares of which 14,000 shares are available
for grant, as of December 31, 2001.
The
terms of incentive stock options and nonqualified stock options granted under the Plan cannot exceed more than 10 and 12 years, respectively, and the option exercise price generally cannot
be less than the fair market value of the Company's common stock on the date of grant. Incentive stock options and NQSOs are not exercisable in any event prior to six months following the grant date.
Stock
appreciation rights generally have a grant price at least equal to 100% of the fair market value of the Company's common stock. The term of the stock appreciation rights cannot exceed
12 years. Stock appreciation rights are not exercisable prior to six months following the grant date.
Restricted
stock generally may not be sold or otherwise transferred for certain periods based on the passage of time, the achievement of performance goals or the occurrence of other events. However,
participants may exercise full voting rights and are entitled to receive all dividends and other distributions with respect to restricted stock. Restricted stock does not vest prior to six months
following the date of grant.
During
1998, the Company and a key executive entered into a deferred stock agreement. Under the agreement the Company has an obligation to issue 73,506 shares of the Company's common stock provided
the executive remains continuously employed with the Company through November 17, 2002. The Company incurred expense of $225,000 in each of the three years ended 2001, 2000 and 1999 related to
this agreement.
On
July 9, 2001, the Company and a key executive entered into a restricted stock agreement. Under the agreement, the Company granted the executive 25,000 shares of common stock, subject to
certain rights and restrictions, in exchange for the surrender for cancellation of 443,857 shares of the executive's nonqualified stock options. The 25,000 shares of restricted stock vested in
December 2001 upon the
occurrence of certain triggering events, as specified under the restricted stock agreement. The Company incurred expense of $139,000 during 2001 related to this agreement.
Effective
January 1, 2000, the Company adopted a deferred compensation plan for the benefit of certain outside directors of the Company who wish to defer the receipt of eligible compensation
which they may otherwise be entitled to receive from the Company. Directors who choose to participate in the plan may elect to have their deferred compensation credited to, in whole or in part, either
an interest account or a Company stock unit account.
F-24
Stock
option activity for all plans is as follows:
|
|
December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
Total number of NQSOs |
|
|
|
|
|
|
|
|
|
|
Outstanding at beginning of year |
|
|
3,460,130 |
|
|
2,809,143 |
|
|
2,918,893 |
|
Granted |
|
|
426,000 |
|
|
715,000 |
|
|
999,000 |
|
Exercised |
|
|
(26,756 |
) |
|
|
|
|
|
|
Forfeited |
|
|
(615,607 |
) |
|
(64,013 |
) |
|
(1,108,750 |
) |
|
|
|
|
|
|
|
|
Outstanding at end of year |
|
|
3,243,767 |
|
|
3,460,130 |
|
|
2,809,143 |
|
|
|
|
|
|
|
|
|
Exercisable at end of year |
|
|
1,826,017 |
|
|
1,807,963 |
|
|
1,504,976 |
|
Available for grant at end of year |
|
|
486,297 |
|
|
296,690 |
|
|
947,677 |
|
Weighted average exercise price of NQSOs |
|
|
|
|
|
|
|
|
|
|
Outstanding at beginning of year |
|
$ |
9.86 |
|
$ |
11.10 |
|
$ |
15.18 |
|
GrantedExercise price equals market price on grant date |
|
|
9.97 |
|
|
5.28 |
|
|
7.33 |
|
GrantedExercise price is less than market price on grant date |
|
|
|
|
|
|
|
|
|
|
GrantedExercise price exceeds market price on grant date |
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
5.15 |
|
|
|
|
|
|
|
Forfeited |
|
|
14.09 |
|
|
13.14 |
|
|
18.45 |
|
Outstanding at end of year |
|
|
9.11 |
|
|
9.86 |
|
|
11.10 |
|
Exercisable at end of year |
|
|
10.33 |
|
|
12.60 |
|
|
13.68 |
|
F-25
NQSOs by exercise price range |
|
|
|
|
|
|
|
|
|
|
Range of exercise prices |
|
$ |
3.01 - $8.88 |
|
$ |
3.01 - $8.88 |
|
$ |
3.01 - $8.88 |
|
Weighted average exercise price |
|
$ |
5.75 |
|
$ |
5.71 |
|
$ |
6.07 |
|
Weighted average remaining contractual life (years) |
|
|
10.08 |
|
|
11.03 |
|
|
11.34 |
|
Exercisable at end of year |
|
|
605,954 |
|
|
260,877 |
|
|
47,960 |
|
Outstanding at end of year |
|
|
1,471,454 |
|
|
1,571,960 |
|
|
856,960 |
|
Weighted average exercise price of options exercisable at end of year |
|
$ |
5.77 |
|
$ |
5.64 |
|
$ |
3.01 |
|
Range of exercise prices |
|
$ |
10.20 - $14.38 |
|
$ |
10.25 - $14.38 |
|
$ |
10.25 - $14.38 |
|
Weighted average exercise price |
|
$ |
11.07 |
|
$ |
11.54 |
|
$ |
11.53 |
|
Weighted average remaining contractual life (years) |
|
|
8.78 |
|
|
8.75 |
|
|
9.79 |
|
Exercisable at end of year |
|
|
964,984 |
|
|
848,151 |
|
|
734,848 |
|
Outstanding at end of year |
|
|
1,517,234 |
|
|
1,189,234 |
|
|
1,230,015 |
|
Weighted average exercise price of options exercisable at end of year |
|
$ |
11.48 |
|
$ |
11.66 |
|
$ |
11.76 |
|
Range of exercise prices |
|
$ |
15.76 - $22.74 |
|
$ |
15.76 - $22.74 |
|
$ |
15.76 - $22.74 |
|
Weighted average exercise price |
|
$ |
16.83 |
|
$ |
16.33 |
|
$ |
16.33 |
|
Weighted average remaining contractual life (years) |
|
|
6.45 |
|
|
7.48 |
|
|
8.50 |
|
Exercisable at end of year |
|
|
255,079 |
|
|
698,936 |
|
|
722,168 |
|
Outstanding at end of year |
|
|
255,079 |
|
|
698,936 |
|
|
722,168 |
|
Weighted average exercise price of options exercisable at end of year |
|
$ |
16.83 |
|
$ |
16.33 |
|
$ |
16.33 |
|
The Black-Scholes option valuation model is commonly used in estimating the fair value of traded options which have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly subjective assumptions including the expected stock price volatility. Since the Company's employee stock options have
characteristics significantly different from those of
traded options, and because changes in the subjective input assumptions can materially affect the fair value estimates, in management's opinion, the existing models do not necessarily provide a
reliable single measure of the fair value of its employee stock options.
The
Company follows Accounting Principles Board Opinion No. 25 under which no compensation expense is recorded when the exercise price of the Company's employee stock options equals the market
price of the underlying stock on the date of grant. The Company's pro forma information regarding net income and net income per share has been determined as if these options had been accounted for
since January 1, 1995, in accordance with the fair value method of Statement of Financial Accounting Standards ("SFAS") No. 123, "Accounting for Stock-Based Compensation".
F-26
For
purposes of pro forma disclosures, the estimated fair value of the options is amortized to expense over the options' vesting period. The Company's pro forma information is as follows:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands, except per share data)
|
|
Net income (loss) |
|
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
Compensation expense in accordance with SFAS No. 123 |
|
|
(1,119 |
) |
|
(933 |
) |
|
(483 |
) |
|
|
|
|
|
|
|
|
Pro forma net income (loss) |
|
$ |
3,056 |
|
$ |
1,736 |
|
$ |
(26,429 |
) |
|
|
|
|
|
|
|
|
Earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.30 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
|
Diluted |
|
$ |
0.29 |
|
$ |
0.18 |
|
$ |
(1.58 |
) |
Pro forma earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.22 |
|
$ |
0.12 |
|
$ |
(1.60 |
) |
|
Diluted |
|
$ |
0.21 |
|
$ |
0.12 |
|
$ |
(1.60 |
) |
The pro forma disclosures only include the effect of options granted subsequent to January 1, 1995. Accordingly, the effects of applying the SFAS
No. 123 pro forma disclosures to future periods may not be indicative of future effects.
In
determining compensation expense in accordance with SFAS No. 123, the fair value for these options was estimated at the date of grant using the Black-Scholes option pricing model with the
following weighted average assumptions:
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
Expected life of options |
|
|
6.00 years |
|
|
6.00 years |
|
|
6.00 years |
|
Risk-free interest rate |
|
|
4.67 |
% |
|
5.73 |
% |
|
6.13 |
% |
Expected dividend yield |
|
|
0.00 |
% |
|
0.00 |
% |
|
0.00 |
% |
Expected volatility factor |
|
|
53 |
% |
|
56 |
% |
|
45 |
% |
Grant date fair value of options: |
|
|
|
|
|
|
|
|
|
|
|
Exercise price equals market price |
|
$ |
5.51 |
|
$ |
3.09 |
|
$ |
3.84 |
|
|
Exercise price is less than market price |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
Exercise price exceeds market price |
|
$ |
|
|
$ |
|
|
$ |
|
|
F-27
11. Quarterly Financial Information (Unaudited)
Selected quarterly financial data for the years ended December 31, 2001 and 2000 are as follows:
|
|
Quarter
|
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Total
|
|
|
(In thousands, except per share data)
|
2001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
232,258 |
|
$ |
223,306 |
|
$ |
213,388 |
|
$ |
207,669 |
|
$ |
876,621 |
Net income (loss) |
|
|
(5,140 |
) |
|
1,466 |
|
|
3,504 |
|
|
4,345 |
|
|
4,175 |
Earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
(0.36 |
) |
|
0.10 |
|
|
0.25 |
|
|
0.31 |
|
|
0.30 |
|
Diluted |
|
|
(0.36 |
) |
|
0.10 |
|
|
0.25 |
|
|
0.30 |
|
|
0.29 |
2000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
257,677 |
|
$ |
250,326 |
|
$ |
241,756 |
|
$ |
240,106 |
|
$ |
989,865 |
Net income (loss) |
|
|
1,659 |
|
|
2,260 |
|
|
(1,376 |
) |
|
126 |
|
|
2,669 |
Earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
0.11 |
|
|
0.15 |
|
|
(0.09 |
) |
|
0.01 |
|
|
0.18 |
|
Diluted |
|
|
0.11 |
|
|
0.15 |
|
|
(0.09 |
) |
|
0.01 |
|
|
0.18 |
12. Segments of the Business
The Company has two reportable segments: 1) health insurance products; and 2) life insurance products. The Company's health insurance products consist of the
following coverages related to small group PPO products: MedOneSM and small group medical, self-funded medical, dental and short-term disability. Life products
consist primarily of group term life insurance. The "All Other" category includes operations not directly related to the business segments and unallocated corporate items (i.e., corporate investment
income, interest expense on corporate debt, amortization of goodwill and intangibles and unallocated overhead expenses). The reportable segments are managed separately because they differ in the
nature of the products offered and in profit margins.
The
Company evaluates segment performance based on income or loss before income taxes, excluding gains and losses on the Company's investment portfolio. The accounting policies of the reportable
segments are the same as those described in the summary of significant accounting policies. Significant intercompany transactions have been eliminated prior to reporting reportable segment
information.
F-28
Selected
financial data for the Company by segment is as follows:
Three months ended March 31, 2002:
|
|
Health
Insurance
|
|
Life
Insurance
|
|
All Other
|
|
Total
Consolidated
|
(Unaudited)
|
|
(In thousands)
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
190,720 |
|
$ |
3,678 |
|
$ |
3 |
|
$ |
194,401 |
|
Net investment income |
|
|
1,934 |
|
|
150 |
|
|
1,840 |
|
|
3,924 |
|
Net realized investment gain |
|
|
|
|
|
|
|
|
14 |
|
|
14 |
|
Other revenue |
|
|
4,460 |
|
|
32 |
|
|
913 |
|
|
5,405 |
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
197,114 |
|
|
3,860 |
|
|
2,770 |
|
|
203,744 |
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
130,564 |
|
|
1,218 |
|
|
18 |
|
|
131,800 |
|
Selling, general and administrative |
|
|
58,208 |
|
|
1,219 |
|
|
2,597 |
|
|
62,024 |
|
Interest |
|
|
|
|
|
|
|
|
494 |
|
|
494 |
|
Amortization of other intangibles |
|
|
|
|
|
|
|
|
183 |
|
|
183 |
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
188,772 |
|
|
2,437 |
|
|
3,292 |
|
|
194,501 |
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
8,342 |
|
$ |
1,423 |
|
$ |
(522 |
) |
$ |
9,243 |
|
|
|
|
|
|
|
|
|
As of March 31, 2002: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets |
|
$ |
143,720 |
|
$ |
4,024 |
|
$ |
300,602 |
|
$ |
448,346 |
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2001:
|
|
Health
Insurance
|
|
Life
Insurance
|
|
All Other
|
|
Total
Consolidated
|
|
(Unaudited)
|
|
(In thousands)
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
216,974 |
|
$ |
4,963 |
|
$ |
533 |
|
$ |
222,470 |
|
|
Net investment income |
|
|
2,450 |
|
|
174 |
|
|
1,890 |
|
|
4,514 |
|
|
Net realized investment losses |
|
|
|
|
|
|
|
|
(27 |
) |
|
(27 |
) |
|
Other revenue |
|
|
4,230 |
|
|
42 |
|
|
1,029 |
|
|
5,301 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
223,654 |
|
|
5,179 |
|
|
3,425 |
|
|
232,258 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
164,197 |
|
|
1,992 |
|
|
391 |
|
|
166,580 |
|
|
Selling, general and administrative |
|
|
67,963 |
|
|
1,437 |
|
|
2,011 |
|
|
71,411 |
|
|
Interest |
|
|
|
|
|
|
|
|
876 |
|
|
876 |
|
|
Amortization of goodwill and other intangibles |
|
|
|
|
|
|
|
|
907 |
|
|
907 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
232,160 |
|
|
3,429 |
|
|
4,185 |
|
|
239,774 |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes(a) |
|
$ |
(8,506 |
) |
$ |
1,750 |
|
$ |
(760 |
) |
$ |
(7,516 |
) |
|
|
|
|
|
|
|
|
|
|
As of March 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets |
|
$ |
154,217 |
|
$ |
3,808 |
|
$ |
306,492 |
|
$ |
464,517 |
|
|
|
|
|
|
|
|
|
|
|
- (a)
- Excluding the first quarter 2001 litigation charge, pre-tax income for the health segment would have been $494,000 and consolidated pre-tax
income would have been $1,484,000.
F-29
Year ended December 31, 2001:
|
|
Health
Insurance
|
|
Life
Insurance
|
|
All Other
|
|
Total
Consolidated
|
|
|
|
(In thousands)
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
820,658 |
|
$ |
17,424 |
|
$ |
590 |
|
$ |
838,672 |
|
|
Net investment income |
|
|
9,197 |
|
|
656 |
|
|
7,590 |
|
|
17,443 |
|
|
Net realized investment losses |
|
|
|
|
|
|
|
|
(779 |
) |
|
(779 |
) |
|
Other revenue |
|
|
17,272 |
|
|
154 |
|
|
3,859 |
|
|
21,285 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
847,127 |
|
|
18,234 |
|
|
11,260 |
|
|
876,621 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
595,811 |
|
|
6,334 |
|
|
(203 |
) |
|
601,942 |
|
|
Selling, general and administrative |
|
|
244,453 |
|
|
5,446 |
|
|
7,843 |
|
|
257,742 |
|
|
Interest |
|
|
|
|
|
|
|
|
2,877 |
|
|
2,877 |
|
|
Amortization of goodwill and other intangibles |
|
|
|
|
|
|
|
|
3,628 |
|
|
3,628 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
840,264 |
|
|
11,780 |
|
|
14,145 |
|
|
866,189 |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes(a) |
|
$ |
6,863 |
|
$ |
6,454 |
|
$ |
(2,885 |
) |
$ |
10,432 |
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets |
|
$ |
147,889 |
|
$ |
3,958 |
|
$ |
321,168 |
|
$ |
473,015 |
|
|
|
|
|
|
|
|
|
|
|
- (a)
- Excluding
the first quarter 2001 litigation charge, pre-tax income for the health segment would have been $15,863,000 and consolidated pre-tax income would
have been $19,432,000.
Year ended December 31, 2000:
|
|
Health
Insurance
|
|
Life
Insurance
|
|
All Other
|
|
Total
Consolidated
|
|
|
|
(In thousands)
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
907,722 |
|
$ |
22,578 |
|
$ |
20,771 |
|
$ |
951,071 |
|
|
Net investment income |
|
|
9,513 |
|
|
638 |
|
|
8,856 |
|
|
19,007 |
|
|
Net realized investment losses |
|
|
|
|
|
|
|
|
(325 |
) |
|
(325 |
) |
|
Other revenue |
|
|
16,115 |
|
|
217 |
|
|
3,780 |
|
|
20,112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
933,350 |
|
|
23,433 |
|
|
33,082 |
|
|
989,865 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
700,511 |
|
|
7,781 |
|
|
16,321 |
|
|
724,613 |
|
|
Selling, general and administrative |
|
|
235,649 |
|
|
6,581 |
|
|
9,537 |
|
|
251,767 |
|
|
Interest |
|
|
|
|
|
|
|
|
3,584 |
|
|
3,584 |
|
|
Amortization of goodwill and other intangibles |
|
|
|
|
|
|
|
|
3,785 |
|
|
3,785 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
936,160 |
|
|
14,362 |
|
|
33,227 |
|
|
983,749 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
$ |
(2,810 |
) |
$ |
9,071 |
|
$ |
(145 |
) |
$ |
6,116 |
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2000: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets |
|
$ |
180,683 |
|
$ |
4,292 |
|
$ |
286,948 |
|
$ |
471,923 |
|
|
|
|
|
|
|
|
|
|
|
F-30
Year ended December 31, 1999:
|
|
Health
Insurance
|
|
Life
Insurance
|
|
All Other
|
|
Total
Consolidated
|
|
|
|
(In thousands)
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
|
$ |
985,322 |
|
$ |
26,183 |
|
$ |
44,602 |
|
$ |
1,056,107 |
|
|
Net investment income |
|
|
9,254 |
|
|
202 |
|
|
10,310 |
|
|
19,766 |
|
|
Net realized investment losses |
|
|
|
|
|
|
|
|
(854 |
) |
|
(854 |
) |
|
Other revenue |
|
|
17,857 |
|
|
258 |
|
|
4,246 |
|
|
22,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
1,012,433 |
|
|
26,643 |
|
|
58,304 |
|
|
1,097,380 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical and other benefits |
|
|
805,768 |
|
|
10,270 |
|
|
44,435 |
|
|
860,473 |
|
|
Selling, general and administrative |
|
|
245,676 |
|
|
7,640 |
|
|
14,743 |
|
|
268,059 |
|
|
Interest |
|
|
|
|
|
|
|
|
3,564 |
|
|
3,564 |
|
|
Amortization of goodwill and other intangibles |
|
|
|
|
|
|
|
|
4,273 |
|
|
4,273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
1,051,444 |
|
|
17,910 |
|
|
67,015 |
|
|
1,136,369 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes(a) |
|
$ |
(39,011 |
) |
$ |
8,733 |
|
$ |
(8,711 |
) |
$ |
(38,989 |
) |
|
|
|
|
|
|
|
|
|
|
As of December 31, 1999: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets |
|
$ |
186,611 |
|
$ |
4,229 |
|
$ |
312,254 |
|
$ |
503,094 |
|
|
|
|
|
|
|
|
|
|
|
- (a)
- Excluding
the third quarter 1999 premium deficiency charge, pre-tax loss for the health segment would have been $23,926,000 and consolidated pre-tax loss would
have been $17,904,000.
13. Stock Purchase Agreement (unaudited)
On
March 19, 2002, the Company entered into a stock purchase agreement with Cobalt Corporation ("Cobalt") and its wholly owned subsidiary, Blue Cross & Blue Shield United of Wisconsin, the
Company's largest shareholder, to purchase 1.4 million shares of the Company's common stock owned by BCBSUW at a total cost of $19.5 million, including related transaction costs. In
conjunction with the stock purchase, the Company received a $20.0 million dividend from UWLIC with regulatory approval. The Company's revolving bank line of credit agreement was amended in
March 2002 to allow for the stock purchase. Also in conjunction with the stock purchase, which was completed on March 22, 2002, the Company, Cobalt and BCBSUW agreed to an underwritten
secondary offering of at least 3.0 million shares of the remaining shares of the Company's common stock owned by BCBSUW.
F-31
Schedule II
American Medical Security Group, Inc.
(Parent Company Only)
Condensed Financial Information of Registrant
Condensed Balance Sheets
|
|
December 31,
|
|
|
|
2001
|
|
2000
|
|
|
|
(In thousands)
|
|
Assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
3,137 |
|
$ |
1,671 |
|
Other assets: |
|
|
|
|
|
|
|
|
Investment in consolidated subsidiaries |
|
|
250,794 |
|
|
240,784 |
|
|
Goodwill and other intangibles, net |
|
|
19,666 |
|
|
20,229 |
|
|
Due from affiliates |
|
|
|
|
|
1,761 |
|
|
Other assets |
|
|
239 |
|
|
309 |
|
|
|
|
|
|
|
|
|
Total other assets |
|
|
270,699 |
|
|
263,083 |
|
|
|
|
|
|
|
Total assets |
|
$ |
273,836 |
|
$ |
264,754 |
|
|
|
|
|
|
|
Liabilities and Shareholders' Equity: |
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Notes payable |
|
$ |
35,158 |
|
$ |
35,158 |
|
|
Taxes payable |
|
|
7,821 |
|
|
7,019 |
|
|
Payables and accrued expenses |
|
|
5 |
|
|
50 |
|
|
Due to affiliates |
|
|
634 |
|
|
|
|
|
Other liabilities |
|
|
818 |
|
|
1,350 |
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
44,436 |
|
|
43,577 |
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Common stock |
|
|
16,654 |
|
|
16,654 |
|
|
Paid-in capital |
|
|
187,927 |
|
|
187,956 |
|
|
Retained earnings |
|
|
40,470 |
|
|
36,295 |
|
|
Accumulated other comprehensive gain (loss) |
|
|
1,903 |
|
|
(3,948 |
) |
|
Treasury stock |
|
|
(17,554 |
) |
|
(15,780 |
) |
|
|
|
|
|
|
|
|
Total shareholders' equity |
|
|
229,400 |
|
|
221,177 |
|
|
|
|
|
|
|
Total liabilities and shareholders' equity |
|
$ |
273,836 |
|
$ |
264,754 |
|
|
|
|
|
|
|
F-32
Schedule II
American Medical Security Group, Inc.
(Parent Company Only)
Condensed Financial Information of Registrant
Condensed Statements of Operations
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
Fees from consolidated subsidiaries |
|
$ |
4,427 |
|
$ |
4,139 |
|
$ |
3,199 |
|
|
Other revenue |
|
|
103 |
|
|
140 |
|
|
92 |
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
4,530 |
|
|
4,279 |
|
|
3,291 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
General and administrative |
|
|
563 |
|
|
430 |
|
|
1,071 |
|
|
Interest |
|
|
2,377 |
|
|
2,972 |
|
|
2,802 |
|
|
Amortization of goodwill and other intangibles |
|
|
563 |
|
|
563 |
|
|
563 |
|
|
|
|
|
|
|
|
|
|
|
Total expenses |
|
|
3,503 |
|
|
3,965 |
|
|
4,436 |
|
|
|
|
|
|
|
|
|
Income (loss) before income tax expense (benefit) and equity in net income (loss) of subsidiaries |
|
|
1,027 |
|
|
314 |
|
|
(1,145 |
) |
Income tax expense (benefit) |
|
|
874 |
|
|
154 |
|
|
(347 |
) |
|
|
|
|
|
|
|
|
Income (loss) before equity in net income (loss) of subsidiaries |
|
|
153 |
|
|
160 |
|
|
(798 |
) |
Equity in net income (loss) of subsidiaries |
|
|
4,022 |
|
|
2,509 |
|
|
(25,148 |
) |
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
|
|
|
|
|
|
|
F-33
Schedule II
American Medical Security Group, Inc.
(Parent Company Only)
Condensed Financial Information of Registrant
Condensed Statements of Cash Flows
|
|
Year ended December 31,
|
|
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
(In thousands)
|
|
Operating Activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
4,175 |
|
$ |
2,669 |
|
$ |
(25,946 |
) |
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Equity in net (income) loss of subsidiaries |
|
|
(4,022 |
) |
|
(2,509 |
) |
|
25,148 |
|
|
|
Dividends received from subsidiaries |
|
|
|
|
|
16,400 |
|
|
15,250 |
|
|
|
Amortization of intangibles |
|
|
563 |
|
|
563 |
|
|
563 |
|
|
|
Deferred income tax expense (benefit) |
|
|
72 |
|
|
186 |
|
|
(399 |
) |
|
|
Changes in operating accounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net other assets and liabilities |
|
|
2,481 |
|
|
(7,622 |
) |
|
3,011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
3,269 |
|
|
7,018 |
|
|
17,627 |
|
Investing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
|
|
|
|
|
|
|
|
Financing Activities: |
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
413 |
|
|
4 |
|
|
5 |
|
|
Purchase of treasury stock |
|
|
(2,216 |
) |
|
(8,292 |
) |
|
(7,488 |
) |
|
Proceeds from notes payable borrowings |
|
|
|
|
|
39,158 |
|
|
5,000 |
|
|
Repayment of notes payable |
|
|
|
|
|
(39,158 |
) |
|
(15,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(1,803 |
) |
|
(8,288 |
) |
|
(17,483 |
) |
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
Net increase during year |
|
|
1,466 |
|
|
1,399 |
|
|
144 |
|
|
Balance at beginning of year |
|
|
1,671 |
|
|
272 |
|
|
128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of year |
|
$ |
3,137 |
|
$ |
1,671 |
|
$ |
272 |
|
|
|
|
|
|
|
|
|
F-34
Schedule III
American Medical Security Group, Inc.
Supplementary Insurance Information
Segment
|
|
Deferred
Policy
Acquisition
Costs
|
|
Medical and
Other
Benefits
Payable
|
|
Advance
Premiums
|
|
Other
Policyholder
Funds
|
|
|
(In thousands)
|
December 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
$ |
|
|
$ |
125,834 |
|
$ |
15,472 |
|
$ |
|
|
Life |
|
|
|
|
|
9,480 |
|
|
816 |
|
|
|
|
All Other |
|
|
|
|
|
190 |
|
|
449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
$ |
135,504 |
|
$ |
16,737 |
|
$ |
|
|
|
|
|
|
|
|
|
|
December 31, 2000: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
$ |
|
|
$ |
133,001 |
|
$ |
16,367 |
|
$ |
|
|
Life |
|
|
|
|
|
9,924 |
|
|
745 |
|
|
|
|
All Other |
|
|
|
|
|
2,385 |
|
|
456 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
$ |
145,310 |
|
$ |
17,568 |
|
$ |
|
|
|
|
|
|
|
|
|
|
December 31, 1999: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
$ |
|
|
$ |
150,201 |
|
$ |
16,171 |
|
$ |
|
|
Life |
|
|
|
|
|
9,328 |
|
|
530 |
|
|
|
|
All Other |
|
|
|
|
|
9,588 |
|
|
576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
$ |
169,117 |
|
$ |
17,277 |
|
$ |
|
|
|
|
|
|
|
|
|
|
Segment
|
|
Premium
Revenue
|
|
Net
Investment
Income
|
|
Medical and
Other
Benefit
Expenses
|
|
Amortization of
Deferred
Policy
Acquisition
Costs
|
|
Other
Operating
Expenses
|
|
Premiums
Written
|
|
|
(In thousands)
|
December 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
$ |
820,658 |
|
$ |
9,197 |
|
$ |
595,811 |
|
$ |
|
|
$ |
244,453 |
|
$ |
819,763 |
|
Life |
|
|
17,424 |
|
|
656 |
|
|
6,334 |
|
|
|
|
|
5,446 |
|
|
|
|
All Other |
|
|
590 |
|
|
6,811 |
|
|
(203 |
) |
|
|
|
|
7,843 |
|
|
583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
838,672 |
|
$ |
16,664 |
|
$ |
601,942 |
|
$ |
|
|
$ |
257,742 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2000: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
$ |
907,722 |
|
$ |
9,513 |
|
$ |
700,511 |
|
$ |
|
|
$ |
235,649 |
|
$ |
907,918 |
|
Life |
|
|
22,578 |
|
|
638 |
|
|
7,781 |
|
|
|
|
|
6,581 |
|
|
|
|
All Other |
|
|
20,771 |
|
|
8,531 |
|
|
16,321 |
|
|
|
|
|
9,537 |
|
|
20,651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
951,071 |
|
$ |
18,682 |
|
$ |
724,613 |
|
$ |
|
|
$ |
251,767 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 1999: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health |
|
$ |
985,322 |
|
$ |
9,254 |
|
$ |
805,768 |
|
$ |
|
|
$ |
245,676 |
|
$ |
984,715 |
|
Life |
|
|
26,183 |
|
|
202 |
|
|
10,270 |
|
|
|
|
|
7,640 |
|
|
|
|
All Other |
|
|
44,602 |
|
|
9,456 |
|
|
44,435 |
|
|
|
|
|
14,743 |
|
|
44,726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,056,107 |
|
$ |
18,912 |
|
$ |
860,473 |
|
$ |
|
|
$ |
268,059 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-35
Schedule IV
American Medical Security Group, Inc.
Reinsurance
|
|
Direct
Business
|
|
Ceded to
Other
Companies
|
|
Assumed
From Other
Companies
|
|
Net
Amount
|
|
Percentage
Of Amount
Assumed
to Net
|
|
|
|
(In thousands)
|
|
Year Ended December 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force |
|
$ |
9,351,321 |
|
$ |
6,913,662 |
|
$ |
|
|
$ |
2,437,659 |
|
0.0 |
% |
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accident and Health |
|
|
821,994 |
|
|
2,259 |
|
|
1,513 |
|
|
821,248 |
|
0.2 |
% |
|
|
Life |
|
|
17,695 |
|
|
273 |
|
|
2 |
|
|
17,424 |
|
0.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Premiums |
|
|
839,689 |
|
|
2,532 |
|
|
1,515 |
|
|
838,672 |
|
0.2 |
% |
Year Ended December 31, 2000: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force |
|
$ |
14,839,256 |
|
$ |
11,412,772 |
|
$ |
1,942 |
|
$ |
3,428,426 |
|
0.1 |
% |
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accident and Health |
|
|
922,087 |
|
|
2,236 |
|
|
8,642 |
|
|
928,493 |
|
0.9 |
% |
|
|
Life |
|
|
22,782 |
|
|
287 |
|
|
83 |
|
|
22,578 |
|
0.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Premiums |
|
|
944,869 |
|
|
2,523 |
|
|
8,725 |
|
|
951,071 |
|
0.9 |
% |
Year Ended December 31, 1999: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force |
|
$ |
14,355,089 |
|
$ |
12,731,969 |
|
$ |
9,455 |
|
$ |
1,632,575 |
|
0.6 |
% |
|
Premiums: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accident and Health |
|
|
976,457 |
|
|
4,309 |
|
|
57,776 |
|
|
1,029,924 |
|
5.6 |
% |
|
|
Life |
|
|
25,642 |
|
|
607 |
|
|
1,148 |
|
|
26,183 |
|
4.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Premiums |
|
|
1,002,099 |
|
|
4,916 |
|
|
58,924 |
|
|
1,056,107 |
|
5.6 |
% |
F-36
Schedule V
American Medical Security Group, Inc.
Valuation and Qualifying Accounts
|
|
Balance at
Beginning
of Period
|
|
Additions
Charged to
Costs and
Expenses
|
|
Deductions
|
|
Balance at
End of Period
|
|
|
(In thousands)
|
Year ended December 31, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for bad debts |
|
$ |
344 |
|
$ |
1,250 |
|
$ |
302 |
|
$ |
1,292 |
|
Valuation allowance for deferred taxes |
|
|
3,861 |
|
|
1,810 |
|
|
277 |
|
|
5,394 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,205 |
|
$ |
3,060 |
|
$ |
579 |
|
$ |
6,686 |
|
|
|
|
|
|
|
|
|
Year ended December 31, 2000: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for bad debts |
|
$ |
651 |
|
$ |
7 |
|
$ |
314 |
|
$ |
344 |
|
Valuation allowance for deferred taxes |
|
|
3,549 |
|
|
398 |
|
|
86 |
|
|
3,861 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,200 |
|
$ |
405 |
|
$ |
400 |
|
$ |
4,205 |
|
|
|
|
|
|
|
|
|
Year ended December 31, 1999: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for bad debts |
|
$ |
1,118 |
|
$ |
14 |
|
$ |
481 |
|
$ |
651 |
|
Valuation allowance for deferred taxes |
|
|
2,654 |
|
|
1,029 |
|
|
134 |
|
|
3,549 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,772 |
|
$ |
1,043 |
|
$ |
615 |
|
$ |
4,200 |
|
|
|
|
|
|
|
|
|
F-37
3,500,000 Shares
Common Stock
PROSPECTUS
, 2002
CIBC World Markets
Robert W. Baird & Co.
Stifel, Nicolaus & Company
Incorporated
You should rely only on the information contained in this prospectus. No dealer, salesperson or other person is authorized to give
information that is not contained in this prospectus. This prospectus is not an offer to sell nor is it seeking an offer to buy these securities in any jurisdiction where the offer or sale is not
permitted. The information contained in this prospectus is correct only as of the date of this prospectus, regardless of the time of the delivery of this prospectus or any sale of these securities.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
SEC registration fee |
|
$ |
6,647 |
NASD filing fee |
|
|
7,725 |
Printing and engraving expenses |
|
|
150,000 |
Legal fees and expenses |
|
|
350,000 |
Accounting fees and expenses |
|
|
90,000 |
Transfer agent fees and other miscellaneous expenses |
|
|
110,628 |
|
|
|
Total |
|
$ |
715,000 |
|
|
|
All of the above fees and expenses up to an aggregate of $650,000 will be paid by American Medical Security Group, Inc. (the "registrant"). Any expenses
in excess of such amount will be borne equally by
the registrant and the selling shareholder. Other than the SEC registration fee and the NASD filing fee, all fees and expenses are estimated.
Item 15. Indemnification of Directors and Officers.
The
registrant is incorporated under the Wisconsin Business Corporation Law ("WBCL"). Under Section 180.0851(1) of the WBCL, the registrant is required to indemnify a director or
officer, to the extent such person is successful on the merits or otherwise in the defense of a proceeding, for all reasonable expenses incurred in the proceeding if such person was a party because he
or she was a director or officer of the registrant. In all other cases, the registrant is required by Section 180.0851(2) of the WBCL to indemnify a director or officer against liability
incurred in a proceeding to which such person was a party because he or she was an officer or director of the registrant, unless it is determined that he or she breached or failed to perform a duty
owed to the registrant and the breach or failure to perform constitutes: (i) a willful failure to deal fairly with the registrant or its shareholders in connection with a matter in which the
director or officer has a material conflict of interest; (ii) a violation of criminal law, unless the director or officer had reasonable cause to believe his or her conduct was lawful or no
reasonable cause to believe his or her conduct was unlawful; (iii) a transaction from which the director or officer derived an improper personal profit; or (iv) willful misconduct.
Section 180.0858(1) of the WBCL provides that, subject to certain limitations, the mandatory indemnification provisions do not preclude any additional right to indemnification or allowance of
expenses that a director or officer may have under the registrant's articles of incorporation, bylaws, a written agreement or a resolution of the board of directors or shareholders.
Section 180.0859
of the WBCL provides that it is the public policy of the State of Wisconsin to require or permit indemnification, allowance of expenses and insurance to the extent required or
permitted under Sections 180.0850 to 180.0858 of the WBCL for any liability incurred in connection with a proceeding involving a federal or state statute, rule or regulation regulating the offer, sale
or purchase of securities.
Section 180.0828
of the WBCL provides that, with certain exceptions, a director is not liable to a corporation, its shareholders, or any person asserting rights on behalf of the corporation or
its shareholders, for damages, settlements, fees, fines, penalties or other monetary liabilities arising from a breach of, or failure to perform, any duty resulting solely from his or her status as a
director, unless the person asserting liability proves that the breach or failure to perform constitutes any of the four exceptions to mandatory indemnification under Section 180.0851(2)
referred to above.
II-1
Under
Section 180.0833 of the WBCL, directors of the registrant against whom claims are asserted with respect to the declaration of an improper dividend or other distribution to shareholders to
which they assented are entitled to contribution from other directors who assented to such distribution and from shareholders who knowingly accepted the improper distribution, as provided therein.
Article VII
of the registrant's bylaws contains provisions that generally parallel the indemnification provisions of the WBCL. Directors and officers of the registrant are also covered by
directors' and officers' liability insurance under which they are insured (subject to certain exceptions and limitations specified in the policy) against expenses and liabilities arising out of
proceedings to which they are parties by reason of being or having been directors or officers.
The
underwriting agreement provides that the underwriters will indemnify the directors, certain officers of the registrant, the selling shareholder, and the selling shareholder's parent, Cobalt
Corporation, against certain liabilities, including liabilities under the Securities Act of 1933, or will contribute to payments which may be made in respect thereof.
Section 8.01
of the stock purchase agreement by and among the selling shareholder, its parent and the registrant, dated as of March 19, 2002, provides that the registrant agrees to
indemnify the selling shareholder, its parent and the underwriters, and their respective officers, directors and controlling persons, against certain liabilities, including liabilities under the
Securities Act of 1933, or to contribute to payments which may be made in respect thereof, and provides that the selling shareholder and its parent agree to indemnify the registrant, its directors and
officers and each controlling person of the registrant against certain liabilities, including liabilities under the Securities Act of 1933, or to contribute to payments which may be made in respect
thereof.
Section 4.01
of the distribution and indemnity agreement between Newco/UWS, Inc. and United Wisconsin Services, Inc. dated as of September 11, 1998 provides that Cobalt
Corporation (formerly Newco/UWS) shall indemnify the registrant's directors and officers from certain liabilities, including those arising from any breach of the distribution agreement by Cobalt
Corporation.
Item 16. Exhibits.
The
exhibits listed in the accompanying exhibit index are filed or incorporated by reference as exhibits to this registration statement.
Item 17. Undertakings.
The
undersigned registrant hereby undertakes (in accordance with the corresponding lettered undertaking in Item 512 of Regulation S-K):
(b) That,
for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(h) Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant
pursuant to the indemnification provisions described in Item 15 of this registration statement, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against
II-2
public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses
incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
(i) (1) For
purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration
statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be
deemed to be part of this registration statement as of the time it was declared effective.
(2) For
the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
II-3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this amendment to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Green Bay, State of Wisconsin, on May 22, 2002.
|
|
AMERICAN MEDICAL SECURITY GROUP, INC. |
|
|
By: |
|
/s/ SAMUEL V. MILLER
|
|
|
Samuel V. Miller, Chairman of the Board, President and Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, this amendment to the registration statement has been signed by the following persons in the capacities indicated as of the
22nd day of May, 2002.
Signature
|
|
Title
|
|
|
|
/s/ SAMUEL V. MILLER Samuel V. Miller |
|
Chairman of the Board, President and Chief Executive Officer; Director
(Principal Executive Officer) |
/s/ GARY D. GUENGERICH Gary D. Guengerich |
|
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
/s/ ROGER H. BALLOU* Roger H. Ballou |
|
Director |
/s/ W. FRANCIS BRENNAN* W. Francis Brennan |
|
Director |
/s/ MARK A. BRODHAGEN* Mark A. Brodhagen |
|
Director |
/s/ KENNETH L. EVASON* Kenneth L. Evason |
|
Director |
/s/ THOMAS R. HEFTY* Thomas R. Hefty |
|
Director |
/s/ JAMES C. HICKMAN* James C. Hickman |
|
Director |
|
|
|
II-4
/s/ WILLIAM R. JOHNSON* William R. Johnson |
|
Director |
/s/ EUGENE A. MENDEN* Eugene A. Menden |
|
Director |
/s/ EDWARD L. MEYER, JR.* Edward L. Meyer, Jr. |
|
Director |
/s/ MICHAEL T. RIORDAN* Michael T. Riordan |
|
Director |
/s/ H.T. RICHARD SCHREYER* H.T. Richard Schreyer |
|
Director |
/s/ FRANK L. SKILLERN* Frank L. Skillern |
|
Director |
/s/ J. GUS SWOBODA* J. Gus Swoboda |
|
Director |
* By: |
|
/s/ TIMOTHY J. MOORE Timothy J. Moore Attorney-in-Fact |
|
|
|
|
II-5
AMERICAN MEDICAL SECURITY GROUP, INC.
(the "Registrant")
(Commission File No. 1-13154)
EXHIBIT INDEX
to
AMENDMENT NO. 2
to
FORM S-3 REGISTRATION STATEMENT
Exhibit Number
|
|
Document Description
|
|
Incorporated Herein
by Reference to
|
|
Filed
Herewith
|
1 |
|
Form of Underwriting Agreement |
|
|
|
X |
2.1 |
|
Distribution and Indemnity Agreement between United Wisconsin Services, Inc., now known as American Medical Security Group, Inc. ("AMSG f/k/a UWS" or "Registrant") and Newco/UWS, Inc. ("Newco/UWS") dated as of September 11,
1998 |
|
Exhibit 2.1 to Newco/UWS' Registration Statement on Form 10, as amended (File No. 1-14177) |
|
|
2.2 |
|
Employee Benefits Agreement dated as of September 11, 1998, by and between AMSG f/k/a UWS and Newco/UWS |
|
Exhibit 10.1 to Newco/UWS' Registration Statement on Form 10, as amended (File No. 1-14177) |
|
|
2.3 |
|
Tax Allocation Agreement, entered into as of September 11, 1998, by and between AMSG f/k/a UWS and Newco/UWS |
|
Exhibit 10.2 to Newco/UWS' Registration Statement on Form 10, as amended (File No. 1-14177) |
|
|
4.1(a) |
|
Restated Articles of Incorporation of Registrant dated as February 17, 1999 |
|
Exhibit 3.1 to the Registrant's Form 10-K for the year ended December 31, 1998 (the "1998 10-K") |
|
|
4.1(b) |
|
Articles of Amendment to Restated Articles of Incorporation with Respect to Designation, Preferences, Limitations and Relative Rights of Series B Junior Cumulative Preferred Stock |
|
Exhibit 3 to the Registrant's Form 10-Q for the quarter ended June 30, 2001. |
|
|
4.2 |
|
Bylaws of Registrant as amended and restated November 17, 1999 |
|
Exhibit 3.2 to the Registrant's Form 10-K for the year ended December 31, 1999 |
|
|
4.3(a) |
|
Credit Agreement dated as of March 24, 2000, (the "Credit Agreement") among the Registrant, LaSalle Bank National Association and other Lenders |
|
Exhibit 4 to the Registrant's Form 10-Q for the quarter ended March 31, 2000 |
|
|
4.3(b) |
|
First Amendment dated as of July 18, 2000 to Credit Agreement |
|
Exhibit 4 to the Registrant's Form 10-Q for the quarter ended June 30, 2000 |
|
|
|
|
|
|
|
|
|
EI-1
4.3(c) |
|
Second Amendment dated as of November 10, 2000 to Credit Agreement |
|
Exhibit 4 to the Registrant's Form 10-Q for the quarter ended September 30, 2000 |
|
|
4.3(d) |
|
Third Amendment dated as of January 29, 2001 to Credit Agreement |
|
Exhibit 4.4 to the Registrant's Form 10-K for the year ended December 31, 2000 |
|
|
4.3(e) |
|
Fourth Amendment dated as of April 27, 2001 to Credit Agreement |
|
Exhibit 4 to the Registrant's Form 10-Q for the quarter ended March 31, 2001 |
|
|
4.3(f)(i) |
|
Fifth Amendment dated as of March 21, 2002 to Credit Agreement |
|
Exhibit 4 to the Registrant's Form 8-K dated March 25, 2002 |
|
|
4.3(f)(ii) |
|
Revised Fifth Amendment dated as of March 21, 2002 to Credit Agreement (replacing Exhibit 4.3(f)(i)) |
|
|
|
X* |
4.4(a) |
|
Rights Agreement, dated as of August 9, 2001, between the Registrant and Firstar Bank, N.A., as Rights Agent (the "Rights Agreement') including the form of Rights Certificate as Exhibit B thereto |
|
Exhibit 1 to the Registrant's Registration Statement on Form 8-A filed August 14, 2001 and Exhibit 4 to the Registrant's Current Report on Form 8-K dated August 9, 2001, and filed on August 14, 2001 |
|
|
4.4(b) |
|
Amendment dated as of February 1, 2002 to the Rights Agreement |
|
Exhibit 4.1 to the Registrant's Form 8-K dated February 1, 2002 (the "2/1/02 8-K") |
|
|
4.4(c) |
|
Appointment and Assumption Agreement dated December 17, 2001, between the Registrant and Firstar Bank, N.A., appointing LaSalle Bank, N.A. as Rights Agent for the Rights Agreement |
|
Exhibit 4.2 to the 2/1/02 8-K |
|
|
5 |
|
Opinion of Quarles & Brady LLP |
|
|
|
X** |
23.1 |
|
Consent of Ernst & Young LLP |
|
|
|
X |
23.2 |
|
Consent of Quarles & Brady LLP |
|
|
|
Contained in Exhibit 5 |
24 |
|
Power of Attorney |
|
|
|
Contained in Signatures page to original registration statement |
|
|
|
|
|
|
|
EI-2
99.1 |
|
Registration Rights Agreement between the Registrant and Blue Cross & Blue Shield United of Wisconsin dated as of September 1, 1998 |
|
Exhibit 10.19 to 1998 10-K |
|
|
99.2 |
|
Agreement dated February 1, 2002, among the Registrant, Cobalt Corporation and Blue Cross & Blue Shield United of Wisconsin concerning the Rights Agreement |
|
Exhibit 10.1 to the 2/1/02 8-K |
|
|
99.3 |
|
Stock Purchase Agreement, dated as of March 19, 2002, among Blue Cross & Blue Shield United of Wisconsin, Cobalt Corporation and the Registrant |
|
Exhibit 10 to the Registrant's Form 8-K dated March 19, 2002 |
|
|
- *
- Filed with original registration statement.
- **
- Filed
with amendment No. 1 to the registration statement.
EI-3
QuickLinks
Table of Contents
Prospectus Summary
Risk Factors
Forward-Looking Statements
Common Stock Market Data
Use of Proceeds
Dividend Policy
Capitalization
Selected Consolidated Financial Data
Management's Discussion and Analysis of Financial Condition and Results of Operations
Business
Management
Principal and Selling Shareholders
Certain Transactions
Description of Capital Stock
Shares Eligible For Future Sale
Underwriting
Legal Matters
Experts
Where You Can Find More Information
Index to Financial Statements
Report of Ernst & Young LLP, Independent Auditors
American Medical Security Group, Inc. Consolidated Balance Sheets (in thousands, except share data)
American Medical Security Group, Inc. Consolidated Statements of Operations (In thousands, except share data)
American Medical Security Group, Inc. Consolidated Statements of Cash Flows (In thousands)
American Medical Security Group, Inc. Consolidated Statements of Changes in Shareholders' Equity and Comprehensive Income (Loss) (In thousands, except share data)
American Medical Security Group, Inc. Notes to Consolidated Financial Statements
American Medical Security Group, Inc. (Parent Company Only)
Condensed Financial Information of Registrant Condensed Balance Sheets
American Medical Security Group, Inc. (Parent Company Only)
Condensed Financial Information of Registrant Condensed Statements of Operations
American Medical Security Group, Inc. (Parent Company Only)
Condensed Financial Information of Registrant Condensed Statements of Cash Flows
American Medical Security Group, Inc. Supplementary Insurance Information
American Medical Security Group, Inc. Reinsurance
American Medical Security Group, Inc. Valuation and Qualifying Accounts
PART II INFORMATION NOT REQUIRED IN PROSPECTUS
SIGNATURES
EX-1
3
a2080838zex-1.txt
UNDERWRITING AGREEMENT
EXHIBIT 1
3,500,000 SHARES
AMERICAN MEDICAL SECURITY GROUP, INC.
COMMON STOCK
UNDERWRITING AGREEMENT
May [ ], 2002
CIBC World Markets Corp.
Robert W. Baird & Co. Incorporated
Stifel, Nicolaus & Company, Incorporated
c/o CIBC World Markets Corp.
417 5th Avenue, 2nd Floor
New York, New York 10016
On behalf of the Several Underwriters named on Schedule I attached hereto.
Ladies and Gentlemen:
Blue Cross & Blue Shield United of Wisconsin (the "Selling
Shareholder"), proposes, subject to the terms and conditions contained herein,
to sell to you and the other underwriters named on Schedule I to this Agreement
(the "Underwriters"), for whom you are acting as Representatives (the
"Representatives"), an aggregate of 3,500,000 shares (the "Firm Shares") of the
Common Stock, no par value (the "Common Stock") of American Medical Security
Group, Inc., a Wisconsin corporation (the "Company"). The respective amounts of
the Firm Shares to be purchased by each of the several Underwriters are set
forth opposite their names on Schedule I hereto. In addition, the Selling
Shareholder proposes to grant to the Underwriters an option to purchase up to an
additional 525,000 shares (the "Option Shares") of Common Stock from it for the
purpose of covering over-allotments in connection with the sale of the Firm
Shares. The Firm Shares and the Option Shares are together called the "Shares."
1. SALE AND PURCHASE OF THE SHARES.
On the basis of the representations, warranties and agreements
contained in, and subject to the terms and conditions of, this Agreement:
(a) The Selling Shareholder agrees to sell to each of the
Underwriters, and each of the Underwriters agrees, severally and not
jointly, to purchase from the Selling Shareholder, at a price of $_____ per
share (the "Initial Price"), the number of Firm
1
Shares set forth opposite the name of such Underwriter under the column
"Number of Firm Shares to be Purchased" on Schedule I to this Agreement,
subject to adjustment in accordance with Section 11 hereof.
(b) The Selling Shareholder grants to the several Underwriters an
option to purchase, severally and not jointly, all or any part of the
Option Shares at the Initial Price. The number of Option Shares to be
purchased by each Underwriter shall be the same percentage (adjusted by the
Representatives to eliminate fractions) of the total number of Option
Shares to be purchased by the Underwriters as such Underwriter is
purchasing of the Firm Shares. Such option may be exercised only to cover
over-allotments in the sales of the Firm Shares by the Underwriters and may
be exercised in whole or in part at any time on or before 12:00 noon, New
York City time, on the business day before the Firm Shares Closing Date (as
defined below), and from time to time thereafter within 30 days after the
date of this Agreement, in each case upon written, facsimile or telegraphic
notice, or verbal or telephonic notice confirmed by written, facsimile or
telegraphic notice, by the Representatives to the Selling Shareholder no
later than 12:00 noon, New York City time, on the business day before the
Firm Shares Closing Date or at least two business days before the Option
Shares Closing Date (as defined below), as the case may be, setting forth
the number of Option Shares to be purchased and the time and date (if other
than the Firm Shares Closing Date) of such purchase.
2. DELIVERY AND PAYMENT. Payment of the purchase price for, and
delivery of certificates for, the Firm Shares shall be made at the offices of
CIBC World Markets Corp., 417 5th Avenue, 2nd Floor, New York, New York, 10016,
or at such other place as shall be agreed upon by the Representatives, the
Company and the Selling Shareholder, at 10:00 a.m., New York City time, on the
third business day following the date of this Agreement or at such time on such
other date, not later than ten (10) business days after the date of this
Agreement, as shall be agreed upon by the Company, the Selling Shareholder and
the Representatives (such time and date of delivery and payment are called the
"Firm Shares Closing Date").
In addition, in the event that any or all of the Option Shares are
purchased by the Underwriters, payment of the purchase price, and delivery of
the certificates, for such Option Shares shall be made at the above-mentioned
offices, or at such other place as shall be agreed upon by the Representatives
and the Company, on each date of delivery as specified in the notice from the
Representatives to the Company and the Selling Shareholder (such time and date
of delivery and payment are called the "Option Shares Closing Date"). The Firm
Shares Closing Date and the Option Shares Closing Date are called, individually,
a "Closing Date" and, together, the "Closing Dates."
Payment shall be made to the Selling Shareholder by wire transfer of
immediately available funds or by certified or official bank check or checks
payable in New York Clearing House (same day) funds drawn to the order of the
Selling Shareholder, against delivery of the respective certificates to the
Representatives for the respective accounts of the Underwriters of certificates
for the Shares to be purchased by them.
2
Certificates evidencing the Shares shall be registered in such names
and shall be in such denominations as the Representatives shall request at least
two full business days before the Firm Shares Closing Date or, in the case of
Option Shares, on the day of notice of exercise of the option as described in
Section l(b) and shall be delivered by or on behalf of the Selling Shareholder
to the Representatives through the facilities of the Depository Trust Company
("DTC") for the account of such Underwriter. The Company and the Selling
Shareholder will cause the certificates representing the Shares to be made
available for checking and packaging, at such place as is designated by the
Representatives, on the full business day before the Firm Shares Closing Date
(or the Option Shares Closing Date in the case of the Option Shares).
3. REGISTRATION STATEMENT AND PROSPECTUS; PUBLIC OFFERING. The Company
has prepared and filed in conformity with the requirements of the Securities Act
of 1933, as amended (the "Securities Act"), and the published rules and
regulations thereunder (the "Rules") adopted by the Securities and Exchange
Commission (the "Commission") a Registration Statement on Form S-3 (No.
333-86660), including a Preliminary Prospectus relating to the Shares, and such
amendments thereof as may have been required to the date of this Agreement.
Copies of such Registration Statement (including all amendments thereof) and of
the related Preliminary Prospectus have heretofore been delivered by the Company
to you. The term "Preliminary Prospectus" means any preliminary prospectus (as
described in Rule 430 of the Rules) included at any time as a part of the
Registration Statement or filed with the Commission by the Company with the
consent of the Representatives pursuant to Rule 424(a) of the Rules. The term
"Registration Statement" as used in this Agreement means the initial
registration statement (including all exhibits, financial schedules and
information deemed to be a part of the Registration Statement through
incorporation by reference or otherwise), as amended at the time and on the date
it becomes effective (the "Effective Date") including the information (if any)
deemed to be part thereof at the time of effectiveness pursuant to Rule 430A of
the Rules. If the Company has filed an abbreviated registration statement to
register additional Shares pursuant to Rule 462(b) under the Rules (the "462(b)
Registration Statement") then any reference herein to the Registration Statement
shall also be deemed to include such 462(b) Registration Statement. The term
"Prospectus" as used in this Agreement means the prospectus in the form included
in the Registration Statement at the time of effectiveness or, if Rule 430A of
the Rules is relied on, the term Prospectus shall also include the final
prospectus filed with the Commission pursuant to Rule 424(b) of the Rules.
Reference made herein to any Preliminary Prospectus or to the Prospectus shall
be deemed to refer to and include any documents incorporated by reference
therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the date
of such Preliminary Prospectus or the Prospectus, as the case may be, and any
reference to any amendment or supplement to any Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include any document filed under the
United States Securities Exchange Act of 1934 (the "Exchange Act") after the
date of such Preliminary Prospectus or the Prospectus, as the case may be, and
incorporated by reference in such Preliminary Prospectus or the Prospectus, as
the case may be.
The Company and the Selling Shareholder understand that the
Underwriters propose to make a public offering of the Shares, as set forth in
and pursuant to the Prospectus, as soon after the Effective Date and the date of
this Agreement as the Representatives deem
3
advisable. The Company and the Selling Shareholder hereby confirm that the
Underwriters and dealers have been authorized to distribute or cause to be
distributed each Preliminary Prospectus and are authorized to distribute the
Prospectus (as from time to time amended or supplemented if the Company
furnishes amendments or supplements thereto to the Underwriters).
4. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company hereby,
represents and warrants to each Underwriter as follows:
(a) On the Effective Date, the Registration Statement complied, and on
the date of the Prospectus, the date any post-effective amendment to the
Registration Statement becomes effective, the date any supplement or
amendment to the Prospectus is filed with the Commission and each Closing
Date, the Registration Statement and the Prospectus (and any amendment
thereof or supplement thereto) will comply, in all material respects, with
the applicable provisions of the Securities Act and the Rules and the
Exchange Act, and the rules and regulations of the Commission thereunder.
The Registration Statement did not, as of the Effective Date, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements
therein not misleading; and on the Effective Date and the other dates
referred to above neither the Registration Statement nor the Prospectus,
nor any amendment thereof or supplement thereto, will contain any untrue
statement of a material fact or will omit to state any material fact
required to be stated therein or necessary in order to make the statements
therein not misleading. When any related Preliminary Prospectus was first
filed with the Commission (whether filed as part of the Registration
Statement or any amendment thereto or pursuant to Rule 424(a) of the Rules)
and when any amendment thereof or supplement thereto was first filed with
the Commission, such Preliminary Prospectus as amended or supplemented
complied in all material respects with the applicable provisions of the
Securities Act and the Rules and did not contain any untrue statement of a
material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein not
misleading. If applicable, each Preliminary Prospectus and the Prospectus
delivered to the Underwriters for use in connection with this offering was
identical to the electronically transmitted copies thereof filed with the
Commission pursuant to EDGAR, except to the extent permitted by Regulation
S-T. If Rule 434 is used, the Company will comply with the requirements of
Rule 434 and the Prospectus shall not be "materially different," as such
term is used in Rule 434, from the Prospectus included in the Registration
Statement at the time it became effective. Notwithstanding the foregoing,
none of the representations and warranties in this paragraph 4(a) shall
apply to statements in, or omissions from, the Registration Statement or
the Prospectus made in reliance upon, and in conformity with, information
herein or otherwise furnished in writing by the Representatives on behalf
of the several Underwriters for use in the Registration Statement or the
Prospectus. With respect to the preceding sentence, the Company
acknowledges that the only information furnished in writing by the
Representatives on behalf of the several Underwriters for use in the
Registration Statement or the Prospectus is the statements contained in the
table under the second paragraph and in the fourth (except for the first
4
sentence), tenth, eleventh and thirteenth (with respect to the absence of
representations by the Underwriters) paragraphs under the caption
"Underwriting" in the Prospectus.
(b) The Registration Statement is effective under the Securities Act
and no stop order preventing or suspending the effectiveness of the
Registration Statement or suspending or preventing the use of the
Prospectus has been issued and no proceedings for that purpose have been
instituted or are threatened under the Securities Act. Any required filing
of the Prospectus and any supplement thereto pursuant to Rule 424(b) of the
Rules has been or will be made in the manner and within the time period
required by such Rule 424(b).
(c) The documents incorporated by reference in the Registration
Statement and the Prospectus, at the time they became effective or were
filed with the Commission as the case may be, complied in all material
respects with the requirements of the Securities Act or the Exchange Act,
as applicable, and, when read together and with the other information in
the Registration Statement and the Prospectus, do not contain an untrue
statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading
and any further documents so filed and incorporated by reference in the
Registration Statement and the Prospectus, when such documents become
effective or are filed with the Commission, as the case may be, will
conform in all material respects to the requirements of the Securities Act
or the Exchange Act, as applicable, and the rules and regulations of the
Commission thereunder and will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein.
(d) The financial statements of the Company (including all notes and
schedules thereto) included or incorporated by reference in the
Registration Statement and Prospectus present fairly in all material
respects the financial position, the results of operations, the statements
of cash flows and the statements of shareholders' equity and the other
information purported to be shown therein of the Company at the respective
dates and for the respective periods to which they apply; and such
financial statements and related schedules and notes have been prepared in
conformity with generally accepted accounting principles, consistently
applied (with the exception of new accounting principles adopted as
described in the Company's Consolidated Financial Statements) throughout
the periods involved, and all adjustments necessary for a fair presentation
of the results for such periods have been made. The summary and selected
financial data included in the Prospectus present fairly in all material
respects the information shown therein as at the respective dates and for
the respective periods specified and the summary and selected financial
data have been presented on a basis consistent with the consolidated
financial statements so set forth in the Prospectus and other financial
information.
(e) Ernst & Young LLP whose reports are filed with the Commission as a
part of the Registration Statement, are and, during the periods covered by
their reports,
5
were independent public accountants as required by the Securities Act and
the Rules.
(f) Each of the Company and its Material Subsidiaries (as hereinafter
defined) has been duly organized and is validly existing as a corporation
or partnership, as the case may be, and in good standing (or equivalent
status) under the laws of their respective jurisdictions of organization.
For purposes of this Agreement, "Material Subsidiaries" shall include the
following direct or indirect Subsidiaries of the Company: (i) American
Medical Security Holdings, Inc.; (ii) American Medical Security, Inc.;
(iii) United Wisconsin Life Insurance Company; (iv) Accountable Health
Plans of America, Inc.; (v) American Medical Security Insurance Company of
Georgia; and (vi) U&C Real Estate Partnership, a general partnership. Other
than the Material Subsidiaries, the Company does not own or control,
directly or indirectly, any other entity whose operations are material to
the Company and its Subsidiaries taken as a whole, or that would constitute
a "significant subsidiary" under Regulation S-X of the Exchange Act. Each
of the Company and its Material Subsidiaries is duly qualified or certified
to transact business and is in good standing or equivalent status as a
foreign corporation or partnership, as the case may be, in each
jurisdiction in which the nature of the business conducted by it or
location of the assets or properties owned, leased or licensed by it
requires such qualification or certification, except for such jurisdictions
where the failure to so qualify or be certified would not have a material
adverse effect on the assets or properties, business, results of operations
or financial condition of the Company and its Subsidiaries, taken as a
whole (a "Material Adverse Effect"). For purposes of this Agreement,
"Subsidiaries" shall include those entities owned and controlled by the
Company directly or indirectly through one or more intermediaries. The
Company does not own, lease or license any asset or property or conduct any
business outside the United States of America. Each of the Company and its
Subsidiaries has all requisite corporate or partnership, as the case may
be, power and authority, and all necessary authorizations, approvals,
consents, orders, licenses, certificates and permits of and from all
governmental or regulatory bodies or any other person or entity
(collectively, the "Permits"), to own, lease and license its assets and
properties and conduct its business, all of which are valid and in full
force and effect, as described in the Registration Statement and the
Prospectus, except where the lack of such Permits, individually or in the
aggregate, would not have a Material Adverse Effect. Each of the Company
and its Material Subsidiaries has fulfilled and performed in all material
respects all of its material obligations with respect to such Permits and
no event has occurred that allows, or after notice or lapse of time would
allow, revocation or termination thereof or results in any other material
impairment of the rights of the Company thereunder.
(g) Each of the Company and its Material Subsidiaries owns or
possesses adequate and enforceable rights to use all trademarks, trademark
applications, trade names, service marks, copyrights, copyright
applications, licenses, know-how and other similar rights and proprietary
knowledge (collectively, "Intangibles") described in the Prospectus as
being owned by it necessary for the conduct of its business. Neither the
Company nor any of its Subsidiaries has received any notice of, or is aware
of, any infringement of or conflict with asserted rights of others with
respect to
6
any Intangibles that, if determined adversely to the Company or any of its
Subsidiaries, would have a Material Adverse Effect.
(h) Except as disclosed in the Prospectus, the Company and its
Subsidiaries have good and marketable title to all real properties and all
personal properties owned by them, in each case free from liens,
encumbrances and defects, except as would not materially affect the Company
and its Subsidiaries taken as a whole, or materially interfere with the use
made or to be made thereof by them, taken as a whole; and except as
disclosed in the Prospectus, the Company and its Subsidiaries hold any
leased real or personal property under valid, existing and enforceable
leases, free and clear of all liens, encumbrances, claims, security
interests and defects, except such as are described in the Registration
Statement and the Prospectus or would not have a Material Adverse Effect or
would not materially interfere with the use made or to be made thereof by
them, taken as a whole.
(i) Except as disclosed in the Registration Statement and the
Prospectus, there are no litigation or governmental proceedings to which
any of the Company or its Subsidiaries is subject or which are pending or,
to the knowledge of the Company, threatened against the Company or any of
its Subsidiaries, which, individually or in the aggregate, could reasonably
be expected to have a Material Adverse Effect or affect the consummation of
this Agreement or that are required to be disclosed in the Registration
Statement and the Prospectus but are not so disclosed.
(j) Subsequent to the respective dates as of which information is
given in the Registration Statement and the Prospectus, except as described
therein, (a) there has not been any material adverse change with regard to
the assets or properties, business, results of operations or financial
condition of the Company; (b) neither the Company nor any of its
Subsidiaries has sustained any loss or interference with its assets,
businesses or properties (whether owned or leased) from fire, explosion,
earthquake, flood or other calamity, whether or not covered by insurance,
or from any labor dispute or any court or legislative or other governmental
action, order or decree which would have a Material Adverse Effect; and (c)
since the date of the latest balance sheet included or incorporated by
reference in the Registration Statement and the Prospectus, except as
reflected therein, neither the Company nor any of its Subsidiaries has (i)
issued any securities or incurred any liability or obligation, direct or
contingent, for borrowed money, except such liabilities or obligations
incurred in the ordinary course of business, (ii) entered into any
transaction not in the ordinary course of business or (iii) declared or
paid any dividend or made any distribution on any shares of its stock or
redeemed, purchased or otherwise acquired or agreed to redeem, purchase or
otherwise acquire any shares of its stock.
(k) There is no document, contract or other agreement of a character
required to be described in the Registration Statement or Prospectus or to
be filed as an exhibit to the Registration Statement which is not described
or filed as required by the Securities Act or Rules. Each description of a
contract, document or other agreement in the Registration Statement and the
Prospectus accurately reflects in all
7
material respects the terms of the underlying document, contract or
agreement. Each agreement described in the Registration Statement and
Prospectus or listed in the Exhibits to the Registration Statement or
incorporated by reference is in full force and effect (unless otherwise so
described) and is valid and enforceable by and against the Company or any
Subsidiary, as the case may be, in accordance with its terms. Neither the
Company nor any Subsidiary, if the Subsidiary is a party, nor to the
Company's knowledge, any other party is in default in the observance or
performance of any term or obligation to be performed by it under any such
agreement, and no event has occurred which with notice or lapse of time or
both would constitute such a default, in any such case which default or
event, individually or in the aggregate, would have, or in the case of the
default of any party other than the Company or a Subsidiary, could
reasonably be expected to have, a Material Adverse Effect. No default
exists, and no event has occurred which with notice or lapse of time or
both would constitute a default, in the due performance and observance of
any term, covenant or condition, by the Company or any Subsidiary, if the
Subsidiary is a party thereto, of any other agreement or instrument to
which the Company or any Subsidiary is a party or by which the Company, any
Subsidiary or their properties or business may be bound or affected which
default or event, individually or in the aggregate, would have a Material
Adverse Effect.
(l) Neither the Company nor any of its Subsidiaries is in violation of
any term or provision of its charter or by-laws or of any franchise,
license, permit, judgment, decree, order, statute, rule or regulation,
where the consequences of such violation, individually or in the aggregate,
would have a Material Adverse Effect.
(m) Neither the execution, delivery and performance of this Agreement
by the Company nor the consummation of any of the transactions contemplated
hereby will (i) give rise to a right to terminate or accelerate the due
date of any payment due under, or conflict with or result in the breach of
any term or provision of, or constitute a default (or an event which with
notice or lapse of time or both would constitute a default) under, or
require any consent or waiver under (except for such consents or waivers
which have already been obtained and are in full force and effect), or
result in the execution or imposition of any lien, charge or encumbrance
upon any properties or assets of the Company or any Subsidiary pursuant to
the terms of, any indenture, mortgage, deed of trust or other agreement or
instrument to which the Company or any Subsidiary is a party or by which
either the Company or any Subsidiary or any of their properties or
businesses is bound, or any franchise, license, permit, judgment, decree,
order, statute, rule or regulation applicable to the Company or any
Subsidiary except where the consequences would not have a Material Adverse
Effect or (ii) violate any provision of the charter or by-laws of the
Company or any Material Subsidiary, except for such consents or waivers
which have already been obtained and are in full force and effect.
(n) The Company has authorized and outstanding capital stock as set
forth under the caption "Capitalization" in the Prospectus. All of the
issued and outstanding shares of Common Stock, including the Shares, have
been duly authorized and validly
8
issued and are fully paid and nonassessable, subject to the personal
liability that may be imposed on shareholders by Section 180.0622(2)(b) of
the Wisconsin Business Corporation Law, as judicially interpreted, for
debts owing to employees for services performed, but not exceeding six
months service in any one case, and were not issued in violation of any
preemptive or other similar rights. None of the outstanding shares of
capital stock of any Material Subsidiary was issued in violation of any
preemptive or other similar rights. There are no preemptive or other
similar rights to subscribe for or to purchase or acquire any shares of the
Company's Common Stock pursuant to the Company's Restated Articles of
Incorporation or Bylaws or any agreement or other instrument to or by which
the Company or any of its Subsidiaries is a party or bound. Except as
disclosed in the Registration Statement and the Prospectus, there is no
outstanding option, warrant or other right calling for the issuance of, and
there is no commitment, plan or arrangement to issue, any shares of stock
of the Company or its Material Subsidiaries or any security convertible
into, or exercisable or exchangeable for, such stock. The Common Stock and
the Shares conform in all material respects to all statements in relation
thereto contained in the Registration Statement and the Prospectus. All
outstanding shares of capital stock of each Material Subsidiary that is a
corporation have been duly authorized and validly issued, and are fully
paid and nonassessable, subject to the personal liability that may be
imposed on shareholders by Section 180.0622(2)(b) of the Wisconsin Business
Corporation Law, as judicially interpreted, for debts owing to employees
for services performed, but not exceeding six months service in any one
case, and are owned directly by the Company or by another wholly-owned
subsidiary of the Company free and clear of any security interests, liens,
encumbrances, equities or claims, other than those described in the
Prospectus.
(o) Except as described in the Prospectus, no holder of any security
of the Company has the right to have any security owned by such holder
included in the Registration Statement or to demand registration of any
security owned by such holder during the period ending 90 days after the
date of this Agreement. The Selling Shareholder and each director of the
Company has delivered to the Representatives a written lock-up agreement in
the form attached to this Agreement ("Lock-Up Agreement").
(p) All necessary corporate action has been duly and validly taken by
the Company to authorize the execution, delivery and performance of this
Agreement by the Company. This Agreement has been duly authorized, executed
and delivered by the Company and constitutes and will constitute a legal,
valid and binding obligation of the Company enforceable against the Company
in accordance with its terms, except as the enforceability thereof may be
limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws affecting the enforcement of creditors' rights generally and
by general equitable principles and, as to indemnification provisions, by
public policy and the undertaking contained in the Registration Statement.
(q) Neither the Company nor any of its Subsidiaries is involved in any
labor dispute nor, to the knowledge of the Company, is any such dispute
threatened,
9
which dispute would have a Material Adverse Effect. The Company is not
aware of any existing or imminent labor disturbance by the employees of any
of its principal suppliers or contractors which would have a Material
Adverse Effect. The Company is not aware of any threatened or pending
litigation between the Company or its Subsidiaries and any of its executive
officers which, if adversely determined, could have a Material Adverse
Effect and has no reason to believe that such officers will not remain in
the employment of the Company.
(r) No transaction has occurred between or among the Company and any
of its officers or directors or five percent shareholders or any affiliate
or affiliates of any such officer or director or five percent shareholders
that is required to be described in and is not described in the
Registration Statement and the Prospectus.
(s) The Company has not taken, nor will it take, directly or
indirectly, any action designed to or which might reasonably be expected to
cause or result in, or which has constituted or which might reasonably be
expected to constitute, the stabilization or manipulation of the price of
the Common Stock to facilitate the sale or resale of any of the Shares.
(t) The Company and its Subsidiaries have filed all Federal, state,
local and foreign tax returns which are required to be filed through the
date hereof, which returns are true and correct in all material respects or
has received extensions thereof, and has paid all taxes shown on such
returns and all assessments received by it to the extent that the same are
material and have become due. There are no tax audits or investigations
pending, which if adversely determined would have a Material Adverse
Effect; nor are there any material proposed additional tax assessments
against the Company and any of its Subsidiaries.
(u) The Shares are listed on the New York Stock Exchange ("NYSE").
(v) The Company has taken no action designed to, or likely to have the
effect of, terminating the registration of the Common Stock under the
Exchange Act or the listing of the Common Stock on the NYSE, nor has the
Company received any notification that the Commission or the NYSE is
contemplating terminating such registration or listing.
(w) The books, records and accounts of the Company and its
Subsidiaries accurately and fairly reflect, in all material respects, the
transactions in, and dispositions of, the assets of, and the results of
operations of, the Company and its Subsidiaries. The Company, with respect
to itself and its Subsidiaries, maintains a system of internal accounting
controls sufficient to provide reasonable assurances that (i) transactions
are executed in conformity with management's general or specific
authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted
accounting principles and to maintain accountability for assets, (iii)
access to assets is permitted only in accordance with management's general
or specific authorization and (iv) the recorded
10
accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences.
(x) The Company and its Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks and in
such amounts as are in accordance with normal industry practice in the
businesses in which they are engaged; all policies of insurance and
fidelity or surety bonds described in the Prospectus insuring the Company
or any of its Subsidiaries or the Company's or its Subsidiaries' respective
businesses, assets, employees, officers and directors are in full force and
effect; and the Company and each of its Subsidiaries are in compliance with
the terms of such policies and instruments in all material respects.
(y) No consent, approval, authorization, or order of, or filing with,
any governmental agency or body or any court is required to be obtained or
made by the Company for the consummation of the transactions contemplated
by this Agreement in connection with the sale of the Shares, except such as
(i) have been obtained and made under the Securities Act, (ii) may be
required under state securities laws and (iii) may be required by the
National Association of Securities Dealers, Inc. (the "NASD"). For purposes
of this Section it is assumed that no investor (whether an individual or
entity), nor any group of investors acting in concert, will acquire control
of the Company requiring prior insurance regulatory approval as a direct
result of the public offering of the Shares.
(z) To the knowledge of the Company, there are no affiliations with
the NASD among the Company's officers, directors or any five percent or
greater shareholder of the Company, except as set forth in the Registration
Statement or in the NASD questionnaires delivered to the Representatives or
otherwise disclosed in writing to the Representatives.
(aa) (i) Each of the Company and its Subsidiaries is in compliance in
all material respects with all rules, laws and regulation relating to the
use, treatment, storage and disposal of toxic substances and protection of
health or the environment ("Environmental Law") which are applicable to its
business; (ii) neither the Company nor any of its Subsidiaries has received
any notice from any governmental authority or third party of an asserted
claim under Environmental Laws; (iii) each of the Company and its
Subsidiaries has received all material permits, licenses or other approvals
required of it under applicable Environmental Laws to conduct its business
and is in compliance with all terms and conditions of any such material
permit, license or approval; (iv) to the Company's knowledge, no facts
currently exist that will require the Company or its Subsidiaries to make
future material capital expenditures to comply with Environmental Laws; and
(v) no property which is or has been owned, or to the Company's knowledge,
leased or occupied by the Company or its Subsidiaries has been designated
as a Superfund site pursuant to the Comprehensive Environmental Response,
Compensation and Liability Act of 1980, as amended (42 U.S.C. Section 9601,
et. seq.) ("CERCLA") or otherwise designated as a contaminated site under
applicable state or local law. Neither the Company nor any of its
Subsidiaries has
11
been named as a "potentially responsible party" under CERCLA.
(bb) The Company is not and, after giving effect to the offering and
sale of the Shares, will not be an "investment company" within the meaning
of the Investment Company Act of 1940, as amended (the "Investment Company
Act").
(cc) To the Company's knowledge, the Company, its Subsidiaries or any
other person associated with or acting on behalf of the Company or its
Subsidiaries including, without limitation, any director, officer, agent or
employee of the Company or its Subsidiaries has not, directly or
indirectly, while acting on behalf of the Company or its Subsidiaries (i)
used any corporate funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity; (ii) made any
unlawful payment to foreign or domestic government officials or employees
or to foreign or domestic political parties or campaigns from corporate
funds; (iii) violated any provision of the Foreign Corrupt Practices Act of
1977, as amended; or (iv) made any other unlawful payment.
5. REPRESENTATIONS AND WARRANTIES OF THE SELLING SHAREHOLDER. The
Selling Shareholder hereby represents and warrants to each Underwriter as
follows:
(a) The Selling Shareholder has caused the Shares to be sold by the
Selling Shareholder hereunder to be transferred to an account with La Salle
Bank National Association (the "Transfer Agent"), on or prior to the date
hereof, free and clear of any lien, claim, security interest or other
encumbrance to be held by the Transfer Agent on behalf of the Selling
Shareholder until the Closing.
(b) This Agreement and the Lock-Up Agreement have each been duly
authorized, executed and delivered by or on behalf of the Selling
Shareholder and, assuming due authorization, execution and delivery by the
other parties hereto, constitutes the valid and legally binding agreement
of the Selling Shareholder, enforceable against the Selling Shareholder in
accordance with its terms.
(c) The execution and delivery by the Selling Shareholder of this
Agreement and the performance by the Selling Shareholder of its obligations
under this Agreement (i) will not contravene any provision of applicable
law, statute, regulation or filing or any agreement or other instrument
binding upon the Selling Shareholder or any judgment, order or decree of
any governmental body, agency or court having jurisdiction over the Selling
Shareholder, (ii) does not require any consent, approval, authorization or
order of or registration or filing with any court or governmental agency or
body having jurisdiction over it, except such as may be required by the
Blue Sky laws of the various states in connection with the offer and sale
of the Shares which have been or will be effected in accordance with this
Agreement, (iii) does not and will not violate any statute, law, regulation
or filing or judgment, injunction, order or decree applicable to the
Selling Shareholder or (iv) will not result in the creation or imposition
of any lien, charge or encumbrance upon any property or assets of the
Selling Shareholder pursuant to the terms of any agreement or instrument to
which the Selling Shareholder is a party or by which the Selling
12
Shareholder may be bound or to which any of the property or assets of the
Selling Shareholder is subject.
(d) The Selling Shareholder has, and on the Firm Shares Closing Date
will have, valid and marketable title to the Shares to be sold by the
Selling Shareholder free and clear of any lien, claim, security interest or
other encumbrance, including, without limitation, any restriction on
transfer, except as otherwise described in the Registration Statement and
Prospectus.
(e) The Selling Shareholder has, and on the Firm Shares Closing Date
will have, full legal right, power and authorization, and any approval
required by law, to sell, assign, transfer and deliver the Shares to be
sold by the Selling Shareholder in the manner provided by this Agreement.
(f) Upon delivery of and payment for the Shares to be sold by the
Selling Shareholder pursuant to this Agreement, the several Underwriters
will receive valid and marketable title to such Shares free and clear of
any lien, claim, security interest or other encumbrance.
(g) All information relating to the Selling Shareholder furnished in
writing by the Selling Shareholder expressly for use in the Registration
Statement and Prospectus is, and on each Closing Date will be, true,
correct, and complete, and does not, and on each Closing Date will not,
contain any untrue statement of a material fact or omit to state any
material fact necessary to make such information not misleading.
(h) The Selling Shareholder has reviewed the Registration Statement
and Prospectus and, although the Selling Shareholder has not independently
verified the accuracy or completeness of all the information contained
therein, nothing has come to the attention of the Selling Shareholder that
would lead the Selling Shareholder to believe that (i) on the Effective
Date, the Registration Statement contained any untrue statement of a
material fact or omitted to state any material fact required to be stated
therein in order to make the statements made therein not misleading and
(ii) on the Effective Date the Prospectus contained and, on each Closing
Date contains, any untrue statement of a material fact or omitted or omits
to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made,
misleading.
(i) The sale of Shares by the Selling Shareholder pursuant to this
Agreement is not prompted by the Selling Shareholder's knowledge of any
material information concerning the Company or its Subsidiaries which is
not set forth in the Prospectus.
(j) The Selling Shareholder has not taken and will not take, directly
or indirectly, any action designed to or that might reasonably be expected
to cause or result in stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the Shares.
13
(k) The Selling Shareholder has no actual knowledge that any
representation or warranty of the Company set forth in Section 4 above is
untrue or inaccurate in any material respect.
6. CONDITIONS OF THE UNDERWRITERS' OBLIGATIONS. The obligations of the
Underwriters under this Agreement are several and not joint. The respective
obligations of the Underwriters to purchase the Shares are subject to each of
the following terms and conditions:
(a) Notification that the Registration Statement has become effective
shall have been received by the Representatives and the Prospectus shall
have been timely filed with the Commission in accordance with Section 7(a)
of this Agreement.
(b) No order preventing or suspending the use of any Preliminary
Prospectus or the Prospectus shall have been or shall be in effect and no
order suspending the effectiveness of the Registration Statement shall be
in effect and no proceedings for such purpose shall be pending before or
threatened by the Commission, and any requests for additional information
on the part of the Commission (to be included in the Registration Statement
or the Prospectus or otherwise) shall have been complied with to the
satisfaction of the Commission and the Representatives. If the Company has
elected to rely upon Rule 430A, Rule 430A information previously omitted
from the effective Registration Statement pursuant to Rule 430A shall have
been transmitted to the Commission for filing pursuant to Rule 424(b)
within the prescribed time period and the Company shall have provided
evidence satisfactory to the Underwriters of such timely filing, or a
post-effective amendment providing such information shall have been
promptly filed and declared effective in accordance with the requirements
of Rule 430A.
(c) The representations and warranties of the Company and the Selling
Shareholder contained in this Agreement and in the certificates delivered
pursuant to Section 6(d) and Section 6(e), respectively, shall be true and
correct when made and on and as of each Closing Date as if made on such
date. The Company and the Selling Shareholder shall have performed all
covenants and agreements and satisfied all the conditions contained in this
Agreement required to be performed or satisfied by them at or before such
Closing Date.
14
(d) The Representatives shall have received on each Closing Date a
certificate, addressed to the Representatives and dated such Closing Date,
of the chief executive or chief operating officer and the chief financial
officer or chief accounting officer of the Company to the effect that (i)
the signers of such certificate have carefully examined the Registration
Statement, the Prospectus and this Agreement and that the representations
and warranties of the Company in this Agreement are true and correct on and
as of such Closing Date with the same effect as if made on such Closing
Date and the Company has performed all covenants and agreements and
satisfied all conditions contained in this Agreement required to be
performed or satisfied by it at or prior to such Closing Date, and (ii) no
stop order suspending the effectiveness of the Registration Statement has
been issued and to the best of their knowledge, no proceedings for that
purpose have been instituted or are pending under the Securities Act.
(e) The Representatives shall have received on each Closing Date a
certificate, addressed to the Representatives and dated such Closing Date,
of the Selling Shareholder, to the effect that the Selling Shareholder has
carefully examined the Registration Statement, the Prospectus and this
Agreement and that the representations and warranties of the Selling
Shareholder in this Agreement are true and correct on and as of such
Closing Date with the same effect as if made on such Closing Date and the
Selling Shareholder has performed all covenants and agreements and
satisfied all conditions contained in this Agreement required to be
performed or satisfied by it at or prior to such Closing Date.
(f) The Representatives shall have received, at the time this
Agreement is executed and on each Closing Date a signed letter from Ernst &
Young LLP addressed to the Representatives and dated, respectively, the
date of this Agreement and each such Closing Date, in form and substance
reasonably satisfactory to the Representatives containing statements and
information of the type ordinarily included in accountants' "comfort
letters" to underwriters with respect to the financial statements and
certain financial information contained in the Registration Statement and
the Prospectus.
(g) The Representatives shall have received on each Closing Date from
Quarles & Brady LLP, counsel for the Company, an opinion, addressed to the
Representatives and dated such Closing Date, and stating in effect that:
(i) The Company has been duly incorporated and is validly
existing as a corporation under the laws of the State of Wisconsin;
and the Company is duly qualified to transact business as a foreign
corporation in the jurisdictions identified on a schedule to such
opinion. The Company has filed its most recent required annual report,
and has not filed articles of dissolution, with the Wisconsin
Department of Financial Institutions.
(ii) The Company has corporate power and authority to own its
properties and conduct its business as described in the Registration
Statement
15
and the Prospectus and to enter into, deliver and perform its
obligations under this Agreement.
(iii) The Company's authorized capital stock is as set forth in
the Registration Statement and the Prospectus under the caption
"Description of Capital Stock". The Shares have been duly authorized
and validly issued, are fully paid and nonassessable (subject to the
personal liability that may be imposed on shareholders by Section
180.0622(2)(b) of the Wisconsin Business Corporation Law, as
judicially interpreted, for debts owing to employees for services
performed, but not exceeding six months service in any one case), and
none of them was issued in violation of any preemptive or other
similar right. The description thereof contained in the Registration
Statement and the Prospectus under the caption "Description of Capital
Stock," to the extent that such information constitutes matters of law
or summaries of legal matters or documents, has been reviewed by such
counsel and is correct in all material respects; and the shareholders
of the Company have no preemptive rights with respect to the Common
Stock.
(iv) All necessary corporate action has been duly and validly
taken by the Company to authorize the execution, delivery and
performance of this Agreement by the Company. This Agreement has been
duly authorized, executed and delivered by the Company.
(v) Neither the execution, delivery and performance of this
Agreement by the Company nor the consummation of any of the
transactions contemplated by this Agreement will (A) give rise to a
right to terminate or accelerate the due date of any payment due
under, or conflict with or result in the breach of any term or
provision of, or constitute a default (or any event which with notice
or lapse of time, or both, would constitute a default) under, or
require consent or waiver under, or result in the execution or
imposition of any lien, charge, claim, security interest or
encumbrance upon any properties or assets of the Company or any
Subsidiary pursuant to (i) any agreement filed as an exhibit to the
Registration Statement, the Company's Annual Report on Form 10-K for
the year ended December 31, 2001 or the Company's Quarterly Report on
Form 10-Q for the period ended March 31, 2002, (ii) any statute, rule
or regulation of any governmental agency or body or any authority of
the United States of America or the State of Wisconsin applicable to
the Company or (iii) any judgment, decree or order of any court or
governmental agency or body of the United States of America or the
State of Wisconsin applicable to the Company set forth in the
officers' certificate to be attached to such opinion (if any) or (B)
contravene any provision of the Restated Articles of Incorporation or
Bylaws of the Company, as amended.
(vi) No consent, approval, registration, qualification,
authorization or order of, or filing with, any Wisconsin or federal
governmental agency, body or court is required to be obtained or made
by the Company for the
16
consummation of the transactions contemplated by this Agreement in
connection with the sale of the Shares by the Selling Shareholder,
except such as (A) have been obtained and made under the Securities
Act, (B) may be required under state securities laws and (C) may be
required by the NASD.
(vii) To the knowledge of such counsel, there is no litigation or
governmental or other proceeding or investigation, before any court or
before or by any public body or board pending or threatened against,
or involving the assets, properties or businesses of, the Company
which is required to be disclosed in the Registration Statement and
the Prospectus and is not so disclosed.
(viii) The statements in the Prospectus under the captions
"Certain Transactions," "Description of Capital Stock," and "Shares
Eligible for Future Sale," insofar as such statements purport to
summarize the Company's authorized capital stock and agreements to
which the Company is a party or matters of law, are accurate in all
material respects and provide a fair summary of such documents and
matters.
(ix) The Registration Statement, all Preliminary Prospectuses and
the Prospectus and each amendment or supplement thereto (except for
the financial statements and schedules and other financial and
statistical data included therein, as to which such counsel expresses
no opinion) comply as to form in all material respects with the
requirements of the Securities Act and the Rules and the documents
incorporated by reference in the Registration Statement, all
Preliminary Prospectuses and the Prospectus and any further amendment
or supplement to any such incorporated document made by the Company
(except for the financial statements and schedules and other financial
and statistical data included therein, as to which such counsel
expresses no opinion) when they became effective or were filed with
the Commission, as the case may be, complied as to form in all
material respects with the requirements of the Securities Act or the
Exchange Act, as applicable, and the rules and regulations of the
Commission thereunder.
(x) The Registration Statement is effective under the Securities
Act, and to such counsel's knowledge no stop order suspending the
effectiveness of the Registration Statement has been issued and no
proceedings for that purpose have been instituted or are threatened,
pending or contemplated. Any required filing of the Prospectus and any
supplement thereto pursuant to Rule 424(b) under the Securities Act
has been made in the manner and within the time period required by
such Rule 424(b).
(xi) The Shares are listed on the NYSE.
(xii) The capital stock of the Company conforms in all material
respects to the description thereof contained in the Prospectus under
the
17
caption "Description of Capital Stock."
(xiii) The Company is not an "investment company" or an entity
controlled by an "investment company" as such terms are defined in the
Investment Company Act of 1940, as amended.
To the extent deemed advisable by such counsel, they may rely as to
matters of fact on certificates of responsible officers of the Company and
public officials and on the opinions of other counsel satisfactory to the
Representatives as to matters which are governed by laws other than the laws of
the State of Wisconsin, the General Corporation Law of the State of Delaware and
the Federal laws of the United States; provided that such counsel shall state
that in their opinion the Underwriters and they are justified in relying on such
other opinions. Copies of such certificates and other opinions shall be
furnished to the Representatives and counsel for the Underwriters. Such counsel
may assume, for purposes of its opinion, that no investor (whether an individual
or entity), nor any group of investors acting in concert, will acquire control
of the Company requiring prior insurance regulatory approval as a direct result
of the public offering of the Shares.
In addition, such counsel shall state that such counsel has
participated in conferences with officers and other representatives of the
Company, representatives of the Representatives and representatives of the
independent certified public accountants of the Company, at which conferences
the contents of the Registration Statement and the Prospectus and related
matters were discussed and, although such counsel is not passing upon and does
not assume any responsibility for the accuracy, completeness or fairness of the
statements contained in the Registration Statement and the Prospectus and have
made no independent check or verification thereof (except as specified in the
foregoing opinion), on the basis of the foregoing, no facts have come to the
attention of such counsel which lead such counsel to believe that (i) the
Registration Statement at the time it became effective (except with respect to
the financial statements and notes and schedules thereto and other financial
data included therein or omitted therefrom, as to which such counsel need
express no belief) contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary to make the
statements therein not misleading, or that the Prospectus as amended or
supplemented (except with respect to the financial statements, notes and
schedules thereto and other financial data included therein or omitted
therefrom, as to which such counsel need make no statement) on the date thereof
contained any untrue statement of a material fact or omitted to state a material
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading or (ii) any document
incorporated by reference in the Prospectus or any further amendment or
supplement to any such incorporated document made by the Company (except with
respect to the financial statements, notes and schedules thereto and other
financial data included therein or omitted therefrom, as to which such counsel
need make no statement), when they became effective or were filed with the
Commission, as the case may be, contained, in the case of a registration
statement which became effective under the Securities Act, any untrue statement
of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein not misleading, or,
in the case of other documents which were filed under the Exchange Act with the
Commission, any untrue statement of a material fact or omitted to state a
material fact necessary in order to make the
18
statements therein, in the light of the circumstances under which they were
made, not misleading.
(h) The Representatives shall have received on each Closing Date from
Timothy J. Moore, general counsel for the Company, an opinion, addressed to
the Representatives and dated such Closing Date, and stating in effect
that:
(i) Each of the Material Subsidiaries has been duly organized and
is validly existing as a corporation or partnership, as the case may
be, in good standing (or equivalent status) under the laws of their
respective jurisdictions of organization. Each of the Material
Subsidiaries is duly qualified or certified to transact business and
in good standing (or equivalent status) as a foreign corporation or
partnership, as the case may be in the jurisdictions listed in an
exhibit to the opinion.
(ii) Each of the Company and the Material Subsidiaries has all
requisite corporate or partnership, as the case may be, power and
authority to own, lease and license its assets and properties and
conduct its business as now being conducted and as described in the
Registration Statement and the Prospectus and with respect to the
Company to enter into, deliver and perform its obligations under this
Agreement.
(iii) The Company has authorized, issued and outstanding capital
stock as set forth in the Registration Statement and the Prospectus
under the caption "Capitalization" as of the dates stated therein; all
of the outstanding shares of Common Stock of the Company, including
the Shares, have been duly and validly authorized and issued and are
fully paid and nonassessable (subject to the personal liability that
may be imposed on shareholders by Section 180.0622(2)(b) of the
Wisconsin Business Corporation Law, as judicially interpreted, for
debts owing to employees for services performed, but not exceeding six
months service in any one case), and none of them was issued in
violation of any preemptive or other similar right. To the best of
such counsel's knowledge, except as disclosed in the Registration
Statement and the Prospectus, there is no outstanding option, warrant
or other right calling for the issuance of, and no commitment, plan or
arrangement to issue, any share of stock of the Company or any
security convertible into, exercisable for, or exchangeable for stock
of the Company. The Common Stock and the Shares conform in all
material respects to the descriptions thereof contained in the
Registration Statement and the Prospectus. The issued and outstanding
shares of capital stock of each of the Company's Material Subsidiaries
that is a corporation have been duly authorized and validly issued,
are fully paid and nonassessable (subject to the personal liability
that may be imposed on shareholders by Section 180.0622(2)(b) of the
Wisconsin Business Corporation Law, as judicially interpreted, for
debts owing to employees for services performed, but not exceeding six
months service in any one case) and are owned by the Company or by
another wholly owned subsidiary of the
19
Company, free and clear of any perfected security interest or, to the
knowledge of such counsel, any other security interests, liens,
encumbrances, equities or claims, other than those described in the
Registration Statement and the Prospectus. Except as disclosed in the
Registration Statement and the Prospectus, there are no preemptive or
other rights to subscribe for or to purchase or any restriction upon
the voting or transfer of the Company's Common Stock pursuant to the
Company's Restated Articles of Incorporation or Bylaws or, to such
counsel's knowledge, any agreements or other instruments to which the
Company is a party or by which it is bound.
(iv) To such counsel's knowledge, except as disclosed in the
Prospectus, neither the Company nor any of its Subsidiaries is in
violation of any term or provision of its charter or by-laws or any
franchise, license, permit, judgment, decree, order, statute, rule or
regulation, domestic or foreign, where the consequences of such
violation, individually or in the aggregate, would have a Material
Adverse Effect. To such counsel's knowledge, except as disclosed in
the Prospectus, the Company and its Subsidiaries are conducting their
respective businesses in compliance in all respects with all laws,
rules, regulations, decisions, directives and orders applicable to
them except where the failure to do so would not have a Material
Adverse Effect.
(v) The statements in the Prospectus under the captions
"Management's Discussion and Analysis of Financial Condition and
Results of Operations--Liquidity and Capital Resources,"
"Business--Industry," "Business--Regulation" and "Business--Legal
Proceedings," insofar as such statements constitute a summary of
documents referred to therein or matters of law, are accurate in all
material respects and accurately present the information called for
with respect to such documents and matters. Accurate copies of all
contracts and other documents required to be filed as exhibits to, or
described in, the Registration Statement have been so filed with the
Commission or are fairly described in the Registration Statement, as
the case may be.
(vi) (A) Each of the Company and its Subsidiaries is in
compliance in all material respects with any and all applicable
Environmental Laws; (B) none of the Company or its Subsidiaries has
received any notice from any governmental authority or third party of
an asserted claim under any Environmental Law; (C) each of the Company
and its Subsidiaries has received all material permits, licenses or
other approvals required of it under applicable Environmental Laws to
conduct its business and is in compliance with all terms and
conditions of any such material permit, license or approval, except
where such failure to receive required permits, licenses or other
approvals or failure to comply with the terms and conditions of such
permits, licenses or other approvals would not, singly or in the
aggregate, have a Material Adverse Effect; and (D) no property which
is or has been owned, or to such counsel's knowledge, leased or
occupied, by the Company or its Subsidiaries has been designated as a
Superfund site pursuant to CERCLA, or
20
otherwise designated as a contaminated site under applicable state or
local law.
(vii) To such counsel's knowledge, no default exists, and no
event has occurred which with notice or lapse of time, or both, would
constitute a default, in the due performance and observance of any
term, covenant or condition by the Company of any indenture, mortgage,
deed of trust, note or any other agreement or instrument to which the
Company is a party or by which it or any of its assets or properties
or businesses may be bound or affected, where the consequences of such
default, individually or in the aggregate, is required to be disclosed
in the Registration Statement and the Prospectus or which would have a
Material Adverse Effect.
Such counsel may assume, for purposes of its opinion, that no investor
(whether an individual or entity), nor any group of investors acting in concert,
will acquire control of the Company requiring prior insurance regulatory
approval as a direct result of the public offering of the Shares.
In addition, such counsel shall state that such counsel has
participated in conferences with officers and other representatives of the
Company, representatives of the Representatives and representatives of the
independent public accountants of the Company, at which conferences the contents
of the Registration Statement and the Prospectus as they related to the matters
set forth in the foregoing opinion were discussed. While such counsel has not
undertaken to independently verify and does not assume any responsibility for
the accuracy, completeness or fairness of the statements contained in the
Registration Statement and the Prospectus (except as specified in the foregoing
opinion), on the basis of the foregoing, no facts have come to the attention of
such counsel which lead such counsel to believe that the Registration Statement
at the time it became effective (except with respect to the financial statements
and notes and schedules thereto and other financial data included therein or
omitted therefrom, as to which such counsel need express no belief) contained
any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading, or that the Prospectus as amended or supplemented (except with
respect to the financial statements, notes and schedules thereto and other
financial data included therein or omitted therefrom, as to which such counsel
need make no statement) on the date thereof and the date of such opinion
contained any untrue statement of a material fact or omitted to state a material
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.
(i) The Representatives shall have received on each Closing Date from
Foley & Lardner, counsel for the Selling Shareholder, an opinion, addressed
to the Representatives and dated such Closing Date, and stating in effect
that:
(i) This Agreement has been duly authorized, executed and
delivered by or on behalf of the Selling Shareholder.
(ii) This Agreement and the Lock-Up Agreement each constitute the
legal, valid and binding obligation of the Selling Shareholder
enforceable against
21
the Selling Shareholder in accordance with its terms, subject, as to
enforcement of remedies, to applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws from time to time in
effect and to general principles of equity, including, without
limitation, concepts of materiality, reasonableness, good faith and
fair dealing, regardless of whether considered in a proceeding in
equity or at law; and provided further that counsel need express no
opinion concerning the enforeceability of indemnification provisions.
The Selling Shareholder has full legal right and authority to enter
into this Agreement and to sell, transfer and deliver in the manner
provided in this Agreement, the Shares to be sold by the Selling
Shareholder hereunder.
(iii) The transfer and sale by the Selling Shareholder of the
Shares to be sold by the Selling Shareholder as contemplated by this
Agreement will not conflict with, result in a breach of, or constitute
a default under any agreement or instrument known to such counsel to
which the Selling Shareholder is a party or by which the Selling
Shareholder or any of its properties may be bound, or any franchise,
license, permit, judgment, decree, or order known to such counsel by
which the Selling Shareholder or any of its properties may be bound,
or any statute, rule or regulation.
(iv) Upon delivery of the Shares to the Underwriters who have
severally purchased such Shares pursuant to this Agreement, in the
manner provided in Section 2 hereof, the several Underwriters will
acquire all of the Selling Shareholder's rights in the Shares, free
and clear of adverse claims within the meaning of the Wisconsin
Uniform Commercial Code, assuming for purposes of this opinion that
the Underwriters purchased the same in good faith without notice of
any adverse claims.
(v) No consent, approval, authorization, license, certificate,
permit or order of any court, governmental or regulatory agency,
authority or body or (to the knowledge of such counsel) any financial
institution is required in connection with the performance of this
Agreement by the Selling Shareholder or the consummation of the
transactions contemplated hereby, including the delivery and sale of
the Shares to be delivered and sold by the Selling Shareholder, except
such as may be required under state securities or blue sky laws in
connection with the purchase and distribution of the Shares by the
several Underwriters.
To the extent deemed advisable by such counsel, they may rely as to
matters of fact on certificates of the Selling Shareholder and on the opinions
of other counsel satisfactory to the Representatives as to matters which are
governed by laws other than the laws of the State of Wisconsin or the Federal
laws of the United States; provided that such counsel shall state that in their
opinion the Underwriters and they are justified in relying on such other
opinions. Copies of such certificates and other opinions shall be furnished to
the Representatives and counsel for the Underwriters.
Such counsel may assume, for purposes of its opinion, that no investor
(whether an individual or entity), nor any group of investors acting in concert,
will acquire control of the Company requiring prior insurance regulatory
approval as a direct result of the public offering of
22
the Shares.
In addition, such counsel shall state that such counsel has
participated in conferences with officers and other representatives of the
Company, representatives of the Representatives and representatives of the
independent public accountants of the Company, at which conferences the contents
of the Registration Statement and the Prospectus as they related to the matters
set forth in the foregoing opinion were discussed. While such counsel has not
undertaken to independently verify and does not assume any responsibility for
the accuracy, completeness or fairness of the statements contained in the
Registration Statement and the Prospectus (except as specified in the foregoing
opinion), on the basis of the foregoing, no facts have come to the attention of
such counsel which lead such counsel to believe that the Registration Statement
at the time it became effective (except with respect to the financial statements
and notes and schedules thereto and other financial data included therein or
omitted therefrom, as to which such counsel need express no belief) contained
any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading, or that the Prospectus as amended or supplemented (except with
respect to the financial statements, notes and schedules thereto and other
financial data included therein or omitted therefrom, as to which such counsel
need make no statement) on the date thereof and the date of such opinion
contained any untrue statement of a material fact or omitted to state a material
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.
(j) All proceedings taken in connection with the sale of the Firm
Shares and the Option Shares as herein contemplated shall be reasonably
satisfactory in form and substance to the Representatives, and their
counsel and the Underwriters shall have received from Latham & Watkins an
opinion, addressed to the Representatives and dated such Closing Date, with
respect to the Shares, the Registration Statement and the Prospectus, and
such other related matters, as the Representatives may reasonably request,
and the Company shall have furnished to Latham & Watkins such documents as
they may reasonably request for the purpose of enabling them to pass upon
such matters.
(k) The Representatives shall have received copies of the Lock-up
Agreements executed by each entity or person described in Section 4(o).
(l) The Company and the Selling Shareholder shall have furnished or
caused to be furnished to the Representatives such further certificates or
documents as the Representatives shall have reasonably requested.
7. COVENANTS OF THE COMPANY AND THE SELLING SHAREHOLDER.
(a) The Company covenants and agrees as follows:
(i) The Company will use its best efforts to cause any amendments
to the Registration Statement, to become effective as promptly as
possible. The Company shall prepare the Prospectus in a form approved
by the
23
Representatives and file such Prospectus pursuant to Rule 424(b) under
the Securities Act not later than the Commission's close of business
on the second business day following the execution and delivery of
this Agreement, or, if applicable, such earlier time as may be
required by Rule 430A(a)(3) under the Securities Act.
(ii) The Company shall promptly advise the Representatives in
writing (i) when any amendment to the Registration Statement shall
have become effective, (ii) of any request by the Commission for any
amendment of the Registration Statement or the Prospectus or for any
additional information, (iii) of the prevention or suspension of the
use of any Preliminary Prospectus or the Prospectus or of the issuance
by the Commission of any stop order suspending the effectiveness of
the Registration Statement or the institution or threatening of any
proceeding for that purpose and (iv) of the receipt by the Company of
any notification with respect to the suspension of the qualification
of the Shares for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose. The Company shall not
file any amendment of the Registration Statement or supplement to the
Prospectus or any document incorporated by reference in the
Registration Statement unless the Company has furnished the
Representatives a copy for its review prior to filing and shall not
file any such proposed amendment or supplement to which the
Representatives reasonably object. The Company shall use its best
efforts to prevent the issuance of any such stop order and, if issued,
to obtain as soon as possible the withdrawal thereof.
(iii) If, at any time when a prospectus relating to the Shares is
required to be delivered under the Securities Act and the Rules, any
event occurs as a result of which the Prospectus as then amended or
supplemented would include any untrue statement of a material fact or
omit to state any material fact necessary to make the statements
therein in the light of the circumstances under which they were made
not misleading, or if it shall be necessary to amend or supplement the
Prospectus to comply with the Securities Act or the Rules, the Company
promptly shall prepare and file with the Commission, subject to the
second sentence of paragraph (ii) of this Section 7(a), an amendment
or supplement which shall correct such statement or omission or an
amendment which shall effect such compliance.
(iv) The Company shall make generally available to its security
holders and to the Representatives as soon as practicable, but not
later than 45 days after the end of the 12-month period beginning at
the end of the fiscal quarter of the Company during which the
Effective Date occurs (or 90 days if such 12-month period coincides
with the Company's fiscal year), an earning statement (which need not
be audited) of the Company, covering such 12-month period, which shall
satisfy the provisions of Section 11(a) of the Securities Act or Rule
158 of the Rules.
24
(v) The Company shall furnish to the Representatives and counsel
for the Underwriters, without charge, signed copies of the
Registration Statement (including all exhibits thereto and amendments
thereof) and to each other Underwriter a copy of the Registration
Statement (without exhibits thereto) and all amendments thereof and,
so long as delivery of a prospectus by an Underwriter or dealer may be
required by the Securities Act or the Rules, as many copies of any
Preliminary Prospectus and the Prospectus and any amendments thereof
and supplements thereto as the Representatives may reasonably request.
If applicable, the copies of the Registration Statement and Prospectus
and each amendment and supplement thereto furnished to the
Underwriters will be identical to the electronically transmitted
copies thereof filed with the Commission pursuant to EDGAR, except to
the extent permitted by Regulation S-T.
(vi) The Company shall cooperate with the Representatives and
their counsel in endeavoring to qualify the Shares for offer and sale
in connection with the offering under the laws of such jurisdictions
as the Representatives may designate and shall maintain such
qualifications in effect so long as required for the distribution of
the Shares; provided, however, that the Company shall not be required
in connection therewith, as a condition thereof, to qualify as a
foreign corporation or to execute a general consent to service of
process in any jurisdiction or subject itself to taxation as doing
business in any jurisdiction.
(vii) The Company, during the period when the Prospectus is
required to be delivered under the Securities Act and the Rules or the
Exchange Act, will file all documents required to be filed with the
Commission pursuant to Section 13, 14 or 15 of the Exchange Act within
the time periods required by the Exchange Act and the regulations
promulgated thereunder.
(viii) Without the prior written consent of CIBC World Markets
Corp., for a period of 90 days after the date of this Agreement, the
Company shall not issue, sell or register with the Commission (other
than on Form S-8 or on any successor form), or otherwise dispose of,
directly or indirectly, any shares of Common Stock of the Company (or
any securities convertible into, exercisable for or exchangeable for
shares of Common Stock of the Company), except for the registration of
the Shares pursuant to the Registration Statement and grants of
options and the issuance of shares pursuant to the Company's existing
stock option, bonus, deferred compensation or savings plans as
described in the Registration Statement and the Prospectus.
(ix) On or before completion of this offering, the Company shall
make all filings required under applicable securities laws and by the
NYSE.
(x) Prior to the Firm Shares Closing Date, the Company will issue
no press release and hold no press conference with respect to the
Company, the
25
condition, financial or otherwise, or the earnings, business affairs
or business prospects of the Company, or the offering of the Shares
without the prior written consent of the Representatives unless in the
judgment of the Company and its counsel, and after notification to the
Representatives, such press release or press conference is required by
law.
(b) The Company agrees to pay, or reimburse if paid by the
Representatives, whether or not the transactions contemplated hereby are
consummated or this Agreement is terminated, all costs and expenses
incident to the public offering of the Shares and the performance of the
obligations of the Company under this Agreement including those relating
to: (i) the preparation, printing, filing and distribution of the
Registration Statement including all exhibits thereto, each Preliminary
Prospectus, the Prospectus, all amendments and supplements to the
Registration Statement and the Prospectus and any document incorporated by
reference therein, and the printing, filing and distribution of this
Agreement; (ii) the registration or qualification of the Shares for offer
and sale under the securities or Blue Sky laws of the various jurisdictions
referred to in Section 7(a)(vi), including the reasonable fees and
disbursements of counsel for the Underwriters in connection with such
registration and qualification and the preparation, printing, distribution
and shipment of preliminary and supplementary Blue Sky memoranda; (iii) the
furnishing (including costs of shipping and mailing) to the Representatives
and to the Underwriters of copies of each Preliminary Prospectus, the
Prospectus and all amendments or supplements to the Prospectus, and of the
several documents required by this Section to be so furnished, as may be
reasonably requested for use in connection with the offering and sale of
the Shares by the Underwriters or by dealers to whom Shares may be sold;
(iv) the filing fees of the NASD in connection with its review of the terms
of the public offering and reasonable fees and disbursements of counsel for
the Underwriters in connection with such review; and (v) all transfer
taxes, if any, with respect to the sale and delivery of the Shares by the
Selling Shareholder to the Underwriters. Subject to the provisions of
Section 10, the Underwriters agree to pay, whether or not the transactions
contemplated hereby are consummated or this Agreement is terminated, all
costs and expenses incident to the performance of the obligations of the
Underwriters under this Agreement not payable by the Company pursuant to
the preceding sentence, including, without limitation, the fees and
disbursements of counsel for the Underwriters.
(c) As provided in Section 6.03(c) of the Stock Purchase Agreement
dated as of March 19, 2002, among the Selling Shareholder, Cobalt
Corporation, and the Company (the "Stock Purchase Agreement"), (1) the
Selling Shareholder shall bear all underwriting discounts, fees and
commissions related to the sale of the Shares, (2) the expenses of the
offering and sale of the Shares up to an aggregate of $650,000 shall be
borne by the Company, and (3) any expenses incurred in excess of such
$650,000 amount shall be borne equally by the Company and the Selling
Shareholder. The Selling Shareholder agrees to reimburse the Company for
half of any amount of such expenses in excess of $650,000 paid by the
Company, in accordance with the Stock Purchase Agreement. The Stock
Purchase Agreement contains indemnification
26
provisions among the Company, the Selling Shareholder and Cobalt
Corporation which shall remain in force as between such parties, provided,
however, that no provision of the Stock Purchase Agreement shall affect or
alter the indemnification and other rights of the Underwriters provided in
this Agreement.
8. INDEMNIFICATION.
(a) The Company agrees to indemnify and hold harmless each Underwriter
and each person, if any, who controls any Underwriter within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act against
any and all losses, claims, damages and liabilities, joint or several
(including any reasonable investigation, legal and other expenses incurred
in connection with, and any amount paid in settlement of, any action, suit
or proceeding or any claim asserted), to which they, or any of them, may
become subject under the Securities Act, the Exchange Act or other Federal
or state law or regulation, at common law or otherwise, insofar as such
losses, claims, damages or liabilities arise out of or are based upon (i)
any untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, the Registration Statement or the
Prospectus or any amendment thereof or supplement thereto, or in any Blue
Sky application or other information or other documents executed by the
Company filed in any state or other jurisdiction to qualify any or all of
the Shares under the securities laws thereof (any such application,
document or information being hereinafter referred to as a "Blue Sky
Application") or arise out of or are based upon any omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) in whole or
in part upon any breach of the representations and warranties set forth in
Section 4 hereof, or (iii) in whole or in part upon any failure of the
Company to perform any of its obligations hereunder or under law; provided,
however, that such indemnity shall not inure to the benefit of any
Underwriter (or any person controlling such Underwriter) on account of any
losses, claims, damages or liabilities arising from the sale of the Shares
to any person by such Underwriter if such untrue statement or omission or
alleged untrue statement or omission was made in such Preliminary
Prospectus, the Registration Statement or the Prospectus, or such amendment
or supplement thereto, or in any Blue Sky Application in reliance upon and
in conformity with information furnished in writing to the Company by the
Representatives on behalf of any Underwriter specifically for use therein;
and provided further that such indemnity shall not inure to the benefit of
any Underwriter (or any person controlling such Underwriter) on account of
any loss, claim, damage or liability arising out of any such untrue
statement or alleged untrue statement or omission or alleged omission in
any Preliminary Prospectus if the Company shall have timely furnished
copies of the Prospectus to such Underwriter and such Underwriter shall not
have given or sent a copy of the Prospectus to the person who purchased
Shares from such Underwriter and who is asserting such loss, claim, damage
or liability, if required by law to have been delivered, at or prior to the
written confirmation of the sale of Shares to such person by such
Underwriter, to the extent that the Prospectus would have cured such defect
or alleged defect giving rise to such loss, claim, damage or liability.
This indemnity agreement will be in addition to any liability which the
Company may otherwise have.
27
(b) The Selling Shareholder agrees to indemnify and hold harmless each
Underwriter and each person, if any, who controls any Underwriter within
the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act to the same extent as the foregoing indemnity from the Company
to each Underwriter, but only insofar as such losses, claims, damages or
liabilities arise out of or are based upon (i) any untrue statement or
omission or alleged untrue statement or omission of a material fact which
was made in any Preliminary Prospectus, the Registration Statement or the
Prospectus, or any amendment thereof or supplement thereto, (ii) in whole
or in part upon any breach of the representations and warranties of the
Selling Shareholder set forth in Section 5 hereof, or (iii) in whole or in
part upon any failure of the Selling Shareholder to perform any of its
obligations hereunder or under law; provided that such indemnity shall not
inure to the benefit of any Underwriter (or any person controlling such
Underwriter) on account of any loss, claim, damage or liability arising out
of any such untrue statement or alleged untrue statement or omission or
alleged omission in any Preliminary Prospectus if the Company shall have
timely furnished copies of the Prospectus to such Underwriter and such
Underwriter shall not have given or sent a copy of the Prospectus to the
person who purchased Shares from such Underwriter and who is asserting such
loss, claim, damage or liability, if required by law to have been
delivered, at or prior to the written confirmation of the sale of Shares to
such person by such Underwriter, to the extent that the Prospectus would
have cured such defect or alleged defect giving rise to such loss, claim,
damage or liability. Notwithstanding the foregoing, the liability of the
Selling Shareholder pursuant to the provisions of this Section 8(b) shall
be limited to an amount equal to the aggregate net proceeds received by
such Selling Shareholder from the sale of the Shares sold by the Selling
Shareholder hereunder. This indemnity agreement will be in addition to any
liability which the Selling Shareholder may otherwise have.
(c) Each Underwriter agrees, severally and not jointly, to indemnify
and hold harmless the Company, the Selling Shareholder and each person, if
any, who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act, each director of the
Company, and each officer of the Company who signs the Registration
Statement, to the same extent as the foregoing indemnity from the Company
and the Selling Shareholder to each Underwriter, but only insofar as such
losses, claims, damages or liabilities (i) arise out of or are based upon
any untrue statement or omission or alleged untrue statement or omission of
a material fact which was made in any Preliminary Prospectus, the
Registration Statement or the Prospectus, or any amendment thereof or
supplement thereto, contained in the table under the second paragraph and
in the fourth (except for the first sentence), tenth, eleventh and
thirteenth (with respect to the absence of representations by the
Underwriters) paragraphs under the caption "Underwriting" in the
Prospectus, or (ii) arise out of or are based upon the failure of such
Underwriter to deliver a Prospectus, if the Company shall have timely
furnished copies of the Prospectus (as then amended if the Company shall
have furnished any amendments thereto) to such Underwriter and the person
who purchased Shares from such Underwriter and who is
28
asserting such loss, claim, damage or liability purchased Shares from such
Underwriter and a copy of the Prospectus (as then amended if the Company
shall have furnished any amendments thereto) was not sent or given by or on
behalf of such Underwriter to such person, if required by law to have been
so delivered, at or prior to the written confirmation of the sale of the
Shares to such person by such Underwriter, and if the Prospectus (as so
amended) would have cured the defect or alleged defect giving rise to such
loss, claim, damage or liability; provided, however, that the obligation of
each Underwriter to indemnify the Company or the Selling Shareholder
(including any controlling person, director or officer thereof) shall be
limited to the net proceeds received by the Selling Shareholder from such
Underwriter. This indemnity agreement will be in addition to any liability
which each Underwriter may otherwise have.
(d) Any party that proposes to assert the right to be indemnified
under this Section will, promptly after receipt of notice of commencement
of any action, suit or proceeding against such party in respect of which a
claim is to be made against an indemnifying party or parties under this
Section, notify each such indemnifying party of the commencement of such
action, suit or proceeding, enclosing a copy of all papers served. No
indemnification provided for in Section 8(a), 8(b) or 8(c) shall be
available to any party who shall fail to give notice as provided in this
Section 8(d) if the party to whom notice was not given was unaware of the
proceeding to which such notice would have related and was prejudiced by
the failure to give such notice but the omission so to notify such
indemnifying party of any such action, suit or proceeding shall not relieve
it from any liability that it may have to any indemnified party for
contribution or otherwise than under this Section. In case any such action,
suit or proceeding shall be brought against any indemnified party and it
shall notify the indemnifying party of the commencement thereof, the
indemnifying party shall be entitled to participate in, and, to the extent
that it shall wish, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel reasonably
satisfactory to such indemnified party, and after notice from the
indemnifying party to such indemnified party of its election so to assume
the defense thereof and the approval by the indemnified party of such
counsel, the indemnifying party shall not be liable to such indemnified
party for any legal or other expenses, except as provided below and except
for the reasonable costs of investigation subsequently incurred by such
indemnified party in connection with the defense thereof. The indemnified
party shall have the right to employ its counsel in any such action, but
the fees and expenses of such counsel shall be at the expense of such
indemnified party unless (i) the employment of counsel by such indemnified
party has been authorized in writing by the indemnifying parties, (ii) the
indemnified party shall have been advised by counsel that there may be one
or more legal defenses available to it which are different from or in
addition to those available to the indemnifying party (in which case the
indemnifying parties shall not have the right to direct the defense of such
action on behalf of the indemnified party), it being understood, however,
that the indemnifying parties shall not be liable for the expenses of more
than one separate counsel (in addition to local counsel) representing the
indemnified parties in connection with any one action or related actions in
the same jurisdiction
29
arising out of the same general allegations or circumstances or (iii) the
indemnifying parties shall not have employed counsel to assume the defense
of such action within a reasonable time after notice of the commencement
thereof, in each of which cases the fees and expenses of counsel shall be
at the expense of the indemnifying parties. An indemnifying party shall not
be liable for any settlement of any action, suit, proceeding or claim
effected without its written consent, which consent shall not be
unreasonably withheld or delayed.
9. CONTRIBUTION. In order to provide for just and equitable
contribution in circumstances in which the indemnification provided for in
Section 8(a), 8(b), or 8(c) is due in accordance with its terms but for any
reason is held to be unavailable to or insufficient to hold harmless an
indemnified party under Section 8(a), 8(b), or 8(c), then each indemnifying
party shall contribute to the aggregate losses, claims, damages and liabilities
(including any investigation, legal and other expenses reasonably incurred in
connection with, and any amount paid in settlement of, any action, suit or
proceeding or any claims asserted, but after deducting any contribution received
by any person entitled hereunder to contribution from any person who may be
liable for contribution) to which the indemnified party may be subject in such
proportion as is appropriate to reflect the relative benefits received by the
Company and the Selling Shareholder on the one hand and the Underwriters on the
other from the offering of the Shares or, if such allocation is not permitted by
applicable law or indemnification is not available as a result of the
indemnifying party not having received notice as provided in Section 8 hereof,
in such proportion as is appropriate to reflect not only the relative benefits
referred to above but also the relative fault of the Company and the Selling
Shareholder on the one hand and the Underwriters on the other in connection with
the statements or omissions which resulted in such losses, claims, damages,
liabilities or expenses, as well as any other relevant equitable considerations.
The relative benefits received by the Company, the Selling Shareholder and the
Underwriters shall be deemed to be in the same proportion as (x) the total
proceeds from the offering (net of underwriting discounts but before deducting
expenses) received by the Selling Shareholder, as set forth in the table on the
cover page of the Prospectus, bear to (y) the underwriting discounts received by
the Underwriters, as set forth in the table on the cover page of the Prospectus.
The relative fault of the Company and the Selling Shareholder or the
Underwriters shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact related to information
supplied by the Company and the Selling Shareholder or the Underwriters and the
parties' relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Company, the Selling
Shareholder and the Underwriters agree that it would not be just and equitable
if contribution pursuant to this Section 9 were determined by pro rata
allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to above. Notwithstanding the provisions of
this Section 9, (i) in no case shall any Underwriter (except as may be provided
in the Master Agreement Among Underwriters) be liable or responsible for any
amount in excess of the underwriting discount applicable to the Shares purchased
by such
30
Underwriter hereunder; (ii) the Company shall be liable and responsible for any
amount in excess of such underwriting discount (to the extent not paid by the
Selling Shareholder); and (iii) in no case shall the Selling Shareholder be
liable and responsible for any amount in excess of the aggregate net proceeds of
the sale of Shares received by the Selling Shareholder; provided, however, that
no person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. For purposes of this
Section 9, each person, if any, who controls an Underwriter within the meaning
of Section 15 of the Securities Act or Section 20(a) of the Exchange Act shall
have the same rights to contribution as such Underwriter, and each person, if
any, who controls the Company within the meaning of the Section 15 of the
Securities Act or Section 20(a) of the Exchange Act, each officer of the Company
who shall have signed the Registration Statement and each director of the
Company shall have the same rights to contribution as the Company, subject in
each case to clauses (i) and (ii) in the immediately preceding sentence of this
Section 9. Any party entitled to contribution will, promptly after receipt of
notice of commencement of any action, suit or proceeding against such party in
respect of which a claim for contribution may be made against another party or
parties under this Section, notify such party or parties from whom contribution
may be sought, but the omission so to notify such party or parties from whom
contribution may be sought shall not relieve the party or parties from whom
contribution may be sought from any other obligation it or they may have
hereunder or otherwise than under this Section. No party shall be liable for
contribution with respect to any action, suit, proceeding or claim settled
without its written consent. The Underwriters' obligations to contribute
pursuant to this Section 9 are several in proportion to their respective
underwriting commitments and not joint.
10. TERMINATION. This Agreement may be terminated with respect to the
Shares to be purchased on a Closing Date by the Representatives by notifying the
Company and the Selling Shareholder at any time
(a) in the absolute discretion of the Representatives at or before any
Closing Date: (i) if on or prior to such date, any domestic or
international event or act or occurrence has materially disrupted, or in
the opinion of the Representatives will in the future materially disrupt,
the securities markets; (ii) if there has occurred any new outbreak or
material escalation of hostilities or other calamity or crisis the effect
of which on the financial markets of the United States is such as to make
it, in the judgment of the Representatives, inadvisable to proceed with the
offering; (iii) if there shall be such a material adverse change in general
financial, political or economic conditions or the effect of international
conditions on the financial markets in the United States is such as to make
it, in the judgment of the Representatives, inadvisable or impracticable to
market the Shares; (iv) if trading in the Shares has been suspended by the
Commission or trading generally on the NYSE on the American Stock Exchange,
Inc. or the National Association of Security Dealers Automated Quotation
National Market has been suspended or limited, or minimum or maximum ranges
for prices for securities shall have been fixed, or maximum ranges for
prices for securities
31
have been required, by said exchanges or by order of the Commission, the
NASD or any other governmental or regulatory authority; or (v) if a banking
moratorium has been declared by any state or Federal authority; or (vi) if,
in the judgment of the Representatives, there has occurred a Material
Adverse Effect, or
(b) at or before any Closing Date, that any of the conditions
specified in Section 6 shall not have been fulfilled when and as required
by this Agreement.
If this Agreement is terminated pursuant to any of its provisions,
neither the Company nor the Selling Shareholder shall be under any liability to
any Underwriter, and no Underwriter shall be under any liability to the Company,
except that (y) if this Agreement is terminated by the Representatives or the
Underwriters because of any failure, refusal or inability on the part of the
Company or the Selling Shareholder to comply with the terms or to fulfill any of
the conditions of this Agreement, the Company will reimburse the Underwriters
for all out-of-pocket expenses (including the reasonable fees and disbursements
of their counsel) incurred by them in connection with the proposed purchase and
sale of the Shares or in contemplation of performing their obligations hereunder
and (z) no Underwriter who shall have failed or refused to purchase the Shares
agreed to be purchased by it under this Agreement, without some reason
sufficient hereunder to justify cancellation or termination of its obligations
under this Agreement, shall be relieved of liability to the Company, the Selling
Shareholder or to the other Underwriters for damages occasioned by its failure
or refusal.
11. SUBSTITUTION OF UNDERWRITERS. If one or more of the Underwriters
shall default in their obligations to purchase on any Closing Date the Shares
agreed to be purchased on such Closing Date by such Underwriter or Underwriters,
the Representatives may find one or more substitute underwriters to purchase
such Shares or make such other arrangements as the Representatives may deem
advisable or one or more of the remaining Underwriters may agree to purchase
such Shares in such proportions as may be approved by the Representatives, in
each case upon the terms set forth in this Agreement. If no such arrangements
have been made by the close of business on the business day following such
Closing Date,
(a) if the number of Shares to be purchased by the defaulting
Underwriters on such Closing Date shall not exceed 10% of the Shares that
all the Underwriters are obligated to purchase on such Closing Date, then
each of the nondefaulting Underwriters shall be obligated to purchase such
Shares on the terms herein set forth in proportion to their respective
obligations hereunder; provided, that in no event shall the maximum number
of Shares that any Underwriter has agreed to purchase pursuant to Section 1
be increased pursuant to this Section 11 by more than one-ninth of such
number of Shares without the written consent of such Underwriter, or
(b) if the number of Shares to be purchased by the defaulting
Underwriters on such Closing Date shall exceed 10% of the Shares that all
the Underwriters are obligated to purchase on such Closing Date, then the
Company or the Selling Shareholder shall be entitled to one additional
business day within which it may, but is not obligated to, find one or more
substitute underwriters reasonably satisfactory to the Representatives to
purchase such Shares upon the terms set forth in this Agreement.
32
In any such case, either the Representatives or the Company and the
Selling Shareholder shall have the right to postpone the applicable Closing Date
for a period of not more than five business days in order that necessary changes
and arrangements (including any necessary amendments or supplements to the
Registration Statement or Prospectus) may be effected by the Representatives,
the Selling Shareholder and the Company. If the number of Shares to be purchased
on such Closing Date by such defaulting Underwriter or Underwriters shall exceed
10% of the Shares that all the Underwriters are obligated to purchase on such
Closing Date, and none of the nondefaulting Underwriters, the Selling
Shareholder or the Company shall make arrangements pursuant to this Section
within the period stated for the purchase of the Shares that the defaulting
Underwriters agreed to purchase, this Agreement shall terminate with respect to
the Shares to be purchased on such Closing Date without liability on the part of
any nondefaulting Underwriter to the Company or the Selling Shareholder and
without liability on the part of the Company, except in both cases as provided
in Sections 7(b), 8, 9 and 10. The provisions of this Section shall not in any
way affect the liability of any defaulting Underwriter to the Company, the
Selling Shareholder or the nondefaulting Underwriters arising out of such
default. A substitute underwriter hereunder shall become an Underwriter for all
purposes of this Agreement.
12. MISCELLANEOUS. The respective agreements, representations,
warranties, indemnities and other statements of the Company or its officers, of
the Selling Shareholder and of the Underwriters set forth in or made pursuant to
this Agreement shall remain in full force and effect, regardless of any
investigation made by or on behalf of any Underwriter or the Company or the
Selling Shareholder or any of the officers, directors or controlling persons
referred to in Sections 8 and 9 hereof, and shall survive delivery of and
payment for the Shares. The provisions of Sections 7(b), 8, 9 and 10 shall
survive the termination or cancellation of this Agreement.
This Agreement has been and is made for the benefit of the
Underwriters, the Company and the Selling Shareholder and their respective
successors and assigns, and, to the extent expressed herein, for the benefit of
persons controlling any of the Underwriters, or the Company, and directors and
officers of the Company, and their respective successors and assigns, and no
other person shall acquire or have any right under or by virtue of this
Agreement. The term "successors and assigns" shall not include any purchaser of
Shares from any Underwriter merely because of such purchase.
All notices and communications hereunder shall be in writing and
mailed or delivered or by telephone or telegraph if subsequently confirmed in
writing, (a) if to the Representatives, c/o CIBC World Markets Corp., 417 5th
Avenue, 2nd Floor, New York, New York 10016 with a copy to Latham & Watkins, 633
West Fifth Street, Suite 4000, Los Angeles, California 90071 Attention: Cynthia
A. Rotell, and (b) if to the Company, to its agent for service as such agent's
address appears on the cover page of the Registration Statement with a copy to
Quarles & Brady LLP, 411 East Wisconsin Avenue, Milwaukee, Wisconsin 53202,
Attention: Bruce C. Davidson, and (c) if to the Selling Shareholder to Blue
Cross & Blue Shield United of Wisconsin, Attn: Stephen E. Bablitch, Vice
President, 401 West Michigan Street, Milwaukee, WI 53203, with a copy to Foley &
Lardner, 777 East Wisconsin Avenue, Milwaukee, Wisconsin
33
53202, Attention: John M. Olson.
This Agreement shall be governed by and construed in accordance with
the laws of the State of New York, applicable to agreements made and to be fully
performed therein.
This Agreement may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if the signatures thereto
and hereto were upon the same instrument.
34
Please confirm that the foregoing correctly sets forth the agreement
among us.
Very truly yours,
American Medical Security Group, Inc.
By:
----------------------------------------
Name:
Title:
Blue Cross & Blue Shield United of Wisconsin
By:
----------------------------------------
Name:
Title:
Confirmed:
CIBC WORLD MARKETS CORP.
ROBERT W. BAIRD & CO. INCORPORATED
STIFEL, NICOLAUS & COMPANY, INCORPORATED
Acting severally on behalf of itself
and as representative of the several
Underwriters named in Schedule I annexed
hereto.
By CIBC WORLD MARKETS CORP.
By:
-----------------------------------
Name:
Title:
SCHEDULE I
NUMBER OF
FIRM SHARES TO
NAME BE PURCHASED
CIBC World Markets Corp.
Robert W. Baird & Co. Incorporated
Stifel, Nicolaus & Company, Incorporated
-------------------
Total 3,500,000
EX-23.1
4
a2077120zex-23_1.htm
CONSENT OF ERNST AND YOUNG
QuickLinks
-- Click here to rapidly navigate through this document
EXHIBIT 23.1
CONSENT
OF INDEPENDENT AUDITORS
We
consent to the reference to our firm under the caption "Experts" and to the use of our report dated January 31, 2002, included and incorporated by reference in the Registration Statement
(Form S-3) and related Prospectus of American Medical Security Group, Inc. for the registration of 4,025,000 shares of its common stock.
Milwaukee,
Wisconsin
May 22, 2002
QuickLinks
GRAPHIC
6
g371182.jpg
G371182.JPG
begin 644 g371182.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#'P,R-2\15"0V*"_]H`#`,!``(1`Q$`/P#?
MZ^$A())P!U-+U_UC;K&%,Y]HF#^@;/W?VCW?C697C5%TO9*9+Y0P3LPU[J/7
MQ]:Z-)LR:HZVC>)]$E45T<.6I6F736]EMA4CGF2\/T(_O8^)Z?6E*=VE3W24
MPH;#">Y3A*U?P%)%%=Z'9%-'\PQ'M]ER9=HS/T-AV*[?U?J"03Q7-U`/6F&`N9QS
M7?Z_NH']T?Q)HGJJ*EZMA?@`$14]3/GNTX4AB6^CKA^.,'U.#3Y(N5DT^UP.O18@']&@`*_=&]44KM*M+9(CQI3
MY'?PA`^IS]*XM1MF$Y&-O?FNW2;"JY!>,N/+(?HI*5N&II\+N5[_`'6>M:FU"MSA:NDQ:R?NI]X_
M+%,$#4&MD$$P'Y:/!V(1GU&*;YMYL.ED!A0;864Y2PPU[Q'C@?QI=E=IR`HB
M);%J'`>:C_#J::KMM%[+1]4;^*SH-D.?*&GK..@4ZZWJWV"&');@;3C#;:!
M[RO)(_R*S6]Z\N=R4IN(HPHQVP@^^H>:N[TI=FSI5QE+DRWE//+ZJ5W>0\!Y
M5'Z"O)RU+GY#(+Z10;#AIP'2]9W@.07TDJ45$DJ/4DY)JSM&GKG>U_R..2T#
MA3R_=0/7O],TT:5T)[2A$Z[H(:/O-QCL5>:_+R^=:!(DPK1!+KRVH\9H8\`/
M(#^`JT5,2,3\@L:_;HC=T5,,3N.[NXI/MW9G$;2E5QEN/K[T->XGY]3]*OF]
M+:=@HXOLZ,`/TGO>^JC2A>NT>0ZM3-H:#+?3GNIRL^83T'KFDR9/ESW"Y,E.
MOJ\7%DX].@JQEA9DP76$>S]I5?6J)2T
$D-
MI^F_UK1DDKLPT`).II-GPG#),YSAPS_?NF%\674,;D.+BS&^H"5A1'F,'(-+
M![,89G<8GO"(=^5PCC^'%X>E7"-":=1@B"KB'Z7.7GYYIB0@-MI0G/"D`#)S
M6O1A_P#(`D!6.ILJ21UCQ`]SZ*EA:0L4$#EV]IQ0_3>',)^=6B8,1"2E,5A*
M2,$!L#^%2**T#6C0)-\\LAN]Q/,JKE:CXV2][RT_!74CXY/G4ZBIPB]U!F>6X2;A%%%%2LT4444(11110A%%%%
M"$4444(11110A%%%%"$4444(11110A%0;M(MT>`I5T6RF*HA"N<,I)/=4ZLP
M[2+KS[BQ;&U>Y'',<`_75T'H/QIJCIOB9A'NW\EA4S]!'C&NY3;YV=MN),FR
M.!.1GV=Q7NG]E7=Z_.N6C-&N"4J?=HZD[1;+;URY:
ML(&R4C[RU=P'G6-WR_3;],+TE9#23^:9!]UL?Q/G3GKK3UZN4H3(ZO:8S:<(
MCH&%-^)`_2S\_*LY4DI44J!"@<$$8(-(U4CKX=`O0[!I*<1],"'/\NS\_9?*
MTK2.B&V$-W"ZMA;Y`4W'4-F_`J'>?+N^-5?9_IY,Z4;K)1EEA6&4GHI?CZ?C
M\*U&K4T`MC.&V4%:O2L_L%A7J"R7BY2T
M_P`IN"E7%@?`58Z_FNR/8K!$.7YC@*P/U8M.C1XG\+*-#W15KU(AATE#<
MG\PX#W*S[OUV]:U_.U9!KFUFUZD6^U[CE^Y1M-ZGL[EU=6(Z$%2?;.'@4"-MP?O#R-4&N=-6NRP8LBWL%E2W2VH
M<94".$GO/E7O1^GOMZV)7<77#;X[J@U&0>$+7U4I1&_?BLC0TSJ43%QM?AY#
MCWK:*OJHJG#'DX#7AW*WM>L=-6F#'M[+[Y;92$\SD*`4>]7J=Z;8G.7#D@O8SRE@I5CR!Z^E06M!:?;C6`D!Z.YGW@//'>""**>EI*F\<;B'=MK%1-45$-
MGO`P]BVNN,J7'A,*?DO-LM)ZK6K`%<(
MUO-@X+C;!X?F<5:6G4=KO>1"DA3@&2TH<*P/'!JR0TVAH-(0E+8&`D#``\,5
ME&L[>G3^I&)5M_D_,3SD!&P0L'!QY';;S-;TT$%4XQ-!:[=G?[Y!9S2S0#&Z
MQ&_*WJM7<=0TGB<6E*1U*C@55KU/9TSV829S;LAY80E#1X]SXD;"HJK;;=7V
MFWS)K2E`M!:0E93@J`ST\Q67MARSZK*(;?-[:JM-E>#,N0><1GEMI*E`>)QTJ3"OEOGVY$YN0E
M#"R0%.G@Z'!ZTHO]G*Y,5V0_=3K9HN%(T_"9O$,^UM
M(4DX<(*,K)[C@]:J^*C$8(>2;YY>0-O-6;)4EY!:+6R_RK=O55G>NC-OCRTO
MONDI'*!4D$#.ZNG=5U6,Z-:_TSA(S]QQ>_CA*JT?5M_^P;1S&N$RG3RV0KH#
MWJ^`_P#RIK*$13MABS)'NHIZLOB=))D`597&[0;2QS9TEME/=Q'=7P'4TO'M
M'L7$0!+4!WAK;\:@Z2T\W=XWVY>LS9#ZB6P]N$I!QG'3??;H!3-+TS9IK/*=
MMT<#&`6T!"A\"*J64L+S')=Q&I%@.[CX*P=42-QLL`>*Z6F_6Z]H6J#(#A1C
MC004J3GID&NUPNT&U,\V=);93W<1W/P'4TL:&M9MDV^-<*^%$D-(4L$<24YP
M<]_6BT:55*N]QN%^8YZR^4QDO*XP$9)!QG&.@`\JK)!`V5W6.$6YFZEDLSF-
MRZQOR%E)':'8"O'-?QG'%R%8J_M]SA72/SX4A#S?0E)Z'P(ZBJNY:/LMPC*;
M$)F.X1[CK"`A23X[=?@:SW2#\BTZR:B$D<;BH[R1T.,[^A&:W;2T]1$Y\%PY
MN=C99.GFAD:V6Q!X+7'I+$=/$^\VTGQ6H)'UJ!#U#;+A<%08Z=]5VI-+6VYLRI[S2S+#!X%!P@`I!QMTK.M(L39EW,6%(,8OLE+KR1E
M2&]B>'S.P]:K3444T#Y,1NW[>MU,]3)'*UF'(K2[CK.RVR2J.])*W4'"TM(*
M^$^!(VKI:]66>[NAF-*`>/1IQ)0H_#/7TJ,UH33[<<-*A%Q6-W%NJXCYY!K/
M-5V`:=NS:([JRRZGF,J)]Y!!W&?$;;UI34U'4GHF%P=Q-K%5FGJ81C<`6K9Z
M*KK#-7<;%"EN?ZQUE*E?'O\`K5C7*7'$M-J<6H)0D$
MJ)[@*]4G]H5X$&R>Q-J_/3"4D#J&Q][Y[#UK2"$S2-C;O5)I!$PO.Y+EN:O.
MIM1S+Y;'&&BTOA:5(&0$D8``P=^'\:8_8M=?^Z6W_E_]M6VE;7]D:?C1U##J
MD\QW]I6Y^6P]*NJH_"M,6E*TE*@"",$'
MOK$;BP]IG5+B6=E17@XSYIZCZ;4[1R_&0OIG``ZBPM^YI:IC^&E;,TD[BGOM
M+`_)^,<#/M2+%<.S\(-D^&4XK,[)/>TMJ8*E-J3RE%F0
M@=>$]2/H13M$<44\;0"Z][<4K4Y/B>[2R?Q`UKD9O5O`[S[/_A4"YZ,O=\=9
M70ZTL92M!R#7R9.BV^.J1+?0RTD9*
MEG'_`)KELJYF/Z@`=V-%_)/NIHW-ZQ)',KA9K;]D6B-`YI=Y*>'C(QG?/3UK
M+HB0KM,`(V^T5GY*4:UUIU#S2'4'*%I"DG'4&L@BKQVDI4D@@W)0^:B*ZN,NFL>T;_/B-^V[_P!*JMNTY:OM
M"W-D^Z&EJ`\^(51Z25G6D%0.Q>6?FE5-W:3:UR+?&N+2>+V8E+N.H0K&_P``
M1]:]1,YK-HQ%W]ONN#&"ZC>!Q]E?Z04E>D[:48P&0-CW@D'ZU=UG/9]J-AAE
M5HF.);/&51U*.`<]4Y\<[CXUHN:JDXTS=4QW$EY#!XDI5ND'KD=
MVV:3>S1^,U=)C3B@F0XVD-9/4`G('TIBDIV?#OJ'C%AT'J5E43.Z9D33:^],
MC5HU5-3F=?D1`?Z.(R"1_>-(]I:,?M#994ZMU385G
MC%Z6Z$D[(;3NM9[@D=2:RJSO+D=H##SC2FEN35+4VKJ@G)P?A3>SWR/CE<0`
M,)T`'^4M5M8U\8!N;C>2MM7K..T]!#]L7G8I<&/5
M-:/6;]IZC[3;$YVX7#]4UCLGZMG?Y%:;0^G=W>:;=(?S2MG]@/Q-7=4>CE!6
MDK:1_N(D5>4I4_S/YGS3$'\3>04>='=E0G6&9*XSBTX2\@9*#XBDZ9V>.7
M!\OR[](?=(QQ.-`G'AUIV=;2\TMM>>%0*3@D''Q&XK/[3/DV;6+T=]UXVZ5(
M\8M3R'DKT]&.@?*#8-[[Z#PN/NFN[095P
MBI:B7%V"L+"BXTD$D8.V_P#G:E25V=+G2%2)=\D/.JP"M;0)('K3-^45HYZ6
M?M!CC4O@'O;%7@%=,^M394R-"8+TI]MEL?I+5@?#XUO#620C^FZW-*S40>
M0)&G/FDU?9TTJ.W&7>9990HJ0V4IX4D]2!4RV:.G6A(;AZAD-LE86IL,)PKQ
MZG;.*@OR;=<=>69ZW2P]Q%U3W"X5`*"=MB=MJN(3;*]82Y;6H%2>8P$BW)6%
M(:X2`5;'KGRSN:#M.>0%I-Q?@/OHMW[)BBL[,'#??QM;7LWJ5=[1<+B]F->G
MX3);X%--M)5D[Y.3N/\`"EV+V<&%);D1KV\T\V8[J]/7RUQX;4MVSTE6F`223SW-R6BW=0M?3N+_P#:0+'MOOO?,D>!'>*@2GQ==:.VF9)4U#CQTK2PATHYZU>)&"0!W
M59Q;)]GWM,F(Z\B(IE27&"\I2>/(X5`'/=FI%9*9.D:<^(L/)#Z")D88\ZB]
MM1V9W2JUV>72$X50KX&@>I0E:"?D:MH6@V/:$R;O.?N3J=PETD('IDD_.K^7
M?+9!=4U)F--K2,J23DI'B<=/6I29<=442DOMF.4\0=XAPX\<],4P_:4[\B[/
ML`!^^J4&SXV`.PFQTO>RK[I;)\UQLP[P[`0E)2I#;25<1\=^E+`[-`E\/B]/
MAT*XPL-#BXLYSG/7-,[&I[)(>Y+5SC*7@G''C8=3O4MBZ0)33SK$MEQMDX<6
ME8*4G&=STZ5G#72Q##&X#N'LM)J#$;RL/?=0;3:+A;WU+E7N1.;*S7EZ$UR^!3;;25<1\%2F[S;7677D3XRFFE<"W.8
M.%*O#/2N2=06E;C#:;A'*GP5-`+^\!G)^&Q^59_$''CN+\AY:*XI'8<&$V[^
M:5H_9M[+(;?8O3S;K9XD+2R,@_.FNW6Z3'BNLSYZKAS#U=:2G"<8X<#8BJ:T
M/QK3%O$@ZC^TQS2[EYT<+.02E`.<;^7RKI8M709=F9D7*X0F92LEQH.!/#N<
M#!.>F*F6ODFL)3Y>:T;LOHKNA:2`0-^\7T*J[IV:Q)#JG+?*5%"M^4M/&@?#
M?('SKE'T)>D)#*]1.H8[TME?3X<5.'VW;?8O;/;6?9N+@YO%[N?#->7[S";L
M[UT;>0[&;0I7&@Y"L=P/QVI@;3J`W"77Y@%*?Z8PNN&$7-MXSX*-9M,P++$?
M9;"WE2!A]QX\1<&,8/EN=O.EF9V9-JD%<&XEIO.4H<;XBGX$$5:V2#(U!#1=
M;P\ZI+_OL1&W%(;;1G;(!'$?,U+F:=2VJ.]:W'XSJ7T%P(D*"5MY'$""2#MF
ML8MH5+"9&'7Q[DS+LZFOT+SF.S('G>_@N=@T;"LJQ)=69)++
MK#^JI2V74\*D>SH&W>,C?>H,+L\[K33%O5NF!TL3
M&5\G=P<6"@>)!Z5[CW2#+0\N/+9=0P<.+0L%*=L[GITJ6U\P:6M<+'L&?@H?
M0-O=S3<<\E[M\=^+"0S)EJENISQ/+2$E6_@-O*J/4ND4ZCDL.KFK8Y*"D)2V
M%9R6VK@4OFCA"L9QGQQ7)[4UECAHO7*,CG("T97]Y)Z'
MX5A'4NB?TC#8]RV=1ND;T982.]0+/IB=9U,-MWY]<1I7$8Y93PJ'AGJ*9:BK
MN,-#;3BI#?`]_JU`Y"N_8BN2KU;$XXI\<92%#+@W!&0?4$42S.E=B><^X>2K
M'3E@PL!\2I])$VU?;=DOB&@1(9N+KK![^-(3MZ[CY4Z/-EYE;86M'$DCB0<*
M3YCSJMMUB9MC[CK$F6KFJ*W$N.\25*.,J(QUVK%[<66Y-TTW0W>#9V5NY+]G
MN:M6OVWB20U!2'Y0(V4_N$#Z%7RJGDO.M0-;+840HRDI*DG<`D@_3-/<6R1H
M,>6S%+C/M3JG5J;("DJ5X;;8[JB1M*0(KKZT.RE"029"''>)+V?^
M->(>?R_1#G.!Q*`\>M6;&CX49!99EW%$4DDQDRE!O![MM\>M
M2+KIFW7=;#CR7&GF`$MNL+*%I'AFIP.R.]4^+BNYA)PF^[,$VSU[+'L53$!+':'/]F:2A2;9Q82,`JR#G\*LOR0MP>8D
M)_;=
M'Q,(;AN3U"W3?!TSI"39US;@>W/,#3]LJC2R%L:JU&R
MLM`CEE09!2CBP1!^?
M7&G,X-W]H(*AW2Q67
M4,QQ$ELF5'2D*6A12I(.2-^_OJB8MTC3FL($.WS9+\:2TXMQAY?%PA(.#\\;
MTR2M.QY%S7<&Y4V-(6D)6IA[A"@.F0014B!9HUO>*HRKZ./!B+FVMA.ER/0YBR4]%FXRK)(4U[$M3LAPR.?Q%:E'
MKQ8\JB2[8[86K!:I\A+T%R>I;H`(1C;A20>X$DTTN:3@^W/3(K\R$Z\RO
ME`6?$BI,C3MNEVK[.?:4XQQ$MPE?%^MQ'?.]5Z)V&V\)@U\73%X^5QN1;,
M9$:WW7R]%)D6V)*?COO,I4MCBXUO%(P"/N[8J7HRR6
M]W35MFN1D+DX4YS2/>S[R<9\,;8Z59,:3A1&GV8LB6PS(45.-MN@)5G;'388
MVVQ4NVV1FU0U18K\D,\/"A*G.+E]?NY&W6JLC((N-%M45C'M>(W'K$'N`(-T
MM6)IL2M7MAM`0E\\*0D8'NJZ"I>F[9'N79]$C.MI_/1U)XN'<'B.#Z5:PM-Q
M($B2\V[)6J5DOAQWB#A(.Y&/,]*YVZR6_3@XFY6DDYPD'`R:&
MQD6OVHFJF/#L!-[M(RX"WY2W;9CT_3;.FUJ*9HD&$_ONEI.ZE?N^[\33-J2W
MJD:4F0HC8!#.&VTC]7!`'RQ42PPHTF^W6^,('`\L,M+'182`%J'D5#']VF6I
M8R[;'EW+.JJ`V<.C%K'%;_L;$_;1+NBKBS/TS%2VH?\*E/Z6M[D]4Z.J1"DJ^^N([R^/XCH?E7Q6E
MXCTAEZ9*FS"RL+;2^^2E*AWX`%%GX<*.DIC,93FTW-B/6_'>J-ZW1)':6EI^
M.TM`@\PHX1PE>>I'?ZU[B-,1>T1$`-AN/&@D1&^Y))RHCSZ_*KLZ:C&Y_:)E
MS?:^'@YG.Q[N<\.,8Q7:Z6&+=7F)"UNL2F#^:D,*X5I\O,>1J.C.O;=:&L8;
M-)-L.'D>/IR)5#J*.$:TL#S*`77RMIY./OMCKGQ&":]:'0WR[VT4IX/;W`48
MVQX8\*OH=F8BRS,<=>DRRG@#SZ@5)3X````?`5";9?
M*$.>.0/&C`0[$%'Q4;H>@<3D`+VX$GUL$N6QJ,[9M8!*4*;#[Q0`!P@!)P15
MWIZUVY6CHH?C,EMZ.%O*4D$J.-R3_G%?)NGX=GLMX=AJ=;2\PZI;7'[A)2<;
M8VQW8J+IS3,:1I^$X[*G+8>92MR*7SRB3U]WP\LXJK6D.`MN]5O-,R6)SP\@
M8ASR;S7W1,%;^EX_-6L-ID.N,'Q004CTW)J7^1%M[RXKPR1L.X?`=*9&VT--
MI;;2E*$C"4I&`!X"O5:B-H:`5SY*R1TKI&&V(W11116B411110A%%%%"$444
M4(11110A%%%%"$4444(11110A%%%%"$4444(15%JMAF1;&D/M-NHYP/"M(4,
MX/C116BBKMT"6D^=W-%%%%2
MJ(HHHH0BBBBA"7M6)"XD=M8"D+<(4D[A0X3U%&DT);BR&T)"4)6`E*1@#;N%
3%%8_\O
GRAPHIC
7
g402348.jpg
G402348.JPG
begin 644 g402348.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#+_V@`(`0$``#\`W^OEQQ#+:G'%
MI0V@%2E*.@`/))K*Y/4J_95=GK7T\M#
M[=;6W%M6I:&U2M@H=4KNWV_8%)Y]:M-*4I2E*4I2E*RWK'EUF1B=QQEN<7KU
M-0EMJ)%!<Y
M]6K;B>/OI:BPD_-7=X(2O:?^WSX\I''.U#VK2*5QW)[PCN'<1O6^=5S6>Y]_
M.4+M%.&?)F"6=/!T-]P<[CS]?IK6M>QW5"Z>M9?DW5J1*R&\+D#'NY+H96/@
M_$4"@(2$@)]R3K?TUH/5[*5XS@LA,51_:-P/R<8(_%M0^I0_)._U(J0Z;8BU
MAN&0[>6TB8XGXTM8'*G5;D5_+L:':V
M`5K43H)2"1R37?M\UJY6Z-.8[@S):0\CN&CVJ`(V/0Z-1L/*;=/RJXXZP7#.
MM[3;KQ('9I?@`[\C8WQZBH7/NH*<'$%`LTRY/2^\I2QPE(3K>U://.]:\`U7
MK5UNB.W>/!OV/W&R(DJ2EF1(^ILD^-GM&AR.1L?I6J[/M67=9LKNEHBVBP65
MXQIM[?+/S0)'PD;2DZ(\$E8Y'(`-1=N?POIH^8,)^-)Z97-,<)*B6I(6L#_"$[W]JLV&9[:,WAO.V_XS,B
M.H)D1)"0EUH_<`G8X//V]*S/J;U?DQKHBUXR\I$>'*0F?<4([D=V]_"!YX^E
M6_?1`\&M8O.7V2Q8W^WYDYOY!2`MI:""7MC:0@?UB152QCK':+S;KQ-NT=5F
M1;2A13(7W*<;6"4$#0/<=?A&_(UNI+&>I]ER+%[GD*T.P(%O>4VXN01L@`$$
M:]3L#7G?'-5[&^J=ZO>5VU,FQHAX[>%O,VV0M6W5K;&^Y7U>#K6M>3P3JJ7U
M+G=0L90)MUS6.PY('XDFR7%MAITMET*05\'1V@ZU^6ZA<9ZD1+YU-N5]$2XSIKK28%HML
M=OE+.P5+6HGM3R-D\ZV?85Z`'BHS([F+-C5SN95V_*Q7'@=;Y2DD?ZZK->D[
MUMQ'I.K)+O,#9GNNS)#KI^I1"BD)']HGMWKSM59R]U,MV4=1&\CR)*V[39VU
M.VZW)'TI+;;?\`6[3P20-G?@:]:F\P
MZBQ,;O5JL42.+A=Y\AMOY9"]?"0H@=RCHZ^P_,^*[&<]1+-@D%#DY2GICP/P
M(;1'>Y]S_93]S^FZJD_KO8HN%0[PRT'[I*!2+8E[ZFE`Z5WJUPGV.MG8T/.K
M_;,DA3<0B9')6B)$>B(E.%U6@T"G9V?MXK"AK8[*?M<1V_P#+6KM-HCQT-H`#;:0D#V`&O]JRKHV57FZYAE:T
M<7&XEME1Y(0C9UOVTI(_2OVZ[Y.FRX,NUH^,F5=MM(6@?2$)*2L$^FP=:]=F
MJ3C]JO'5"+C=L;AO6_$K&AOOD/\`])*<2!W=O^H&N`"23O0KT3S6+=>(IOLO
M&;!;&%OW]Z0MR.$*[>UOM^HDGQR`=^G::Z>%WVX=,[/^S[WT_NB'>Y2GKC";
M#Q?).P5'_P#6OM5J'5*X79@IQS!K]+D'82J6TF.T/S62?7TX_.J._A/4N)?9
MUSA18B+GD2%(F28[P"(*%*!*1L[[M`?4`?MSS7?ZE8-^ZW2&)9K!!>E`SVW)
MSJ&^]QT]JOK.N0.[M`UXX%2N)81=,BD1//=A=`T";<&
M)]]D*L:WEO18+!*0%D:"ECQM/C@_9#CJHJIJ]1
MDJ6-%:/J&]Z!X_6K7E?2V:Q@]_R*_P`M=\RA;*5)4G?PXZ0L=WPT^ND[]``/
M`%3=@ZH,3;!:K%AMDE3+HF,TR4.-%N-$TD`EQ?J!YX\^^ZUMH.!E`>*5.=H[
MRD:!/KH>U8OU]LF.0L7-V-I9%YER4,MRF]H5OE2E*UPKZ4D<\\_:K'T2L:+9
MTYM\EV$RS+E=[JG`V`XMM2R4=RO)XUK[:K2*Z=VMD:]6B7;)B2J-*94RX$G1
M[5#1T?2L`R?"<,Z9,L2KO<9M\EH!5;[2\H);4=_B6!X1OSXWR-'FNO;.CC^0
M=+G+ZTVG]X9[GS<=K?8@,[.D`>`5`[!/]T<,7P6\Y),M]TSV%&;BVN,F/
M;[.`%(!``+C@!().A]/Y>-K<>X81CK:4OP_AQULL`,-+*"A:E:
MTE)&]\\'CSXJ-N6"9E@V763(8++F1WB3\54A?PE+;0^H$-@?EH<56.GO2`.].;D[MMM,V))MT%OO1%2.[X:=#@J*D@D[)/DDUL%N
MSS,'YMEG4[YNVA4,6J"TJ).
M.VVG'1]1"#SHE2E>^@GGS5EAL]44XQD3E[<@ORE05-P(T1*0LN$:*MC7IX'J
M?;UIN*XMU@Q.QI@6?Y%,:8GXG8^X@JAJ)Y.CX.AR/J'/C=6;JU9KU=L1Q6V/
ML.SY2K@PF]:%JN=4I2E*:I7RE"4;[4@;.
MSH:KZKJ7&UV^[L)8N,*/+92L.);?:"TA0\'1]:[0`2D)2``.`!7-5;/WEM*E2"EWL=6
M22?4;`2`->/2O0&J4I2E*4I2E*4I2E*4I606-@]0.L5QOLDI7:<;48<)HG84
M_P`[7K['9W_A]J^[O_U+_*'M,#:C'L$(RG$[V/B*Y'Y'ZF_X5KE*4I2LGQ92
M,KZJY'E,L@P[&?V=`).TI(W\1?Y^3_F^U=SH\GY]C);YSDRCW)=FB(PK>_H1O\`]!%:U2E*5\N%0:44C:@#
MH?>O-V)9+KIH[B-G23E%ZN+T=:`G1;2K7>ZL^P1L;^Q]J]`8[9(^.8]`L\7^
MAB,I;!UKN/JK\R=G]:DZ4I2E*4I2E*4I2E*4KA0"DD$`@^0?6O/,6\/=%\AR
M>R36G1;;@TY*M3S:?+FB$)'\0D^Q2#X-:#T0M)MG3*$\M.GI[CDI9(Y.SI)_
M\4@_K6C4I2E*@[?AV/6N]R+S!M,9BXR"2X^A/)WYUZ#?KK6ZG*4I2E*4I2E*
M4I2E*4I2H3*K;`N=B>;GPHTMM&E)2^TEP`[\@$>:EH[3;$=MEEM+;2$A*$(&
4@D`:``'@5^M*4I2E*4I2E*5__]D_
`
end
-----END PRIVACY-ENHANCED MESSAGE-----